<html xmlns="http://www.w3.org/1999/xhtml" class=" js flexbox flexboxlegacy canvas canvastext webgl no-touch geolocation postmessage no-websqldatabase indexeddb hashchange history draganddrop websockets rgba hsla multiplebgs backgroundsize borderimage borderradius boxshadow textshadow opacity cssanimations csscolumns cssgradients no-cssreflections csstransforms csstransforms3d csstransitions fontface generatedcontent video audio localstorage sessionstorage webworkers applicationcache svg inlinesvg smil svgclippaths"><!--MODERNIZED PAGE--><head id="coid_website_head" profile="http://www.w3.org/2005/10/profile"><style type="text/css">@charset "UTF-8";[ng\:cloak],[ng-cloak],[data-ng-cloak],[x-ng-cloak],.ng-cloak,.x-ng-cloak,.ng-hide{display:none !important;}ng\:form{display:block;}.ng-animate-block-transitions{transition:0s all!important;-webkit-transition:0s all!important;}</style>
	<meta http-equiv="content-type" content="text/html; charset=UTF-8">
	<meta http-equiv="X-UA-Compatible" content="IE=edge">
	<meta name="description" content="View on Westlaw or start a FREE TRIAL today, Abbott Laboratories v. Sandoz, Inc., Cases">







<script>
	

	(function () {
		window['$$errors'] = [];

		//handle js errors (it will be overwritten in GlobalPageHandlers.js. And any error will be processed when this script is loaded on the page.)
		window.onerror = function() {
			window['$$errors'].push(arguments);
		}
	})();
</script>




	<title>Abbott Laboratories v. Sandoz, Inc. | Cases | Westlaw</title>

	
	



	
	
	



	




    
    <link href="https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/utilities.css" type="text/css" rel="stylesheet">
<link href="https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/core.css" type="text/css" rel="stylesheet">
<link href="https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/components.css" type="text/css" rel="stylesheet">
<link href="https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/features.css" type="text/css" rel="stylesheet">
<link href="https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/document.css" type="text/css" rel="stylesheet">
<link href="https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/print.css" type="text/css" rel="stylesheet" media="print">
<!--[if gte IE 6]>
<link href='https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/ie.css' type='text/css' rel='stylesheet' />
<![endif]-->


	<link rel="shortcut icon" type="image/vnd.microsoft.icon" href="https://ia.next.westlaw.com/favicon.ico">
	<link rel="apple-touch-icon" href="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/v2/iphone-webclip-icon.png">
<script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="//ja.next.westlaw.com/StaticContent_40.1.1015/webpack/Products/WestlawNext/js/bundle.923c80f054c89ca796f84c4fbed803b0.dll.js"></script><script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="//ja.next.westlaw.com/StaticContent_40.1.1015/webpack/Products/WestlawNext/js/bundle.e94d5ee75e94c1087b529e979a552bed.dll.js"></script><script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="//ja.next.westlaw.com/StaticContent_40.1.1015/webpack/Products/WestlawNext/js/bundle.83634f9482d1ddf27e96c8f1d9498ac3.dll.js"></script><script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="//ja.next.westlaw.com/StaticContent_40.1.1015/webpack/Products/WestlawNext/js/bundle.82967e6fecb235c1f97c6591de01f9f7.dll.js"></script><script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="//ja.next.westlaw.com/StaticContent_40.1.1015/webpack/Products/WestlawNext/js/Website/Views/Document/DocumentTabView.bootstrap.js"></script><link id="Markman_MarkmanDisplayState"><link id="Markman"></head>



<body class="co_t2Left co_docDisplay">
	<div id="co_pageContainer" class="co_bodyToolbar">
		<div id="co_mainContainer">
			











<div id="co_headerWrapper" class="wlnv2 ">
	<div id="co_newHeader"><div id="co_privacyPolicyContainer"> 
	<p id="co_privacyPolicy">
		<b>We've updated our Privacy Statement.</b> Before you continue, please read our new <a id="coid_website_privacyPolicyLinkOut" href="javascript:void(0)">Privacy Statement</a> and familiarize yourself with the terms.
		<button type="button" id="coid_website_privacyPolicyAcknowledged" title="Close message to acknowledge privacy statement" class="co_absolute">
			<span class="icon25 icon_close_x"></span>
		</button>
	</p>
</div>
		<div id="co_headerContainer">
			<div id="co_newHeader_top" class="headerContent" role="banner">
					<div class="skipButtonContainer"><a href="javascript:void(0);" data-jumpto="co_docHeaderTitle" class="co_tbButton skipButton">Skip to Document</a><a href="javascript:void(0);" data-jumpto="co_footerLinks" class="co_tbButton skipButton">Skip to Footer</a></div>
						<ul id="co_mainNav" class="co_inlineList" role="navigation">
							
														<li id="co_kmFirmNameContainer"></li>


	<li id="co_clientIdContainer" class="navigation_link co_menuListFirst"><div id="co_clientID_title_0" class="co_dropdownTabCollapsed"><span class="co_clientID_label" id="co_clientID_label_0">Client ID:</span><span></span></div><div id="co_clientID_list_0" class="co_clientID_list co_hideState" aria-hidden="true">

<div class="co_dropdownBoxExpanded">
	<div class="co_dropdownBoxHeader">
		<span></span>
	</div>
	<div class="co_dropdownBoxContent">
		<button id="co_clientID_close_0" class="co_overlayBox_closeButton" type="button">Close</button>
		<div class="co_dropdownBoxContentRight" id="co_clientID_content_0"></div>
	</div>
	<div class="co_dropdownBoxFooter">
		<span></span>
	</div>
</div></div></li>
									<li id="co_recentHistoryContainer"><div id="tabIndicator" class="co_dropdownTabCollapsed"><div class="co_dropdownTab"><a href="javascript:void(0);" class="co_dropdownBoxanchorLabel"><span class="icon"></span>History</a><button class="co_hasTooltip co_dropdownArrowCollapsed" title="Recent History Menu"><span class="th_simple_icon icon_down_arrow reversed"></span><span class="co_accessibilityLabel" aria-hidden="true" id="coid_dropdownAriaLabel_1">History Menu</span> </button></div></div><div class="co_dropdownBoxCollapsed" aria-hidden="true" aria-labelledby="coid_dropdownAriaLabel_1"><span class="co_accessibilityLabel">Beginning of history window.</span><div class="co_dropdownBoxContent"><div class="co_recentResearch iac-a11y-header-redesign" id="co_recentResearch">
	<div class="co_recentDocuments co_floatLeft">
		<div class="co_globalNavDropdownBox_header">
			<h3 class="co_recentDocumentsHeader">Recent Documents</h3>
			<a class="co_floatRight co_recentDocumentsAll" href="javascript:void(0);" id="co_recentDocumentsLink">View all</a>
		</div>
		<div class="co_scrollWrapper">
			<ul class="co_recentDocumentsList" id="co_recentDocumentsList"></ul>
		</div>
	</div>
	<div class="co_recentSearches co_floatRight">
		<div class="co_globalNavDropdownBox_header">
			<h3 class="co_recentSearchesHeader">Recent Searches</h3>
			<a class="co_floatRight co_recentSearchesAll" href="javascript:void(0);" id="co_recentSearchesLink">View all</a>
		</div>
		<div class="co_scrollWrapper">
			<ul class="co_recentSearchesList" id="co_recentSearchesList"></ul>
		</div>
	</div>
	<div class="co_clear"></div>
</div></div><button class="co_overlayBox_closeButton" type="button" title="Close history menu">Close Recent History window</button><span class="co_accessibilityLabel">End of history window.</span></div></li>
								<li id="co_signOffContainer" class="">

									<div class="co_dropdownTabCollapsed">
										<div class="co_dropdownTab">
											<button id="coid_website_signOffRegion" class="co_dropdownBoxanchorLabel co_hasTooltip iac-a11y-header-redesign" title="Settings &amp; Sign Off">
												<span class="th_simple_icon icon_user reversed"></span>
												<span class="th_simple_icon icon_down_arrow reversed"></span>
												<span class="co_accessibilityLabel" aria-hidden="true">Settings &amp; Sign Off</span>
											</button>
										</div>
									</div>
									<div class="co_dropdownBoxCollapsed co_globalNavDropdownBox" aria-hidden="true" aria-labelledby="coid_dropdownAriaLabel_0"><span class="co_accessibilityLabel">Beginning of profile settings window.</span>
										<div class="co_globalNavDropdownBox_header">
											<h3 id="coid_dropdownAriaLabel_0">Profile Settings</h3>
										</div>
										<div class="co_globalNavDropdownBox_content">
											<div class="co_signOff_profile">
												<h4></h4>
												<ul>
													<li></li>
												</ul>
											</div>

											<div class="co_signOff_links">
												<ul>


	<li>
		<a id="coid_website_mycontent" href="/MyPlan/Show\?transitionType=Default&amp;contextData=(sc.Default)">My Content</a>
	</li>


													<li>
														<a id="coid_website_userSetting" href="javascript:void(0);">My Preferences</a>
													</li>
													<li>
														<a class="co_signOff_updateProfile" href="https://onepass.westlaw.com/v2/profile/general?productid=CBT&amp;viewproductid=&amp;returnto=1.next.westlaw.com">Update OnePass Profile</a>
													</li>
												</ul>

											</div>

											<div class="co_signOff_buttons">
												<div>
													<button type="button" class="co_primaryBtn js_website_signoff">Sign Off</button>
												</div>
											</div>
										</div>
									<button class="co_overlayBox_closeButton" type="button" title="Close profile menu">Close Profile Settings window</button><span class="co_accessibilityLabel">End of profile settings window.</span></div>

								</li>
						</ul>

			</div>
			<div id="co_newHeader_bottom" class="headerContent">







<div id="headerLogo" class="" data-compartment-start-page-id="">

	<a id="coid_website_logo" href="/?transitionType=Default&amp;contextData=(sc.Default)" tabindex="1" class="co_hasTooltip">
		<img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/v2/logo.png" title="Westlaw Home">
		<span class="co_accessibilityLabel" aria-hidden="true">Westlaw Home</span>
	</a>
</div>







<div id="coid_website_searchWidget" style="display:none;"></div>
<div id="co_headerSearch" class="">
	<div id="co_searchWidgetInnerId" class="co_noAdvancedSearch">
		<form action="" onsubmit="return false;">
			<div id="co_searchFormLeft">
				<a href="javascript:void(0);" id="co_categorySearchButton">
					<span id="co_currentSelectedCategoryText">291 PATENTS</span>
					<span id="co_currentSelectedCategoryToggle" class="th_simple_icon icon_down_arrow co_hasTooltip">
						<span class="co_accessibilityLabel">Content Menu</span>
					</span>
				</a>
				<div class="co_dropdownBoxCollapsed" id="co_searchCategoryDropdown"><ul>  <li class="co_tabLeft" id="co_searchWidgetAllWestlawTab" title="Search All Content">    <div class="co_tabRight"><a href="#" onclick="return false;">All Content</a></div>  </li>  <li class="co_tabLeft co_hideState" id="co_searchWidgetCompartmentCustomTab" title="compartmentCustomTab">    <div id="compartmentCustomTabDivId" class="co_tabRight"><a title="Search " href="#" onclick="return false;">{compartmentCustomTabLinkText}</a></div>  </li>  <li class="co_tabActive co_tabLeft" id="co_searchWidgetCustomTab">    <div id="customTabDivId" class="co_tabRight"><a title="Search 291 PATENTS" href="#" onclick="return false;">291 PATENTS</a></div>  </li></ul>

				</div>
			</div>
			<div class="co_searchFormOuter">
				<div class="co_searchInputContainer" id="co_searchInputContainer">
					<div class="co_inputTop">
						<div class="co_inputTopRight"></div>
					</div>
					<div class="co_inputMidLeft">
						<div class="co_inputMidRight">
							<!-- Search text box -->
							<div class="co_textarea">
								<label id="searchInputIdLabel" for="searchInputId">Search:</label>
									<textarea style="" title="Search" name="searchInputId" aria-label="Westlaw Search. Search suggestions available after typing 3 characters. Use arrow keys to navigate suggestions." id="searchInputId" rows="1" spellcheck="false" autocorrect="off" autocapitalize="off" class="co_defaultInput"></textarea>
							</div>

							<!-- Medical litigator check box container -->
							<div id="co_medLitExpandedTerms" class="co_floatRight co_formInline"></div>



<!-- Recent search query toggle -->
<a id="co_searchLast10Link" class="th_simple_icon icon_down_arrow co_hasTooltip" href="#" onclick="return false;" title="Recent Searches Menu">
		<span class="co_accessibilityLabel">Recent Searches Menu</span>
</a>
						</div>
					</div>
					<div class="co_inputBottom">
						<div class="co_inputBottomRight"></div>
					</div>


<!-- Hold recent query drop down -->
<div id="co_recentQueryListBox" class="co_hideState">
	<ul class="co_searchSuggestionContainer" id="co_searchLast10List"></ul>
</div>
				<span role="application" id="searchBoxIndexSpan" style="display: none;"><p class="co_accessibilityLabel" id="co_resultsAvailable">Results are available, use up and down arrow keys to navigate</p><p class="co_accessibilityLabel" id="co_endOfList">End Of List</p><div id="co_typeAheadStatusAlert" aria-live="assertive" role="alert" aria-labelledby="co_resultsAvailable"></div><ul class="co_searchSuggestionContainer" aria-live="polite" aria-relevant="additions removals" id="co_searchSuggestion" style="display: none;" tabindex="-1"><li class="co_autoCompleteSection" id="coid_westlawanswers_elastic_westlawanswers_allcases" style="display:none"></li><li class="co_autoCompleteSection" id="coid_westlawanswers_elastic_westlawanswers" style="display:none"></li><li class="co_autoCompleteSection" id="coid_westlawanswers_elastic_westlawanswers" style="display:none"></li><li class="co_autoCompleteSection" id="coid_snapshotExactMatch_elastic_snapshots" style="display:none"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_categorypage"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_case"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_docket"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_statute"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_regulation"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_admindecision"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_analytical"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_pendingstatute"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_othercourtdocument"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_snapshots"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_westlawanswers"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_westlawanswers_static_questions"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_westlawanswers_static_questions_allcases"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_westlawanswers_it_depends_question"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_antitrust"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_arbitration"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_bankruptcy"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_capmarket_corpgovern"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_commtrans"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_corp_mna"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_empbenefits_excomp"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_fedcivilpract"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_finance"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_inhousecounsel"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_intelprop_tech"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_labor_emp"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_realestate"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_startup_smallbus"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_trust_estate"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointpicks_practicallaw"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointpicks_forms"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointpicks_secondarysrc"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepoint_rulebooks"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepoint_categorypage"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicallaw"></li></ul></span></div>
			</div>
			<div id="co_searchFormRight">
				<div id="co_searchFormRightWrapper">
					<!-- Jurisdiction selected -->
					<div id="co_jurisdictionWidgetContainer" class="">

<a class="co_jurisdictionSelectorDropDownArrowCollapsed" href="javascript:void(0);" id="jurisdictionId">
    <span id="jurisdictionIdInner">Federal Circuit</span>
</a>
</div>
					<!-- Search button -->
					<button title="Search" id="searchButton" class="co_hasTooltip" aria-label="Search 291 PATENTS">


						Search Westlaw
						<span class="co_accessibilityLabel">Search 291 PATENTS</span>
					</button>
					<!-- Advanced search -->
					<a href="#" onclick="return false;" class="co_hideState" id="co_search_advancedSearchLink" title="Advanced Search">Advanced</a>
					<!-- Holder jurisdiction pop up -->
					<div id="co_searchJurisdictionHoverContainer"></div>
				</div>
			</div>
			<!-- Search error container -->
			<div id="co_searchInputErrorMessageContainer" class="co_hideState"></div>
		</form>
	</div>
</div>
						<div id="coid_website_searchWidget" class="co_hideState"></div>
						<div id="co_researchAcceleratorWrapper">
							
						</div>
						<div class="co_skipToLink">
							<a id="coid_website_startContent" name="coid_website_startContent"></a>
						</div>

			</div><!--newHeader_bottom-->
		</div><!--headerContainer-->
	</div><!--newHeader-->
</div><!--co_headerWrapper-->




	
	
<!-- moved delivery toolbar to separate ascx control -->	








	<div id="co_body">
		<!-- BODY HEADER -->
		<div id="co_bodyHeader"></div>
		

	
	<!-- Reporting Name is "CTA" for document with guid "Ic0acd4ce445311dea82ab9f4ee295c21". -->
	
	<!-- CENTER COLUMN -->  
	<div id="co_contentWrapper">
		<div id="co_contentColumn">
			<div class="co_innertube">










<div id="co_docHeaderContainer">
	<a class="co_skipToLink" href="#coid_website_errorsSummaryPlaceHolder">
		Skip Page Header
	</a>
	<div id="co_docHeader">
		<div id="co_docFixedHeader"><div id="co_docHeaderCitatorFlag"><span class="co_citatorFlag"><a href="https://1.next.westlaw.com/Link/RelatedInformation/Flag?documentGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;transitionType=Document&amp;originationContext=docHeaderFlag&amp;contextData=(sc.CustomDigest)"><img class="crsw_DocumentIndicator" alt="KeyCite Yellow Flag - Negative Treatment" src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/v1/flag_yellow.png" title="KeyCite Yellow Flag - Negative Treatment"></a><span class="co_citatorFlagText">KeyCite Yellow Flag - Negative Treatment</span></span></div><div id="co_docHeaderTitle"><h2 id="co_docHeaderTitleLine" title="Abbott Laboratories v. Sandoz, Inc."><span id="title"><a class="co_drag" href="https://1.next.westlaw.com/Document/Ic0acd4ce445311dea82ab9f4ee295c21/View/FullText.html?listSource=Search&amp;navigationPath=Search%2fv1%2fresults%2fnavigation%2fi0ad604ab000001630667802a2028f1f7%3fNav%3dCUSTOMDIGEST%26fragmentIdentifier%3dIc0acd4ce445311dea82ab9f4ee295c21%26startIndex%3d1%26contextData%3d%2528sc.CustomDigest%2529%26transitionType%3dCustomDigestItem&amp;list=CUSTOMDIGEST&amp;rank=326&amp;listPageSource=edc4a850c828227f4c8d5f819b26133f&amp;originationContext=docHeader&amp;contextData=(sc.CustomDigest)&amp;transitionType=Document&amp;needToInjectTerms=False&amp;enableBestPortion=True&amp;docSource=f1d366ef84a64f21a20e2feca7ddaa1a">Abbott Laboratories v. Sandoz, Inc.</a></span></h2><ul id="co_documentStatusIcons" class="co_document_indicators"></ul><h3 id="co_docHeaderCitation" title="United States Court of Appeals, Federal Circuit. | May 18, 2009 | 566 F.3d 1282 | 90 U.S.P.Q.2d 1769&nbsp;(Approx. 41 pages)"><span id="courtline">United States Court of Appeals, Federal Circuit.</span><span id="filedate">May 18, 2009</span><span id="cite0">566 F.3d 1282</span><span id="cite1">90 U.S.P.Q.2d 1769</span><em>&nbsp;(Approx. 41 pages)</em></h3><h4 id="co_docHeaderNegativeTreatment"><span id="co_document_compositeHeader_citatorFlag" class="co_citatorFlag"></span></h4></div></div>
		<div class="co_clear"></div>
		<div id="co_docPrimaryTabNavigationContainer" class="co_docTabs">
				<a id="co_iPadKeyCiteMenuToggle">
					Toggle Menu
				</a>
			<ul id="co_docPrimaryTabNavigation" class="co_tabs">










<li id="DocumentTab" class="co_tabLeft co_tabActive co_dropdownTab">
	<h2 class="co_tabRight">
		<a id="coid_DocumentTab_link" class="co_tabLink" href="javascript:void(0);">
			<span>Document</span>
		</a>
				<div class="co_clear"></div> 
	</h2>
	</li>







<li id="riFilingsTab" class="co_tabLeft co_tabInactive" countstatus="" categoryenum="riFilings">
	<h2 class="co_tabRight">
		<a id="coid_relatedInfo_riFilings_link" class="co_tabLink" href="javascript:void(0);" hiddenhref="/RelatedInformation/Ic0acd4ce445311dea82ab9f4ee295c21/riFilings.html?originationContext=documentTab&amp;transitionType=Filings&amp;contextData=(sc.CustomDigest)&amp;docSource=f1d366ef84a64f21a20e2feca7ddaa1a&amp;rank=326&amp;rulebookMode=false">
			
			<span>
				Filings 
			</span>
		</a>
		<div class="co_clear"></div> 
	</h2>
</li>







<li id="kcNegativeTreatmentTab" class="co_tabLeft co_tabInactive" countstatus="" categoryenum="kcNegativeTreatment">
	<h2 class="co_tabRight">
		<a id="coid_relatedInfo_kcNegativeTreatment_link" class="co_tabLink" href="javascript:void(0);" hiddenhref="/RelatedInformation/Ic0acd4ce445311dea82ab9f4ee295c21/kcNegativeTreatment.html?originationContext=documentTab&amp;transitionType=NegativeTreatment&amp;contextData=(sc.CustomDigest)&amp;docSource=f1d366ef84a64f21a20e2feca7ddaa1a&amp;rank=326&amp;rulebookMode=false">
			
			<span>
				Negative Treatment 
			</span>
		</a>
		<div class="co_clear"></div> 
	</h2>
</li>







<li id="kcJudicialHistoryTab" class="co_tabLeft co_tabInactive" countstatus="" categoryenum="kcJudicialHistory">
	<h2 class="co_tabRight">
		<a id="coid_relatedInfo_kcJudicialHistory_link" class="co_tabLink" href="javascript:void(0);" hiddenhref="/RelatedInformation/Ic0acd4ce445311dea82ab9f4ee295c21/kcJudicialHistory.html?originationContext=documentTab&amp;transitionType=History&amp;contextData=(sc.CustomDigest)&amp;docSource=f1d366ef84a64f21a20e2feca7ddaa1a&amp;rank=326&amp;rulebookMode=false">
			
			<span>
				History 
			</span>
		</a>
		<div class="co_clear"></div> 
	</h2>
</li>







<li id="kcCitingReferencesTab" class="co_tabLeft co_tabInactive co_dropdownTab" countstatus="" categoryenum="kcCitingReferences">
	<h2 class="co_tabRight">
		<a id="coid_relatedInfo_kcCitingReferences_link" class="co_tabLink" href="javascript:void(0);" hiddenhref="/RelatedInformation/Ic0acd4ce445311dea82ab9f4ee295c21/kcCitingReferences.html?originationContext=documentTab&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)&amp;docSource=f1d366ef84a64f21a20e2feca7ddaa1a&amp;rank=326&amp;rulebookMode=false">
			
			<span>
				Citing References 
			</span>
		</a>





<span id="co_kcCitingReferencesNavAnchor" class="co_dropdownArrowCollapsed">Navigate Citing References</span>
		<div class="co_clear"></div> 
	</h2>
		<div id="co_kcCitingReferencesNavContent" class="co_dropdownBoxCollapsed" style="display:none;"></div>
</li>







<li id="kcTableOfAuthoritiesTab" class="co_tabLeft co_tabInactive" countstatus="" categoryenum="kcTableOfAuthorities">
	<h2 class="co_tabRight">
		<a id="coid_relatedInfo_kcTableOfAuthorities_link" class="co_tabLink" href="javascript:void(0);" hiddenhref="/RelatedInformation/Ic0acd4ce445311dea82ab9f4ee295c21/kcTableOfAuthorities.html?originationContext=documentTab&amp;transitionType=TableOfAuthorities&amp;contextData=(sc.CustomDigest)&amp;docSource=f1d366ef84a64f21a20e2feca7ddaa1a&amp;rank=326&amp;rulebookMode=false">
			
			<span>
				Table of Authorities 
			</span>
		</a>
		<div class="co_clear"></div> 
	</h2>
</li>




<li id="co_powByKCContainer">
	<a id="co_powByKC" href="javascript:void(0)">
		Powered by KeyCite
	</a>
</li>

			</ul>
		</div>
		<div class="co_clear"></div>
		<div id="co_docToolbarContainer" class="">
			<div id="co_docToolbar"><div><ul id="co_docToolbarMenuLeft"><li id="co_docToolbarBackToResults"><div id="co_documentFooterBreadcrumb"><a class="co_tbButton" href="/Search/Results.html?jurisdiction=CTAF&amp;saveJuris=False&amp;contentType=CUSTOMDIGEST&amp;querySubmissionGuid=i0ad604ab000001630667802a2028f1f7&amp;startIndex=1&amp;tocGuid=I4aee2539c6f64c1812a4c2f3395c2607&amp;categoryPageUrl=Home%2FWestKeyNumberSystem&amp;searchId=i0ad604ab000001630667802a2028f1f7&amp;kmSearchIdRequested=False&amp;simpleSearch=False&amp;isAdvancedSearchTemplatePage=False&amp;skipSpellCheck=False&amp;isTrDiscoverSearch=False&amp;ancillaryChargesAccepted=False&amp;proviewEligible=False&amp;transitionType=ReturnToList&amp;contextData=%28sc.CustomDigest%29#Ic0acd4ce445311dea82ab9f4ee295c21"><span class="icon25 icon_back_arrow btnOffset"></span>Return to list</a></div></li><li id="co_docToolbarDocumentNavigation"><div id="co_documentFooterResultsNavigation" class="co_prevNextNavigation"><button title="Previous Document" id="co_documentFooterResultsNavigationPrevious" class="co_prev co_tbButton">
	                <span class="icon25 icon_prev_arrow">Previous Document</span>
                </button>
                <span class="co_navigationText"><strong>326</strong> of <strong>1,157 results</strong></span>
                <button title="Next Document" id="co_documentFooterResultsNavigationNext" class="co_next co_tbButton">
                    <span class="icon25 icon_next_arrow">Next Document</span>
                </button></div></li></ul><ul id="co_docToolbarMenuRight"><li id="co_docToolbarMenuRightChildWidget0" class="co_hideState"></li><li id="co_docHeaderSearchGrading"></li><li id="co_docToolbarGoTo"><div class="co_dropdownTabCollapsed"><div class="co_dropdownTab"><a href="javascript:void(0);" class="co_dropdownBoxanchorLabel" role="button">Go to</a><a href="javascript:void(0);" role="button" class="co_dropdownArrowCollapsed">Open Skip to Menu</a></div></div><div id="co_docGoToWidget" class="co_dropdownBoxCollapsed"><div class="co_dropdownBoxContent" id="co_skipTo"><div class="co_dropdownBoxContentRight"><div><div><a href="#co_synopsis">Synopsis</a></div><div><a href="#co_headnoteHeader">West Headnotes</a></div><div><a href="#co_attorneysAndLawFirms">Attorneys and Law Firms</a></div><div><a href="#co_opinion">Opinion</a></div><div><a href="#co_dissent_opinion">Dissenting Opinion</a></div><div><a href="#co_allCitations">All Citations</a></div></div></div></div><div id="co_starPage" class="co_dropdownBoxContent"><div class="co_dropdownBoxContentRight"><label for="co_document_starPage_starPageNavInput">Page #</label><input id="co_document_starPage_starPageNavInput" maxlength="6" size="6" type="text"><span id="co_document_starPage_starPageNavGo" class="co_primaryBtn">Go</span><div id="co_document_starPage_starPageNavError"></div><div class="co_clear"></div></div></div></div></li><li id="co_docToolbarTocNavigation"></li><li id="co_docToolbarTocFlyout"></li><li id="co_docToolbarMenuRightChildWidget5"></li><li id="co_docToolbarMenuRightChildWidget6"></li><li id="co_docToolbarMenuRightChildWidget7" class="co_toolbarSeparator"></li><li id="co_docToolbarSearchWithinDocument"><div id="co_docSearchWithinContainer"><a role="button" href="javascript:void(0);" class="co_dropdownTitle" title="Search text in this document">Search Within this Document</a>
<div id="co_docSearchWithinDropdownContainer">
	<div id="co_docSearchWithinDropdownContainerInner">
		<div id="co_docSearchWithinDropdownContainerInnerContent" class="co_dropdownBoxCollapsed">
			<!-- toggle between co_dropDownBoxCollapsed and co_dropdownBoxExpanded to show/hide -->
			<div class="co_dropdownBoxHeader">
				<span></span>
			</div>
			<div class="co_dropdownBoxContent">
				<div class="co_dropdownBoxContentRight">
					<div id="co_docSearchWithin_input">
						
<div id="co_docSearchWithin_searchInputContainer_withRecentSearch">
	<a id="co_searchLast10Link" class="co_recentSearchesLink" href="javascript:void(0);" title="Recent Searches">
		Last 10 Searches
	</a>
	<div class="co_textarea">
		<textarea id="co_docSearchWithin_searchInput_withRecentSearch" rows="1" autocorrect="off" autocapitalize="off" role="textbox" aria-label="Enter term to search for in current document"></textarea>
	</div>
	<div id="co_documentRecentQueryListBox" class="co_hideState"><ul class="co_searchSuggestionContainer" id="co_documentSearchLast10List"></ul></div>
</div>

						<input id="co_docSearchWithin_searchButton" class="co_secondaryBtn" value="Search" role="button" aria-label="Search Within this Document" type="button">
					</div>
					<div class="co_prevNextNavigation co_hideState">
						<button title="Previous Term" class="co_prev co_tbButton">
							<span class="icon25 icon_prev_arrow">Previous Term</span>
						</button>
						<button title="Next Term" class="co_next co_tbButton">
							<span class="icon25 icon_next_arrow">Next Term</span>
						</button>
						<span class="co_navigationText co_hideState"></span>
					</div>
					<button id="co_docSearchWithin_help" class="co_helpLink">Terms &amp;amp; Connectors</button>
					<button id="co_docSearchWithinCloseButton" class="co_widget_closeIcon">Close</button>
					<div id="co_docSearchWithinMessage"></div>
					<div class="co_clear"></div>
				</div>
				<div id="searchWithinTncContainer" class="co_hideState"><div id="co_search_advancedSearch_tncLegendBox">  <h2 id="co_search_advancedSearch_tncHelpTitle">Connectors and Expanders</h2>  <a id="co_search_advancedSearch_tncHelpLink" href="#" class="co_hideState">Help</a>  <dl id="co_search_advancedSearch_tncLegendList">    <dt>&amp;</dt><dd>AND</dd>    <dt>/s</dt><dd>In same sentence</dd>    <dt>or</dt><dd>OR</dd>    <dt>+s</dt><dd>Preceding within sentence</dd>    <dt>/p</dt><dd>In same paragraph</dd>    <dt>""</dt><dd>Phrase</dd>    <dt>+p</dt><dd>Preceding within paragraph</dd>    <dt>%</dt><dd>But not</dd>    <dt>/n</dt><dd>Within n terms of</dd>    <dt>!</dt><dd>Root expander</dd>    <dt>+n</dt><dd>Preceding within n terms of</dd>    <dt>*</dt><dd>Universal character</dd>    <dt>#</dt><dd>Prefix to turn off plurals and equivalents</dd>  </dl></div></div>
			</div>
			<div class="co_dropdownBoxFooter">
				<span></span>
			</div>
		</div>
	</div>
</div></div></li><li id="co_docToolbarDisplayOptions"><a role="button" id="co_displayOptionsLink" class="co_tbButton" href="javascript:void(0);" title="Display Options"><span class="icon25 icon_text_resize">Display Options</span></a></li><li id="co_docToolbarDeliveryWidget"><div id="deliveryWidget1" class="co_dropDownMenu collapsed"><div class="co_dropDownButton"><a role="button" id="deliveryLink1" title="Email" class="co_tbButton" href="javascript:void(0);"><span class="icon25 icon_email">Email</span></a><a href="javascript:void(0);" class="co_tbButton co_dropDownAnchor" role="button" id="deliveryDropButton1" aria-label="Delivery menu" title="Delivery menu" aria-describedby="navigation1"><span class="icon25 icon_down_blue_arrow"></span></a><span id="navigation1" class="co_accessibilityLabel">Enter to open, tab to navigate, enter to select</span></div><div id="deliveryWidgetMenu1" class="co_dropDownMenuContent" role="document"><ul class="co_dropDownMenuList checkmarks icons" role="listbox" aria-multiselectable="true" aria-hidden="false" aria-expanded="true"><li id="deliveryRow1Email" name="Email" role="presentation" class="checked"><a title="Email" id="deliveryLinkRow1Email" role="option" aria-posinset="1" aria-setsize="3" class="co_deliveryLinkOptions" tabindex="0" aria-selected="true"><span class="icon25 icon_email"></span>Email</a></li><li id="deliveryRow1Print" name="Print" role="presentation"><a title="Print" id="deliveryLinkRow1Print" role="option" aria-posinset="2" aria-setsize="3" class="co_deliveryLinkOptions" tabindex="0" aria-selected="false"><span class="icon25 icon_print"></span>Print</a></li><li id="deliveryRow1Download" name="Download" role="presentation"><a title="Download" id="deliveryLinkRow1Download" role="option" aria-posinset="3" aria-setsize="3" class="co_deliveryLinkOptions" tabindex="0" aria-selected="false"><span class="icon25 icon_download"></span>Download</a></li></ul><div class="co_deliveryWidgetMenuFooter"></div></div><div id="co_deliveryWidget_Message1"></div></div></li><li id="co_docToolbarReadingModeWidget"><a role="button" id="co_fullscreenModeLink" class="co_tbButton" href="javascript:void(0);" title="Fullscreen Mode"><span class="icon25 icon_fullscreen">Fullscreen Mode</span></a></li></ul></div></div> 
			<div class="co_clear"></div>
		</div>
	</div>
</div>

				<div id="coid_website_errorsSummaryPlaceHolder"><div class="co_infoBox failure" style="display: none;"><div class="co_infoBox_container"><div class="co_infoBox_outer"><div class="co_infoBox_inner"><a id="co_website_errorSumarryCloseLink" class="co_infoBox_closeButton">Close</a><div class="co_infoBox_message" tabindex="-1">Sorry, there was an error on this page.<a href="javascript:void(0);" id="co_website_errorSummaryToggleLink">More info</a><a href="javascript:void(0);" id="co_website_errorSummaryToggleLinkLessInfo" style="display: none; margin-left: 6px;">Less info</a><ul class="co_website_errorsSummaryList" style="display: none;"></ul></div></div></div></div></div></div>
				<div id="coid_website_messagePlaceholder"></div>







				<div id="test_hplink"></div>
				<div class="co_scrollWrapper">





							<div id="coid_website_documentWidgetDiv" class=" co_khSpeedReadExpandAll">
<div id="co_briefItDiv" class="co_excludeAnnotations"><button id="co_briefItButton" class="co_primaryBtn co_floatRight">Brief It</button><div class="undefined"></div></div><div id="co_document" class="co_addFocusCorrection"><div id="co_document_0" class="co_document co_caselawNRS"><div id="co_readingModeKC" class="co_keyCiteFlagWidgetContainer co_excludeAnnotations"><div id="co_readingModeCitatorFlag"><span class="co_citatorFlag"><a href="https://1.next.westlaw.com/Link/RelatedInformation/Flag?documentGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;transitionType=Document&amp;originationContext=docHeaderSntTitleFlag&amp;contextData=(sc.CustomDigest)"><img class="crsw_DocumentIndicator" alt="KeyCite Yellow Flag - Negative Treatment" src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/v1/flag_yellow.png" title="KeyCite Yellow Flag - Negative Treatment"></a><span class="co_citatorFlagText">KeyCite Yellow Flag - Negative Treatment</span></span></div><div id="co_readingModeNegativeTreatment"><span id="NegativeTreatmentWidget_Ic0acd4ce445311dea82ab9f4ee295c21"><span class="co_snt_treatmentPhrase">Declined to Extend by </span><a href="https://1.next.westlaw.com/Document/I9eded3e87ddb11e3a659df62eba144e8/View/FullText.html?navigationPath=RelatedInfo%2Fv4%2Fkeycite%2Fnav%2F%3Fguid%3DI9eded3e87ddb11e3a659df62eba144e8%26ss%3D2018850794%26ds%3D2032543591&amp;listSource=RelatedInfo&amp;list=NegativeCitingReferences&amp;rank=0&amp;originationContext=docHeader&amp;transitionType=NegativeTreatment&amp;contextData=%28sc.CustomDigest%29">In re OxyContin Antitrust Litigation</a><span>, </span><span class="co_snt_courtLine">S.D.N.Y., </span><span class="co_snt_dateFiled">January 14, 2014</span></span></div></div><input id="co_keyCiteFlagPlaceHolder" type="hidden"><input id="co_document_starPageMetadata" value="{ &quot;citations&quot;: { &quot;S367e169b5a7511deabded03f2b83b8a4&quot;:&quot;566 F.3d 1282&quot; }, &quot;pubs&quot;: { &quot;S367e169b5a7511deabded03f2b83b8a4&quot;:&quot;506&quot; } }" alt="metadata" type="hidden"><div><a href="https://1.next.westlaw.com/Link/Document/Blob/I298F20BA1DD211B29A81A900920CB1E6/566_F.3d_1282.pdf?targetType=NRS&amp;originationContext=pagepdflink&amp;transitionType=DocumentImage&amp;uniqueId=d949a47b-c3e3-416f-b804-f0f85746023a&amp;contextData=(sc.CustomDigest)" class="co_blobLink" type="application/pdf"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/v1/co_pdf-icon.gif" class="co_pdfIcon" alt="PDF">​Original Image of 566 F.3d 1282 (PDF)</a></div><div class="co_cites">566 F.3d 1282</div><input id="co_document_paraNumbersSourceCiteMetadata" value="{ &quot;paraNumbersSourceCite&quot;: &quot;566 F.3d 1282&quot;, &quot;publicationNumber&quot;: &quot;506&quot; }" alt="metadata" type="hidden"><div class="co_contentBlock co_briefItState co_courtBlock"><div><div class="co_hAlign2">United States Court of Appeals,</div>Federal Circuit.</div></div><div class="co_contentBlock co_briefItState co_courtBlock"></div><div class="co_title"><div class="co_suit"><div class="co_partyLine">ABBOTT LABORATORIES, Plaintiff–Appellant,</div><div>and</div><div class="co_partyLine">Astellas Pharma, Inc., Plaintiff–Appellant,</div><div>v.</div><div class="co_partyLine">SANDOZ, INC., Defendant–Appellee,</div><div>and</div><div class="co_partyLine">Sandoz GMBH, Defendant,</div><div>and</div><div class="co_partyLine">Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries, Ltd., Defendants–Appellees,</div><div>and</div><div class="co_partyLine">Ranbaxy Laboratories, Ltd. and Ranbaxy, Inc., Defendants,</div><div>and</div><div class="co_partyLine">Par Pharmaceutical Companies, Inc. and Par Pharmaceutical, Defendants.</div></div><div class="co_suit"><div class="co_partyLine">Lupin Limited, Plaintiff/Counterclaim Defendant–Appellee,</div><div>and</div><div class="co_partyLine">Lupin Pharmaceuticals, Inc., Counterclaim Defendant–Appellee,</div><div>v.</div><div class="co_partyLine">Abbott Laboratories, Defendant/Counterclaimant–Appellant,</div><div>and</div><div class="co_partyLine">Astellas Pharma, Inc., Defendant/Counterclaimant–Appellant.</div></div></div><div class="co_docketDate"><div class="co_contentBlock co_briefItState co_docketBlock"><span>Nos. 2007–1400, 2007–1446.</span></div><div class="co_date"><span>May 18, 2009.</span></div></div><div class="co_contentBlock co_briefItState co_synopsis"><h2 id="co_synopsis" class="co_printHeading">Synopsis</h2><div><div class="co_paragraph"><div class="co_paragraphText"><strong>Background:</strong> Competitor brought action against patent licensee seeking declaratory judgment of non-infringement of patent for crystalline cefdinir. The United States District Court for the Eastern District of Virginia, <a id="co_link_I817ac39a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0109049101&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Robert E. Payne</a>, J., <a id="co_link_I817ac39b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2012128034&amp;pubNum=0004637&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">484 F.Supp.2d 448</a>, construed patent, and entered summary judgment of noninfringement, <a id="co_link_I817ac39c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2012504755&amp;pubNum=4637&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">491 F.Supp.2d 563.</a> Licensee appealed. In another action, licensee brought patent infringement action against competitors. The United States District Court for the Northern District of Illinois, <a id="co_link_I817ac39d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0506128401&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Wayne R. Andersen</a>, J., <a id="co_link_I817ac39e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2012184789&amp;pubNum=0004637&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">486 F.Supp.2d 767</a>, construed patent, and denied licensee's motion for preliminary injunction. Licensee appealed. Appeals were consolidated.</div></div></div><div class="co_contentBlock co_briefItState co_synopsisHolding"><div class="co_paragraph"><div class="co_paragraphText"><strong>Holdings:</strong> Following sua sponte order of review en banc, the Court of Appeals, <a id="co_link_I817ac3a022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0168544101&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Rader</a>, Circuit Judge, held that:</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F72018850794" class="co_internalLink co_excludeAnnotations co_disableHighlightFeatures">1</a> patent was limited to “Crystal A” form of compound;</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F82018850794" class="co_internalLink co_excludeAnnotations co_disableHighlightFeatures">2</a> process terms in product-by-process claims serve as limitations in determining patent infringement; overruling <a id="co_link_I817ac3a122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1991051497&amp;pubNum=350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Scripps Clinic &amp; Research Foundation v. Genentech, Inc.,</em> 927 F.2d 1565;</a></div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F102018850794" class="co_internalLink co_excludeAnnotations co_disableHighlightFeatures">3</a> phrase “obtainable by” introduced limiting process steps;</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F132018850794" class="co_internalLink co_excludeAnnotations co_disableHighlightFeatures">4</a> patent's claims could not be extended under doctrine of equivalents to embrace known but unclaimed subject matter; and</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F182018850794" class="co_internalLink co_excludeAnnotations co_disableHighlightFeatures">5</a> district court did not abuse its discretion in denying preliminary injunction.</div></div></div><div class="co_paragraph"><div class="co_paragraphText">Affirmed.</div></div><div class="co_paragraph"><div class="co_paragraphText"><a id="co_link_I817ac3a322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0245882601&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Newman</a>, Circuit Judge, dissented in part and filed opinion in which <a id="co_link_I817ac3a422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0146644601&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Mayer</a> and <a id="co_link_I817ac3a522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0225327201&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Lourie</a>, Circuit Judges, joined.</div></div></div><div id="co_headnotes" class="co_headnotes co_fancyHeadnotes"><h2 id="co_headnoteHeader" class="co_headnoteHeader co_printHeading"><span class="co_headnoteHeaderSpan">West Headnotes (21)</span><a id="co_headnoteExpandCollapseLink" class="co_accLink co_excludeAnnotations co_disableHighlightFeatures" href="javascript:void(0);" role="button">Collapse West Headnotes</a></h2><div class="co_headnotesContentContainer"><div id="co_expandedHeadnotes"><div id="co_headnoteTools"><a id="co_headnotesShowOrHideFancy" href="javascript:void(0);" class="co_fancyHeadnotesShowHide co_excludeAnnotations co_disableHighlightFeatures">Change View</a></div><div class="co_headnoteRow" id="co_anchor_2018850794001"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F12018850794"><span class="co_headnoteNumber" id="co_anchor_headNote_1"><a href="#co_anchor_B12018850794" class="co_internalLink">1</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EGAAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EOBAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1327/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Specifications and Drawings;  Written Description</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Patent's specification provides necessary context for understanding patent's claims, and is always highly relevant to claim construction analysis.</div></div><div id="co_headnoteId_201885079400120180308023127" class="co_headnoteCitedCaseRef"><a id="co_link_ID0ERCAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;headnoteId=201885079400120180308023127&amp;originationContext=document&amp;docSource=f1d366ef84a64f21a20e2feca7ddaa1a&amp;rank=326&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 1"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">12 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3a622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3a722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291V/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291V</a></span><span class="co_headnoteTopicKey">Construction and Operation of Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3a822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291V(A)/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291V(A)</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3a922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1327/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1327</a></span><span class="co_headnoteTopicKey">Specifications and Drawings;  Written Description</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3aa22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1328/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1328</a></span><span class="co_headnoteTopicKey">In general</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k167(1))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2018850794002"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F22018850794"><span class="co_headnoteNumber" id="co_anchor_headNote_2"><a href="#co_anchor_B22018850794" class="co_internalLink">2</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EDDAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EZEAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1329/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Specification as limiting or enlarging claims in general</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">When consulting patent specification to clarify meaning of claim terms, courts must take care not to import limitations into claims from specification.</div></div><div id="co_headnoteId_201885079400220180308023127" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EOFAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;headnoteId=201885079400220180308023127&amp;originationContext=document&amp;docSource=f1d366ef84a64f21a20e2feca7ddaa1a&amp;rank=326&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 2"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">67 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3ab22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3ac22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291V/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291V</a></span><span class="co_headnoteTopicKey">Construction and Operation of Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3ad22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291V(A)/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291V(A)</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3ae22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1327/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1327</a></span><span class="co_headnoteTopicKey">Specifications and Drawings;  Written Description</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3af22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1329/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1329</a></span><span class="co_headnoteTopicKey">Specification as limiting or enlarging claims in general</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k167(1.1))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2018850794003"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F32018850794"><span class="co_headnoteNumber" id="co_anchor_headNote_3"><a href="#co_anchor_B32018850794" class="co_internalLink">3</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EGGAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0E3HAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1332/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Preferred embodiment</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">When patent specification describes single embodiment to enable invention, court will not limit broader claim language to that single application unless patentee has demonstrated clear intention to limit claim scope using words or expressions of manifest exclusion or restriction.</div></div><div id="co_headnoteId_201885079400320180308023127" class="co_headnoteCitedCaseRef"><a id="co_link_ID0ERIAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;headnoteId=201885079400320180308023127&amp;originationContext=document&amp;docSource=f1d366ef84a64f21a20e2feca7ddaa1a&amp;rank=326&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 3"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">65 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3b022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3b122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291V/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291V</a></span><span class="co_headnoteTopicKey">Construction and Operation of Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3b222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291V(A)/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291V(A)</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3b322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1327/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1327</a></span><span class="co_headnoteTopicKey">Specifications and Drawings;  Written Description<input id="co_docMarker_0" type="hidden"></span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3b422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1332/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1332</a></span><span class="co_headnoteTopicKey">Preferred embodiment</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k167(1.1))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2018850794004"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F42018850794"><span class="co_headnoteNumber" id="co_anchor_headNote_4"><a href="#co_anchor_B42018850794" class="co_internalLink">4</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EDJAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EZKAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1329/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Specification as limiting or enlarging claims in general</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Claims cannot enlarge what is patented beyond what inventor has described as invention.</div></div><div id="co_headnoteId_201885079400420180308023127" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EOLAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;headnoteId=201885079400420180308023127&amp;originationContext=document&amp;docSource=f1d366ef84a64f21a20e2feca7ddaa1a&amp;rank=326&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 4"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">28 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3b522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3b622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291V/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291V</a></span><span class="co_headnoteTopicKey">Construction and Operation of Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3b722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291V(A)/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291V(A)</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3b822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1327/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1327</a></span><span class="co_headnoteTopicKey">Specifications and Drawings;  Written Description</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3b922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1329/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1329</a></span><span class="co_headnoteTopicKey">Specification as limiting or enlarging claims in general</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k167(1.1))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2018850794005"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F52018850794"><span class="co_headnoteNumber" id="co_anchor_headNote_5"><a href="#co_anchor_B52018850794" class="co_internalLink">5</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EAMAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EWNAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1329/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Specification as limiting or enlarging claims in general</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Court may reach narrower construction of patent, limited to embodiments disclosed in specification, when claims themselves, specification, or prosecution history clearly indicate that invention encompasses no more than that confined structure or method.</div></div><div id="co_headnoteId_201885079400520180308023127" class="co_headnoteCitedCaseRef"><a id="co_link_ID0ELOAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;headnoteId=201885079400520180308023127&amp;originationContext=document&amp;docSource=f1d366ef84a64f21a20e2feca7ddaa1a&amp;rank=326&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 5"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">47 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3ba22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3bb22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291V/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291V</a></span><span class="co_headnoteTopicKey">Construction and Operation of Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3bc22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291V(A)/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291V(A)</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3bd22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1327/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1327</a></span><span class="co_headnoteTopicKey">Specifications and Drawings;  Written Description</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3be22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1329/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1329</a></span><span class="co_headnoteTopicKey">Specification as limiting or enlarging claims in general</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k167(1.1))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2018850794006"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F62018850794"><span class="co_headnoteNumber" id="co_anchor_headNote_6"><a href="#co_anchor_B62018850794" class="co_internalLink">6</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0E4OAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EBRAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1338(4)/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Prosecution disclaimer</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Doctrine of patent prosecution disclaimer only applies to unambiguous disavowals.</div></div><div id="co_headnoteId_201885079400620180308023127" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EWRAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;headnoteId=201885079400620180308023127&amp;originationContext=document&amp;docSource=f1d366ef84a64f21a20e2feca7ddaa1a&amp;rank=326&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 6"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">19 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3bf22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3c022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291V/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291V</a></span><span class="co_headnoteTopicKey">Construction and Operation of Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3c122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291V(A)/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291V(A)</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3c222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1335/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1335</a></span><span class="co_headnoteTopicKey">Accompanying Documents and Proceedings in Patent and Trademark Office</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3c322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1338/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1338</a></span><span class="co_headnoteTopicKey">Rejection and Amendment of Claims;  Prosecution History</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3c422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1338(4)/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1338(4)</a></span><span class="co_headnoteTopicKey">Prosecution disclaimer</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k168(2.1))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2018850794007"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F72018850794"><span class="co_headnoteNumber" id="co_anchor_headNote_7"><a href="#co_anchor_B72018850794" class="co_internalLink">7</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EISAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0E5TAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1408/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Drugs and medicines</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Term “crystalline,” as used in patent for antibiotic crystalline cefdinir, was limited to “Crystal A” form of compound, where Crystal A was only embodiment described in specification, specification stated that Crystal A showed its distinguishing peaks at seven particular powder X-ray diffraction (PXRD) angles enumerated in claim, prosecution history showed clear and intentional disavowal of claim scope beyond Crystal A, and patent offered no suggestion that recited processes could produce non-Crystal A compounds, even though other types of cefdinir crystals, namely Crystal B, were known in art.</div></div><div id="co_headnoteId_201885079400720180308023127" class="co_headnoteCitedCaseRef"><a id="co_link_ID0ETUAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;headnoteId=201885079400720180308023127&amp;originationContext=document&amp;docSource=f1d366ef84a64f21a20e2feca7ddaa1a&amp;rank=326&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 7"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">14 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3c522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3c622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291V/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291V</a></span><span class="co_headnoteTopicKey">Construction and Operation of Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3c722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291V(C)/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291V(C)</a></span><span class="co_headnoteTopicKey">Particular Fields of Invention</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3c822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1406/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1406</a></span><span class="co_headnoteTopicKey">Health Care and Medical Products</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3c922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1408/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1408</a></span><span class="co_headnoteTopicKey">Drugs and medicines</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k101(4))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2018850794008"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F82018850794"><span class="co_headnoteNumber" id="co_anchor_headNote_8"><a href="#co_anchor_B82018850794" class="co_internalLink">8</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EFVAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0E2WAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1555/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">In general;  comparison with patent claims</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Process terms in product-by-process claims serve as limitations in determining patent infringement; overruling <a id="co_link_I817ac3cf22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1991051497&amp;pubNum=350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Scripps Clinic &amp; Research Foundation v. Genentech, Inc.,</em> 927 F.2d 1565.</a>.</div></div><div id="co_headnoteId_201885079400820180308023127" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EQXAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;headnoteId=201885079400820180308023127&amp;originationContext=document&amp;docSource=f1d366ef84a64f21a20e2feca7ddaa1a&amp;rank=326&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 8"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">16 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3ca22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3cb22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII</a></span><span class="co_headnoteTopicKey">Patent Infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3cc22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(A)/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(A)</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3cd22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1554/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1554</a></span><span class="co_headnoteTopicKey">Substantial Identity of Subject Matter</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3ce22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1555/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1555</a></span><span class="co_headnoteTopicKey">In general;  comparison with patent claims</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k226.6)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2018850794009"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F92018850794" tabindex="0"><span class="co_headnoteNumber" id="co_anchor_headNote_9"><a href="#co_anchor_B92018850794" class="co_internalLink">9</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0ENYAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0ED1AE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k445/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Products or results</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">If inventor invents product whose structure is either not fully known or too complex to analyze, inventor is free to use process steps to define product, subject to ordinary requirements of patentability.</div></div><div id="co_headnoteId_201885079400920180308023127" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EY1AE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;headnoteId=201885079400920180308023127&amp;originationContext=document&amp;docSource=f1d366ef84a64f21a20e2feca7ddaa1a&amp;rank=326&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 9"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">1 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3d022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3d122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3d222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(B)/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(B)</a></span><span class="co_headnoteTopicKey">Eligible Subject Matter</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3d322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k442/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k442</a></span><span class="co_headnoteTopicKey">Classes of Invention or Discovery;  Statutory Subject Matter</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3d422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k445/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k445</a></span><span class="co_headnoteTopicKey">Products or results</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k8)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2018850794010"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F102018850794"><span class="co_headnoteNumber" id="co_anchor_headNote_10"><a href="#co_anchor_B102018850794" class="co_internalLink">10</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EK2AE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EA4AE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1408/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Drugs and medicines</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Phrase “obtainable by,” as used in patent for antibiotic crystalline cefdinir, introduced limiting process steps, where patentee's claims did not furnish any test by which to identify cefdinir crystals except that they were result of claimed process, and patentee chose to differentiate prior art reference on basis that its claimed processes were different.</div></div><div id="co_headnoteId_201885079401020180308023127" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EV4AE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;headnoteId=201885079401020180308023127&amp;originationContext=document&amp;docSource=f1d366ef84a64f21a20e2feca7ddaa1a&amp;rank=326&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 10"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">2 </span>Cases that cite this headnote<input id="co_docMarker_1" type="hidden"></a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3d522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3d622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291V/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291V</a></span><span class="co_headnoteTopicKey">Construction and Operation of Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3d722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291V(C)/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291V(C)</a></span><span class="co_headnoteTopicKey">Particular Fields of Invention</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3d822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1406/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1406</a></span><span class="co_headnoteTopicKey">Health Care and Medical Products</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3d922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1408/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1408</a></span><span class="co_headnoteTopicKey">Drugs and medicines</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k101(3))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2018850794011"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F112018850794"><span class="co_headnoteNumber" id="co_anchor_headNote_11"><a href="#co_anchor_B112018850794" class="co_internalLink">11</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EH5AE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0E46AE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1565/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Substitution of equivalents</a></span></div><div class="co_secondaryHeadnoteNodes"> <span class="co_hiddenKeyText"><strong><a id="co_link_ID0ETAAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EJCAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1574/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Substitution of Equivalents</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Infringement analysis under doctrine of equivalents proceeds element-by-element; generalized showing of equivalency between claim as a whole and allegedly infringing product or process is not sufficient to show infringement.</div></div><div id="co_headnoteId_201885079401120180308023127" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EMDAG" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;headnoteId=201885079401120180308023127&amp;originationContext=document&amp;docSource=f1d366ef84a64f21a20e2feca7ddaa1a&amp;rank=326&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 11"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">19 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3da22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3db22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII</a></span><span class="co_headnoteTopicKey">Patent Infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3dc22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(A)/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(A)</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3dd22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1562/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1562</a></span><span class="co_headnoteTopicKey">Patents for Processes and Methods</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3de22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1565/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1565</a></span><span class="co_headnoteTopicKey">Substitution of equivalents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k230)</span></span></div></div></div></div></div><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3df22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3e022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII</a></span><span class="co_headnoteTopicKey">Patent Infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3e122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(A)/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(A)</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3e222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1568/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1568</a></span><span class="co_headnoteTopicKey">Patents for Machines, Products, or Devices</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3e322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1574/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1574</a></span><span class="co_headnoteTopicKey">Substitution of Equivalents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3e422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1574(1)/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1574(1)</a></span><span class="co_headnoteTopicKey">In general</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k237)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2018850794012"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F122018850794"><span class="co_headnoteNumber" id="co_anchor_headNote_12"><a href="#co_anchor_B122018850794" class="co_internalLink">12</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0E5DAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EUFAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1565/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Substitution of equivalents</a></span></div><div class="co_secondaryHeadnoteNodes"> <span class="co_hiddenKeyText"><strong><a id="co_link_ID0EJGAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0E6HAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1574/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Substitution of Equivalents</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Although primary test for equivalency under doctrine of equivalents is “function-way-result” or “triple identity” test, whereby patentee may show equivalent when accused product or process performs substantially same function, in substantially same way, to achieve substantially same result, as disclosed in claim, equivalency may also be proven where differences between invention as claimed and accused product or process are insubstantial.</div></div><div id="co_headnoteId_201885079401220180308023127" class="co_headnoteCitedCaseRef"><a id="co_link_ID0ECJAG" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;headnoteId=201885079401220180308023127&amp;originationContext=document&amp;docSource=f1d366ef84a64f21a20e2feca7ddaa1a&amp;rank=326&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 12"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">40 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3e522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3e622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII</a></span><span class="co_headnoteTopicKey">Patent Infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3e722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(A)/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(A)</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3e822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1562/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1562</a></span><span class="co_headnoteTopicKey">Patents for Processes and Methods</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3e922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1565/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1565</a></span><span class="co_headnoteTopicKey">Substitution of equivalents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k230)</span></span></div></div></div></div></div><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3ea22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3eb22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII</a></span><span class="co_headnoteTopicKey">Patent Infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3ec22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(A)/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(A)</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3ed22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1568/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1568</a></span><span class="co_headnoteTopicKey">Patents for Machines, Products, or Devices</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3ee22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1574/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1574</a></span><span class="co_headnoteTopicKey">Substitution of Equivalents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3ef22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1574(1)/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1574(1)</a></span><span class="co_headnoteTopicKey">In general</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k237)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2018850794013"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F132018850794"><span class="co_headnoteNumber" id="co_anchor_headNote_13"><a href="#co_anchor_B132018850794" class="co_internalLink">13</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EUJAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EKLAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1668/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Drugs and medicines</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Owner of patent for antibiotic crystalline cefdinir could not extend its exclusive right in patent's claims under doctrine of equivalents to embrace known but unclaimed subject matter, even if accused product was bioequivalent to patentee's product, where patentee emphasized sole teaching of Crystal A in communications with Patent and Trademark Office (PTO), as well as in patent specification itself, and removed Crystal B disclosure from parent application, and bulk of accused product was Crystal B, not Crystal A.</div></div><div id="co_headnoteId_201885079401320180308023127" class="co_headnoteCitedCaseRef"><a id="co_link_ID0E6LAG" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;headnoteId=201885079401320180308023127&amp;originationContext=document&amp;docSource=f1d366ef84a64f21a20e2feca7ddaa1a&amp;rank=326&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 13"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">2 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3f022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3f122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII</a></span><span class="co_headnoteTopicKey">Patent Infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3f222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(B)/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(B)</a></span><span class="co_headnoteTopicKey">Particular Fields of Invention</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3f322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1666/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1666</a></span><span class="co_headnoteTopicKey">Health Care and Medical Products</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3f422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1668/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1668</a></span><span class="co_headnoteTopicKey">Drugs and medicines</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k251)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2018850794014"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F142018850794"><span class="co_headnoteNumber" id="co_anchor_headNote_14"><a href="#co_anchor_B142018850794" class="co_internalLink">14</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EXMAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0ENOAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1574/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Substitution of Equivalents</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">“Equivalency” for purposes of patent infringement requires element-by-element comparison of patent claim and accused product, requiring not only equivalent function but also equivalent way and result.</div></div><div id="co_headnoteId_201885079401420180308023127" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EQPAG" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;headnoteId=201885079401420180308023127&amp;originationContext=document&amp;docSource=f1d366ef84a64f21a20e2feca7ddaa1a&amp;rank=326&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 14"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">43 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3f522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3f622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII</a></span><span class="co_headnoteTopicKey">Patent Infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3f722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(A)/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(A)</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3f822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1568/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1568</a></span><span class="co_headnoteTopicKey">Patents for Machines, Products, or Devices</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3f922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1574/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1574</a></span><span class="co_headnoteTopicKey">Substitution of Equivalents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3fa22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1574(1)/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1574(1)</a></span><span class="co_headnoteTopicKey">In general</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k237)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2018850794015"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F152018850794"><span class="co_headnoteNumber" id="co_anchor_headNote_15"><a href="#co_anchor_B152018850794" class="co_internalLink">15</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EGQAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0E3RAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1591/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Substitution of ingredients</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Bioequivalency of accused product with product produced from patent at issue is not sufficient to establish infringement by equivalents.</div></div><div id="co_headnoteId_201885079401520180308023127" class="co_headnoteCitedCaseRef"><a id="co_link_ID0ERSAG" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;headnoteId=201885079401520180308023127&amp;originationContext=document&amp;docSource=f1d366ef84a64f21a20e2feca7ddaa1a&amp;rank=326&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 15"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">20 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3fb22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3fc22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII</a></span><span class="co_headnoteTopicKey">Patent Infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3fd22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(A)/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(A)</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3fe22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1587/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1587</a></span><span class="co_headnoteTopicKey">Patents for Compositions of Matter</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac3ff22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1591/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1591</a></span><span class="co_headnoteTopicKey">Substitution of ingredients</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k251)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2018850794016"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F162018850794"><span class="co_headnoteNumber" id="co_anchor_headNote_16"><a href="#co_anchor_B162018850794" class="co_internalLink">16</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EDTAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170B/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Federal Courts</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0ERVAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170Bk3616(2)/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Preliminary injunction;  temporary restraining order</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Court of Appeals reviews grant or denial of preliminary injunction for abuse of discretion.</div></div><div id="co_headnoteId_201885079401620180308023127" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EGWAG" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;headnoteId=201885079401620180308023127&amp;originationContext=document&amp;docSource=f1d366ef84a64f21a20e2feca7ddaa1a&amp;rank=326&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 16"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">10 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac40022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170B/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170B</a></span><span class="co_headnoteTopicKey">Federal Courts</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac40122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170BXVII/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170BXVII</a></span><span class="co_headnoteTopicKey">Courts of Appeals</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac40222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170BXVII(K)/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170BXVII(K)</a></span><span class="co_headnoteTopicKey">Scope and Extent of Review</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac40322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170BXVII(K)2/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170BXVII(K)2</a></span><span class="co_headnoteTopicKey">Standard of Review<input id="co_docMarker_2" type="hidden"></span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac40422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170Bk3612/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170Bk3612</a></span><span class="co_headnoteTopicKey">Remedial Matters</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac40522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170Bk3616/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170Bk3616</a></span><span class="co_headnoteTopicKey">Injunction</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac40622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170Bk3616(2)/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170Bk3616(2)</a></span><span class="co_headnoteTopicKey">Preliminary injunction;  temporary restraining order</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 170Bk815)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2018850794017"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F172018850794"><span class="co_headnoteNumber" id="co_anchor_headNote_17"><a href="#co_anchor_B172018850794" class="co_internalLink">17</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EYWAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EYYAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1877/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Grounds in general;  multiple factors</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">District court may enter preliminary injunction in patent infringement case based on its consideration of four factors: (1) likelihood of patentee's success on merits; (2) irreparable harm if injunction is not granted; (3) balance of hardships between parties; and (4) public interest.</div></div><div id="co_headnoteId_201885079401720180308023127" class="co_headnoteCitedCaseRef"><a id="co_link_ID0ENZAG" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;headnoteId=201885079401720180308023127&amp;originationContext=document&amp;docSource=f1d366ef84a64f21a20e2feca7ddaa1a&amp;rank=326&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 17"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">10 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac40722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac40822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII</a></span><span class="co_headnoteTopicKey">Patent Infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac40922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(C)/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(C)</a></span><span class="co_headnoteTopicKey">Actions</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac40a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(C)5/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(C)5</a></span><span class="co_headnoteTopicKey">Relief</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac40b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1874/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1874</a></span><span class="co_headnoteTopicKey">Preliminary or Temporary Injunctions</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac40c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1877/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1877</a></span><span class="co_headnoteTopicKey">Grounds in general;  multiple factors</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k294)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2018850794018"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F182018850794"><span class="co_headnoteNumber" id="co_anchor_headNote_18"><a href="#co_anchor_B182018850794" class="co_internalLink">18</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0E6ZAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0E62AG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1881/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Establishment of infringement</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">District court did not abuse its discretion in denying preliminary injunction in action alleging that generic cefdinir monohydrate products infringed patents for crystalline cefdinir, where patent excluded Crystal B compounds, including cefdinir monohydrate, and there was no evidence that any trace amounts of claimed cefdinir anhydrate in accused products could be contributing factor in their efficacy.</div></div><div id="co_headnoteId_201885079401820180308023127" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EU3AG" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;headnoteId=201885079401820180308023127&amp;originationContext=document&amp;docSource=f1d366ef84a64f21a20e2feca7ddaa1a&amp;rank=326&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 18"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">5 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac40d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac40e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII</a></span><span class="co_headnoteTopicKey">Patent Infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac40f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(C)/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(C)</a></span><span class="co_headnoteTopicKey">Actions</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac41022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(C)5/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(C)5</a></span><span class="co_headnoteTopicKey">Relief</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac41122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1874/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1874</a></span><span class="co_headnoteTopicKey">Preliminary or Temporary Injunctions</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac41222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1881/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1881</a></span><span class="co_headnoteTopicKey">Establishment of infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k298)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2018850794501"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_2018850794"><span class="co_headnoteNumber" id="co_anchor_headNote_19">19</span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EE4AG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EC5AG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k2091/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">In general;  utility</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText"><a id="co_link_I817ac41622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1985169484&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I3903a21071f311d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">US Patent 4,559,334</a>. Cited as Prior Art.</div></div><div id="co_headnoteId_201885079450120180308023127" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EX5AG" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;headnoteId=201885079450120180308023127&amp;originationContext=document&amp;docSource=f1d366ef84a64f21a20e2feca7ddaa1a&amp;rank=326&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 19"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">7 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac41322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac41422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291X/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291X</a></span><span class="co_headnoteTopicKey">Patents Enumerated</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac41522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k2091/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k2091</a></span><span class="co_headnoteTopicKey">In general;  utility</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k328(2))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2018850794502"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_2018850794_0"><span class="co_headnoteNumber" id="co_anchor_headNote_20">20</span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EQ6AG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EOABG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k2091/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">In general;  utility</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText"><a id="co_link_I817ac41a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">US Patent 4,935,507</a>. Construed and Ruled Not Infringed.</div></div><div id="co_headnoteId_201885079450220180308023127" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EDBBG" class="co_link co_excludeAnnotations co_disableHighlightFeatures co_hideState" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;headnoteId=201885079450220180308023127&amp;originationContext=document&amp;docSource=f1d366ef84a64f21a20e2feca7ddaa1a&amp;rank=326&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 20"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">0 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac41722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac41822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291X/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291X</a></span><span class="co_headnoteTopicKey">Patents Enumerated</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac41922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k2091/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k2091</a></span><span class="co_headnoteTopicKey">In general;  utility</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k328(2))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2018850794503"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_2018850794_1"><span class="co_headnoteNumber" id="co_anchor_headNote_21">21</span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0E3BBG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0E1CBG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k2094/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Reissue</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText"><a id="co_link_I817ac41e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1871172039&amp;pubNum=0004073&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9f20a0ed1b7911dbb0d3b726c66cf290&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">US Patent RE4,321</a>. Cited.</div></div><div id="co_headnoteId_201885079450320180308023127" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EPDBG" class="co_link co_excludeAnnotations co_disableHighlightFeatures co_hideState" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;headnoteId=201885079450320180308023127&amp;originationContext=document&amp;docSource=f1d366ef84a64f21a20e2feca7ddaa1a&amp;rank=326&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 21"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">0 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac41b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac41c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291X/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291X</a></span><span class="co_headnoteTopicKey">Patents Enumerated</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I817ac41d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k2094/View.html?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k2094</a></span><span class="co_headnoteTopicKey">Reissue</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k328(4))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div></div></div><div> </div></div><a id="co_headnotesEnd"></a><h2 class="co_attorneyBlockLabel co_printHeading co_briefItState" id="co_attorneysAndLawFirms">Attorneys and Law Firms</h2><div class="co_contentBlock co_briefItState co_attorneyBlock"><div> <span class="co_starPage" id="co_pp_sp_506_1284"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1284&quot; }" alt="metadata" type="hidden">*1284</span> <a id="co_link_I817ac41f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0185600001&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">James F. Hurst</a>, Winston &amp; Strawn LLP, of Chicago, IL, argued for all plaintiffs-appellants in 2007–1400 and defendants/counterclaimants-appellants in 2007–1446. With him on the briefs for Abbott Laboratories were Todd J. Ehlman, Kathleen B. Barry, and Ivan M. Poullaos, and <a id="co_link_I817ac42022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0200826201&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Steffen N. Johnson</a>, of Washington, DC. Of counsel on the brief for Abbott Laboratories were William F. Cavanaugh, Jr., Jeffrey I.D. Lewis, and <a id="co_link_I817ac42122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0324427901&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Stuart E. Pollack</a>, Patterson Belknap Webb &amp; Tyler LLP, of New York, NY. Of counsel was <a id="co_link_I817ac42222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0383171101&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">John C. Knapp</a>. On the briefs for Astellas Pharma, Inc., were Richard D. Kelly, Stephen G. Baxter and Frank J. West, Oblon, Spivak, McClelland, Maier &amp; Neustadt, P.C., of Alexandria, VA.</div><div><a id="co_link_I817ac42322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0320987501&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Meredith Martin Addy</a>, Brinks, Hofer, Gilson &amp; Lione, of Chicago, IL, argued for defendant-appellee Sandoz, Inc. With her on the brief were <a id="co_link_I817ac42422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0110739401&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Thomas J. Filarski</a>, <a id="co_link_I817ac42522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0178325001&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Mark H. Remus</a>, <a id="co_link_I817ac42622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0327652401&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">C. Noel Kaman</a>, and <a id="co_link_I817ac42722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0375030401&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Laura A. Lydigsen</a>. Of counsel was <a id="co_link_I817ac42822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0369263901&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Rashad L. Morgan</a>.</div><div><a id="co_link_I817ac42922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0172765001&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Thomas J. Meloro, Jr.</a>, Wilkie Farr &amp; Gallagher LLP, of New York, NY, argued for defendants-appellees Teva Pharmaceuticals USA, Inc., et al. With him on the brief was <a id="co_link_I817ac42a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0324421901&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Neal K. Feivelson</a>. Of counsel were <a id="co_link_I817ac42b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0273720601&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Michael W. Johnson</a> and <a id="co_link_I817ac42c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0334503701&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Alexander H. Swirnoff</a>.</div><div> <span class="co_starPage" id="co_pp_sp_506_1285"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1285&quot; }" alt="metadata" type="hidden">*1285</span> <a id="co_link_I817ac42d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0320748301&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Deanne M. Mazzochi</a>, Rakoczy Molino Mazzochi Siwik, LLP, of Chicago, IL, argued for plaintiff/counterclaim defendant-appellee Lupin Limited and counterclaim defendant-appellee, Lupin Pharmaceuticals, Inc. in 2007–1446. With her on the brief were <a id="co_link_I817ac42e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0203637401&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">William A. Rakoczy</a>, <a id="co_link_I817ac42f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0261873301&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Paul J. Molino</a>, and <a id="co_link_I817ac43022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0333974001&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Amy D. Brody</a>.</div></div><div class="co_contentBlock co_briefItState co_panelBlock"><div>Before <a id="co_link_I817ac43122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0168544101&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">RADER</a>, <a id="co_link_I817ac43222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0211198701&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">PLAGER</a>, and <a id="co_link_I817ac43322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0112582701&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">BRYSON</a>, Circuit Judges. <a id="co_link_I817ac43422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0241391201&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">MICHEL</a>, Chief Judge, and <a id="co_link_I817ac43522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0168544101&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">RADER</a>, <a id="co_link_I817ac43622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0112582701&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">BRYSON</a>, GAJARSA, <a id="co_link_I817ac43822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0166807701&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">LINN</a>, <a id="co_link_I817ac43922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0127930301&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">DYK</a>, <a id="co_link_I817ac43a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0324402101&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">PROST</a>, and <a id="co_link_I817ac43b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0368246101&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">MOORE</a>, Circuit Judges, have joined Section III.A.2 of the opinion.<input id="co_docMarker_3" type="hidden"> Dissenting opinion as to Section III.A.2 filed by <a id="co_link_I817ac43c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0245882601&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">NEWMAN</a>, Circuit Judge, in which <a id="co_link_I817ac43d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0146644601&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">MAYER</a> and <a id="co_link_I817ac43e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0225327201&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">LOURIE</a>, Circuit Judges, join. Dissenting opinion filed by <a id="co_link_I817ac43f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0225327201&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">LOURIE</a>, Circuit Judge. <a id="co_link_I817ac44022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0144380101&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">SCHALL</a>, Circuit Judge, did not participate as a member of the en banc court.</div></div><div class="co_contentBlock co_briefItState co_opinionBlock"><h2 id="co_opinion" class="co_printHeading">Opinion</h2><div class="co_docDelivery_dottedLine"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/co_docDelivery_dottedLine.png" alt=""></div><div class="co_contentBlock x_opinionBlockBody"><div class="co_contentBlock x_opinionLead"><div class="co_contentBlock x_leadAuthorLineBlock"><div class="co_contentBlock x_leadAuthorLine"><a id="co_link_I817ac44122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0168544101&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">RADER</a>, Circuit Judge.</div></div><div class="co_contentBlock x_opinionBody"><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I43bdb7f422b911e89bf099c0ee06c731"><div class="co_paragraph"><div class="co_paragraphText">In this case, the same patent, <a id="co_link_I817ac44222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">U.S. Patent No. 4,935,507 (the ′507 patent)</a>, occasions litigation in both the United States District Court for the Eastern District of Virginia and the United States District Court for the Northern District of Illinois. The Virginia District Court granted the motion of Lupin Ltd. and Lupin Pharmaceuticals Inc. (collectively Lupin) for summary judgment of noninfringement. In the other case, the Illinois District Court denied a preliminary injunction to Abbott Laboratories, the exclusive licensee of the ′<a id="co_link_I817ac44322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a>, based on the claim construction from the Eastern District of Virginia.</div></div><div class="co_paragraph"><div class="co_paragraphText">Because the Eastern District of Virginia correctly construed the claims of the ′<a id="co_link_I817ac44422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a> and correctly discerned no genuine issues of material fact on literal infringement of claims 2–5 or infringement by equivalents of claims 1–5, this court affirms its partial summary judgment of noninfringement. Likewise, this court affirms the Northern District of Illinois' denial of Abbott's motion for a preliminary injunction, based in large part on the same correct claim construction.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I43bdb7f522b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign2"><span class="co_smallCaps">I.</span></div><div class="co_paragraph"><div class="co_paragraphText">Abbott Laboratories, the exclusive licensee of the ′<a id="co_link_I817ac44522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a>, markets crystalline cefdinir according to the ′<a id="co_link_I817ac44622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a> under the trade name Omnicef. The Virginia case arose when Lupin sought a declaratory judgment of noninfringement against Abbott Laboratories and Astellas Pharma Inc., the owner of the ′<a id="co_link_I817ac44722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a> (collectively Abbott). The Food and Drug Administration had previously approved Lupin's Abbreviated New Drug Application (ANDA) to market a generic version of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I36ca442d475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I36ca442d475111db9765f9243f53508a">Omnicef</a>. Lupin's generic product contains almost exclusively the Crystal B form of crystalline <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3c66ba55475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3c66ba55475111db9765f9243f53508a">cefdinir</a> (<a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3c66ba55475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3c66ba55475111db9765f9243f53508a_0">cefdinir</a> monohydrate), whereas Abbott's <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I36ca442d475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I36ca442d475111db9765f9243f53508a_0">Omnicef</a> product contains the Crystal A form of crystalline <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3c66ba55475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3c66ba55475111db9765f9243f53508a_1">cefdinir</a> (<a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3c66ba55475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3c66ba55475111db9765f9243f53508a_2">cefdinir</a> anhydrate). Further, Lupin makes its products with processes other than those claimed in the ′<a id="co_link_I817ac44e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a>. For these reasons, Lupin brought the Virginia action to clarify that its proposed product would not infringe a valid patent. Abbott counterclaimed for infringement. The Eastern District of Virginia construed the claims, <a id="co_link_I817ac44f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2012128034&amp;pubNum=0004637&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Lupin Ltd. v. Abbott Laboratories,</em> 484 F.Supp.2d 448 (E.D.Va.2007)</a> (<a id="co_link_I817ac45022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2012128034&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Lupin CC Order</em></a> ), and ultimately granted-in-part Lupin's motion for summary judgment of noninfringement, as to both literal and equivalent infringement for claims 2–5 and as to equivalent infringement for claim 1, <a id="co_link_I817ac45122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2012504755&amp;pubNum=0004637&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Lupin Ltd. v. Abbott Labs.,</em> 491 F.Supp.2d 563 (E.D.Va.2007)</a> (<a id="co_link_I817ac45222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2012504755&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Lupin SJ Order</em></a> ). The parties stipulated to the dismissal without prejudice of the remaining claims (invalidity) and counterclaims (literal infringement of claim 1).</div></div><div class="co_paragraph"><div class="co_paragraphText">In the Illinois action, Abbott sued Sandoz, Inc. and Sandoz GmbH (collectively Sandoz), Teva Pharmaceuticals USA, Inc.  <span class="co_starPage" id="co_pp_sp_506_1286"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1286&quot; }" alt="metadata" type="hidden">*1286</span> and Teva Pharmaceuticals Industries, Ltd. (collectively Teva), Ranbaxy Laboratories, Ltd., Ranbaxy, Inc., Par Pharmaceutical Companies, Inc., and Par Pharmaceutical (all defendants, collectively, Sandoz and Teva) for infringement of the ′<a id="co_link_I817ac45322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a>. Like Lupin, Sandoz and Teva had previously filed ANDAs, seeking to market generic versions of Omnicef. Abbott sought a preliminary injunction in the Illinois case. For purposes of that motion, the parties agreed to adopt the Eastern District of Virginia's claim construction from the <input id="co_docMarker_4" type="hidden"><em>Lupin</em> case. <a id="co_link_I817ac45522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2012184789&amp;pubNum=0004637&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Abbott Labs. v. Sandoz, Inc.,</em> 486 F.Supp.2d 767 (N.D.Ill.2007)</a> (<a id="co_link_I817ac45622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2012184789&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Sandoz PI Order</em></a> ). Despite this agreement, the parties to the <em>Sandoz</em> case disagreed as to how to interpret some of the <a id="co_link_I817ac45822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2012184789&amp;pubNum=0004637&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_4637_770&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_4637_770">Eastern District of Virginia's constructions, necessitating some clarification by the Northern District of Illinois. 486 F.Supp.2d at 770–71</a> (disputing “Crystal A,” “peaks,” and “about,” and seeking construction of “powder X-ray diffraction pattern,” which the Eastern District of Virginia had not defined). Ultimately, the Northern District of Illinois, based on the claim construction from Virginia, denied the preliminary injunction.</div></div><div class="co_paragraph"><div class="co_paragraphText">Both cases arrived at this court on appeal. This court heard the cases together and decides them together with this decision.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I43bdb7f622b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign2"><span class="co_smallCaps">II.</span></div><div class="co_paragraph"><div class="co_paragraphText">The ′<a id="co_link_I817ac45922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a> has five claims, all of which Abbott asserts against Lupin as well as Sandoz and Teva. Claim 1 claims crystalline cefdinir, using its chemical name, and defining its unique characteristics with powder X-ray diffraction (PXRD) angle peaks:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>1. Crystalline 7–[2–(2–a minothiazol–4–yl)–2–hydroxyiminoacetamido]–3–vinyl–3–cephem.–4–carboxylic acid (syn isomer) which shows the peaks at the diffraction angles shown in the following table in its powder <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=mproc&amp;entityId=Ibf04a8c7475411db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_Ibf04a8c7475411db9765f9243f53508a">X-ray diffraction</a> pattern:</div></blockquote></div></div></div><div id="co_anchor_tbl3"><table class="co_borderTop co_extraPadding co_ampexHorizRule " style="width:100%;"><tbody><tr><td class="co_hAlign1 co_vAlign3 " style="width:11.1%"><div class="co_paragraph"><div class="co_paragraphText"> </div></div></td><td class="co_hAlign2 co_vAlign3 co_borderBottom " style="width:88.9%"><div class="co_paragraph"><div class="co_paragraphText">diffraction angle (°)</div></div></td></tr><tr><td class="co_hAlign1 co_vAlign3 " style="width:11.1%"><div class="co_paragraph"><div class="co_paragraphText"></div></div></td><td class="co_hAlign2 co_vAlign3 " style="width:88.9%"><div class="co_paragraph"><div class="co_paragraphText">about 14.7°</div></div></td></tr><tr><td class="co_hAlign1 co_vAlign3 " style="width:11.1%"><div class="co_paragraph"><div class="co_paragraphText"></div></div></td><td class="co_hAlign2 co_vAlign3 " style="width:88.9%"><div class="co_paragraph"><div class="co_paragraphText">about 17.8°</div></div></td></tr><tr><td class="co_hAlign1 co_vAlign3 " style="width:11.1%"><div class="co_paragraph"><div class="co_paragraphText"></div></div></td><td class="co_hAlign2 co_vAlign3 " style="width:88.9%"><div class="co_paragraph"><div class="co_paragraphText">about 21.5°</div></div></td></tr><tr><td class="co_hAlign1 co_vAlign3 " style="width:11.1%"><div class="co_paragraph"><div class="co_paragraphText"></div></div></td><td class="co_hAlign2 co_vAlign3 " style="width:88.9%"><div class="co_paragraph"><div class="co_paragraphText">about 22.0°</div></div></td></tr><tr><td class="co_hAlign1 co_vAlign3 " style="width:11.1%"><div class="co_paragraph"><div class="co_paragraphText"></div></div></td><td class="co_hAlign2 co_vAlign3 " style="width:88.9%"><div class="co_paragraph"><div class="co_paragraphText">about 23.4°</div></div></td></tr><tr><td class="co_hAlign1 co_vAlign3 " style="width:11.1%"><div class="co_paragraph"><div class="co_paragraphText"></div></div></td><td class="co_hAlign2 co_vAlign3 " style="width:88.9%"><div class="co_paragraph"><div class="co_paragraphText">about 24.5°</div></div></td></tr><tr><td class="co_hAlign1 co_vAlign3 " style="width:11.1%"><div class="co_paragraph"><div class="co_paragraphText"></div></div></td><td class="co_hAlign2 co_vAlign3 co_borderBottom " style="width:88.9%"><div class="co_paragraph"><div class="co_paragraphText">about 28.1°</div></div></td></tr></tbody></table></div><div class="co_paragraph"><div class="co_paragraphText co_flush">′<a id="co_link_I817ac45b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a>, col.16 ll.13–27. In contrast, claims 2–5 claim crystalline cefdinir, without any PXRD peak limitations, but with descriptions of processes used to obtain the crystalline cefdinir. Claims 2 and 5 are independent:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">2. Crystalline 7–[2–(2–a minothiazol–4–yl)–2–hydroxyiminoacetamido] –3–vinyl–3–cephem–4–carboxylic acid (syn isomer) which is obtainable by acidifying a solution containing 7–[2–(2–aminothiazol–4–yl)–2–hydroxyiminoacetamido]–3–vinyl –3–cephem–4–carboxylic acid (syn isomer) at room temperature or under warming.</div></div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">5. Crystalline 7–[2–(2–aminothiazol–4–yl)–2–hydroxyiminoacetamido]–3–vinyl –3–cephem–4–carboxylic acid (syn isomer) which is obtainable by dissolving 7–[2–(2–aminothiazol–4–yl)–2 –hydroxyiminoacetamido]–3–vinyl–3–cephem–4–carboxylic acid (syn isomer) in an alcohol, continuing to stir the solution slowly under warming, then cooling the solution to room temperature and allowing the solution to stand.</div></div><div class="co_paragraphText co_flush"><a id="co_link_I817ac45c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> at col. 16 ll.29–34, 43–50.</div></div><div class="co_paragraph"><div class="co_paragraphText">These claims use PXRD as a way to claim the structure and characteristics of the unique crystalline form. PXRD is a method for identifying and distinguishing different crystalline compounds. The method beams X-rays toward a powdered chemical. The method then measures the ways the rays reflect or bend upon contact with the chemical. The diffraction angles  <span class="co_starPage" id="co_pp_sp_506_1287"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1287&quot; }" alt="metadata" type="hidden">*1287</span> and intensities vary with the type and purity of the test compound. A graph then plots the diffraction angle on one axis and the intensity on another. These graphs yield a unique “fingerprint” for each crystalline form of a chemical. A more sensitive form of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=mproc&amp;entityId=Ibf04a8c7475411db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_Ibf04a8c7475411db9765f9243f53508a_0">X-ray diffraction</a> is single crystal <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=mproc&amp;entityId=Ibf04a8c7475411db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_Ibf04a8c7475411db9765f9243f53508a_1">X-ray diffraction</a> (SCXRD). As this name suggests, this method uses only a single crystal as a sample. SCXRD does not detect intensity, but produces a more precise diffraction angle measurement.</div></div><div class="co_paragraph"><div class="co_paragraphText">The ′<a id="co_link_I817ac45f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a> was not the first cefdinir patent. Rather, Astellas' prior art <a id="co_link_I817ac46022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1985169484&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I3903a21071f311d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">U.S. Patent No. 4,559,334 (the ′334 patent)</a> describes the discovery of cefdinir as a compound demonstrating high antimicrobial activity. <a id="co_link_I817ac46122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1985169484&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I3903a21071f311d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">′334 patent</a>, col. 11 ll.18–24. The ′<a id="co_link_I817ac46222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1985169484&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I3903a21071f311d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">334 patent</a> expired on May 6, 2007.</div></div><div class="co_paragraph"><div class="co_paragraphText">The ′<a id="co_link_I817ac46322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a> claims priority to Japanese Patent Application No. 62–206199 (the JP ′199 application), which claimed two crystalline forms of cefdinir, “Crystal A” and “Crystal B.” The JP ′199 application claimed Crystals A and B very specifically, defining Crystal A by three infrared (IR)-absorption wavelengths and sixteen PXRD angles and intensities. In contrast, Crystal B featured five IR-absorption wavelengths and twenty-one PXRD angles/intensities.<input id="co_docMarker_5" type="hidden"></div></div><div class="co_paragraph"><div class="co_paragraphText">Despite using the JP ′199 application for priority, the ′<a id="co_link_I817ac46422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a>'s specification differs significantly. Specifically, Abbott (actually Fujisawa Pharmaceutical Co., Ltd., Astellas' predecessor in interest) jettisoned the Crystal B disclosure found in the JP ′199 application and crafted broader claims in its prosecution of the ′<a id="co_link_I817ac46522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a>. Because the JP ′199 applications defines Crystal A and Crystal B physiochemically rather than structurally, the forms actually represent subgenuses of crystalline cefdinir. Thus Crystals A and B comprise crystalline forms of varying structures, which in the context of this case means varying levels of hydration.</div></div><div class="co_paragraph"><div class="co_paragraphText">The Eastern District of Virginia construed the claim terms “crystalline,” “shows,” “peaks,” and “about” as follows:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">1) “crystalline” means “Crystal A as outlined in the specification”;</div></div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">2) “shows” requires the display of a powder X-ray diffraction pattern which demonstrates the existence of the relevant peaks to a scientifically acceptable degree of certainty either visually or by other appropriate means of data display;</div></div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">3) “peaks” is the plural of “peak;” a “peak exists at a powder <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=mproc&amp;entityId=Ibf04a8c7475411db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_Ibf04a8c7475411db9765f9243f53508a_2">X-ray diffraction</a> angle that corresponds to an intensity measurement greater than measurements attributable to “noise” if that angle is immediately preceded by and followed by powder <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=mproc&amp;entityId=Ibf04a8c7475411db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_Ibf04a8c7475411db9765f9243f53508a_3">X-ray diffraction</a> angle with a lower intensity measurement; “noise” refers to those portions of a PXRD pattern produced by intrinsic measurement error, and which cannot be associated with a scientifically significant quantity of the material which is the subject of the PXRD test;</div></div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">4) “about” encompasses measurement errors inherently associated with powder X-ray diffraction testing.</div></div><div class="co_paragraphText co_flush"><a id="co_link_I817ac46822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2012128034&amp;pubNum=4637&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_4637_459&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_4637_459"><em>Lupin CC Order,</em> 484 F.Supp.2d at 459, 466.</a> The Eastern District of Virginia also concluded that claims 2–5 were product-by-process claims. <em>Id.</em> Later the district court concluded that the process terms of claims 2–5, indicated by the phrase “obtainable by,” limit the claims to the specified processes and process steps. In reaching that conclusion, the trial court followed this court's opinion in <a id="co_link_I817ac46a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1992124244&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Atlantic Thermoplastics Co. v. Faytex Corp.,</em> 970 F.2d 834 (Fed.Cir.1992)</a>. <a id="co_link_I817ac46b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2012504755&amp;pubNum=4637&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_4637_567&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_4637_567"><em>Lupin SJ Order,</em> 491 F.Supp.2d at 567–68;</a> <em>Lupin Ltd. v. Abbott Labs.,</em> No. 3:06–CV–400 (E.D.Va. May 10, 2007) (<em>Lupin PbyP Order</em> ). In the <em>Lupin</em> appeal, Abbott challenges only  <span class="co_starPage" id="co_pp_sp_506_1288"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1288&quot; }" alt="metadata" type="hidden">*1288</span> the Eastern District of Virginia's constructions of “crystalline” and “obtainable by.”</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I43bdb7f722b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign2"><span class="co_smallCaps">III.</span></div><div class="co_paragraph"><div class="co_paragraphText">Evaluation of a summary judgment of noninfringement requires two steps: claim construction, which this court reviews without deference, <a id="co_link_I817ac46e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998077754&amp;pubNum=0000506&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1451&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1451"><em>Cybor Corp. v. FAS Technologies, Inc.,</em> 138 F.3d 1448, 1451 (Fed.Cir.1998)</a> (en banc), and comparison of the properly construed claims to the accused product, process, or composition of matter, which in the context of summary judgment also occurs without deference, <em>see </em><a id="co_link_I817ac46f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2012981465&amp;pubNum=0000506&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1312&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1312"><em>Ormco Corp. v. Align Technology, Inc.,</em> 498 F.3d 1307, 1312 (Fed.Cir.2007)</a>. Although infringement by equivalency is a question of fact, this court may affirm summary judgment “where no reasonable fact finder could find equivalence.” <a id="co_link_I817ac47022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997192974&amp;pubNum=0000506&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1423&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1423"><em>Sage Prods., Inc. v. Devon Indus., Inc.,</em> 126 F.3d 1420, 1423 (Fed.Cir.1997)</a> (citing <a id="co_link_I817ac47122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997060689&amp;pubNum=708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Warner–Jenkinson Co. v. Hilton Davis Chemical Co.,</em> 520 U.S. 17, 39 n. 8, 117 S.Ct. 1040, 137 L.Ed.2d 146 (1997))</a>.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I43bdb7f822b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign2">A. Claim Construction</div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F12018850794" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF1">1</a><a id="co_anchor_B12018850794"></a> Because the claims define the patent right, <em>see </em><a id="co_link_I817ac47222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004844816&amp;pubNum=0000506&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1115&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1115"><em>Innova/Pure Water, Inc. v. Safari Water Filtration Systems, Inc.,</em> 381 F.3d 1111, 1115 (Fed.Cir.2004)</a>, naturally “the claims themselves provide substantial guidance as to the meaning of particular claim terms.”<input id="co_docMarker_6" type="hidden"> <a id="co_link_I817ac47322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2006931523&amp;pubNum=0000506&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1314&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1314"><em>Phillips v. AWH Corp.,</em> 415 F.3d 1303, 1314 (Fed.Cir.2005)</a> (en banc). But the claims “must be read in view of the specification, of which they are a part.” <a id="co_link_I817ac47422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1995081690&amp;pubNum=0000506&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_979&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_979"><em>Markman v. Westview Instruments, Inc.,</em> 52 F.3d 967, 979 (Fed.Cir.1995)</a> (en banc), <em>aff'd,</em> <a id="co_link_I817ac47522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1996098750&amp;pubNum=0000708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">517 U.S. 370, 116 S.Ct. 1384, 134 L.Ed.2d 577 (1996)</a>. A patent's specification provides necessary context for understanding the claims, and “is always highly relevant to the claim construction analysis.” <a id="co_link_I817ac47622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2006931523&amp;pubNum=0000506&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1315&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1315"><em>Phillips,</em> 415 F.3d at 1315</a> (quoting <a id="co_link_I817ac47722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1996170371&amp;pubNum=0000506&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1582&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1582"><em>Vitronics Corp. v. Conceptronic, Inc.,</em> 90 F.3d 1576, 1582 (Fed.Cir.1996)</a>). While equally true in a general sense, sometimes the specification offers practically incontrovertible directions about claim meaning. For example, inventors may act as their own lexicographers and give a specialized definition of claim terms. <em>See </em><a id="co_link_I817ac47822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2006931523&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>id.</em> at 1316.</a> Likewise, inventors and applicants may intentionally disclaim, or disavow, subject matter that would otherwise fall within the scope of the claim. <em>See <a id="co_link_I817ac47922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2006931523&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">id.</a></em></div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F22018850794" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF2">2</a><a id="co_anchor_B22018850794"></a><a href="#co_anchor_F32018850794" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF3">3</a><a id="co_anchor_B32018850794"></a><a href="#co_anchor_F42018850794" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF4">4</a><a id="co_anchor_B42018850794"></a><a href="#co_anchor_F52018850794" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF5">5</a><a id="co_anchor_B52018850794"></a> When consulting the specification to clarify the meaning of claim terms, courts must take care not to import limitations into the claims from the specification. This court has recognized the “fine line between” the encouraged and the prohibited use of the specification. <a id="co_link_I817ac47a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998191488&amp;pubNum=0000506&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1186&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1186"><em>Comark Commc'ns, Inc. v. Harris Corp.,</em> 156 F.3d 1182, 1186 (Fed.Cir.1998)</a>. When the specification describes a single embodiment to enable the invention, this court will not limit broader claim language to that single application “unless the patentee has demonstrated a clear intention to limit the claim scope using ‘words or expressions of manifest exclusion or restriction.’ ” <a id="co_link_I817ac47b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004121243&amp;pubNum=0000506&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_906&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_906"><em>Liebel–Flarsheim Co. v. Medrad, Inc.,</em> 358 F.3d 898, 906 (Fed.Cir.2004)</a> (quoting <a id="co_link_I817ac47c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002390499&amp;pubNum=0000506&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1327&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1327"><em>Teleflex, Inc. v. Ficosa N. Am. Corp.,</em> 299 F.3d 1313, 1327 (Fed.Cir.2002)</a>). By the same token, the claims cannot “enlarge what is patented beyond what the inventor has described as the invention.” <a id="co_link_I817ac47d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2003124674&amp;pubNum=0000506&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1140&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1140"><em>Biogen, Inc. v. Berlex Labs., Inc.,</em> 318 F.3d 1132, 1140 (Fed.Cir.2003)</a> (quoting <a id="co_link_I817ac47e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2001224511&amp;pubNum=0000506&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1352&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1352"><em>Netword, LLC v. Centraal Corp.,</em> 242 F.3d 1347, 1352 (Fed.Cir.2001)</a>). Thus this court may reach a narrower construction, limited to the embodiment(s) disclosed in the specification, when the claims themselves, the specification, or the prosecution history clearly indicate that the invention encompasses no more than that confined structure or method. <em>See </em><a id="co_link_I817ac47f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004121243&amp;pubNum=0000506&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_908&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_908"><em>Liebel–Flarsheim,</em> 358 F.3d at 908</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F62018850794" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF6">6</a><a id="co_anchor_B62018850794"></a> Along with the specification, the prosecution history is “intrinsic evidence”  <span class="co_starPage" id="co_pp_sp_506_1289"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1289&quot; }" alt="metadata" type="hidden">*1289</span> of the meaning of the claims, because it “provides evidence of how the [United States Patent &amp; Trademark Office (PTO) ] and the inventor understood the patent.” <a id="co_link_I817ac48022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2006931523&amp;pubNum=506&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1317&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1317"><em>Phillips,</em> 415 F.3d at 1317.</a> Although often producing ambiguities occasioned by ongoing negotiations between the inventor and the PTO, “the prosecution history can often inform the meaning of the claim language by demonstrating how the inventor understood the invention and whether the inventor limited the invention in the course of prosecution, making the claim scope narrower than it would otherwise be.” <em>Id.</em> “[C]lear and unmistakable” statements during prosecution may also disavow claim scope. <a id="co_link_I817ac48222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2015548564&amp;pubNum=0000506&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1374&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1374"><em>Computer Docking Station Corp. v. Dell, Inc.,</em> 519 F.3d 1366, 1374 (Fed.Cir.2008)</a> (quoting <a id="co_link_I817ac48322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2008327056&amp;pubNum=0000506&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1136&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1136"><em>Purdue Pharma L.P. v. Endo Pharms., Inc.,</em> 438 F.3d 1123, 1136 (Fed.Cir.2006)</a>). Again owing in part to the inherent ambiguities of prosecution history, the doctrine of prosecution disclaimer only applies to unambiguous disavowals. <em>See </em><a id="co_link_I817ac48422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2015548564&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>id.</em> at 1375.</a></div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I43bdb7f922b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign2">1. “crystalline”</div><div class="co_paragraph"><div class="co_paragraphText">The Eastern District of Virginia's construction of “crystalline” in claims 1–5 as “Crystal A” included the important caveat “as outlined in the specification.” <input id="co_docMarker_7" type="hidden"><a id="co_link_I817ac48522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2012128034&amp;pubNum=4637&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_4637_459&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_4637_459"><em>Lupin CC Order,</em> 484 F.Supp.2d at 459.</a> Although the Eastern District noted the parties agreed that “crystalline” ordinarily means exhibiting “uniformly arranged molecules or atoms,” <a id="co_link_I817ac48622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2012128034&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>id.</em> at 454,</a> the court relied on the language of the claims themselves, the specification, and the prosecution history to arrive at the more specific meaning recited in the specification.</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F72018850794" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF7">7</a><a id="co_anchor_B72018850794"></a> The ′507 specification states that “Crystal A of the compound (I) [cefdinir] shows its distinguishing peaks” at the seven particular PXRD angles enumerated in claim 1. ′<a id="co_link_I817ac48722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a> col.1 ll.51–62. Indeed, the phrase “Crystal A of the compound (I)” appears throughout the written description, and the patent offers the following definition: “any crystal of the compound (I) which shows substantially the same diffraction pattern [as in the table in col.1/claim 1] is identified as Crystal A of the compound (I).” <a id="co_link_I817ac48822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> at col.1 l.67–col.2 l.2. As the Eastern District correctly concluded:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>Had Astellas intended, in the chart found in column 1, to distinguish Crystal A from other forms of crystalline cefdinir that also fall within the scope of claim 1, it would have listed, at a minimum, an eighth peak associated only with Crystal A. However, by listing in column 1 only the same seven ‘distinguishing’ peaks featured in Claim 1, Astellas confirmed that Crystal A was synonymous with the invention listed in Claim 1.</div></blockquote></div></div><div class="co_paragraphText co_flush"><a id="co_link_I817ac48922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2012128034&amp;pubNum=4637&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_4637_456&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_4637_456"><em>Lupin CC Order,</em> 484 F.Supp.2d at 456–57.</a> The problem, within the confines of claim 1, is that defining “crystalline” as “Crystal A,” where “Crystal A” incorporates the seven PXRD peak limitations, arguably renders the remainder of that claim redundant. To distinguish the invention, however, the specification refers several times to “Crystal A of the compound (I) of the present invention,” <em>see, e.g.,</em> ′<a id="co_link_I817ac48a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a>, col.2 ll.15–17, and offers no suggestion that the recited processes could produce non-Crystal A compounds, even though other types of cefdinir crystals, namely Crystal B, were known in the art. As noted earlier, the Crystal B formulation actually appears in the parent JP ′199 application. Thus, Abbott knew exactly how to describe and claim Crystal B compounds. Knowing of Crystal B, however, Abbott chose to claim only the A form in the ′<a id="co_link_I817ac48c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a>. Thus, the trial court properly limited the term “crystalline” to “Crystal A.” The trial court's definition correctly identifies claim 1's literal scope.</div></div><div class="co_paragraph"><div class="co_paragraphText"> <span class="co_starPage" id="co_pp_sp_506_1290"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1290&quot; }" alt="metadata" type="hidden">*1290</span> Unlike claim 1, claims 2–5 do not recite the seven PXRD peaks expressly associated with Crystal A in the ′507 specification. Nonetheless, the Eastern District of Virginia limited “crystalline” to “Crystal A” in these claims as well, The trial court gave two reasons for this limitation. First, “[t]he process steps detailed in those claims [claims 2–5] correspond with the processes for making Crystal A disclosed in the specification under the heading ‘The Process For Preparing Crystal A of The Compound (I).’ ” <a id="co_link_I817ac48d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2012128034&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 457 (quoting ′507 patent, col.2 ll.13–14)</a>. Second, the parent JP ′199 application recited these steps “to distinguish between preparations of Crystal A and Crystal B.” <a id="co_link_I817ac48e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2012128034&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> (citing JP ′199 application, col.6 ll.1–25).</div></div><div class="co_paragraph"><div class="co_paragraphText">In limiting “crystalline” to “Crystal A” in claims 1–5, the Eastern District of Virginia did not improperly import the preferred embodiment into the claims. Initially, Crystal A is the only embodiment described in the specification. As discussed above, the specification's recitation of Crystal A as its sole embodiment does not alone justify the trial court's limitation of claim scope to that single disclosed embodiment. <input id="co_docMarker_8" type="hidden"><em>See </em><a id="co_link_I817ac48f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2004121243&amp;pubNum=0000506&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_906&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_906"><em>Liebel–Flarsheim,</em> 358 F.3d at 906</a> (“[T]his court has expressly rejected the contention that if a patent describes only a single embodiment, the claims of the patent must be construed as being limited to that embodiment.”). In this case, however, the rest of the intrinsic evidence, including the prosecution history and the priority JP ′199 application, evince a clear intention to limit the ′<a id="co_link_I817ac49022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a> to Crystal A as defined by the seven PXRD peaks in the specification and in claim 1.</div></div><div class="co_paragraph"><div class="co_paragraphText">Initially, the Eastern District of Virginia properly considered the JP ′199 application as relevant objective evidence of the inventor's knowledge at the filing of the ′<a id="co_link_I817ac49122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a>. While statements made during prosecution of a foreign counterpart to a U.S. patent application have a narrow application to U.S. claim construction, <a id="co_link_I817ac49222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2009645330&amp;pubNum=0000506&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1290&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1290"><em>Pfizer Inc. v. Ranbaxy Labs. Ltd.,</em> 457 F.3d 1284, 1290 (Fed.Cir.2006)</a>, in this case the JP ′199 application is part of the prosecution history of the ′<a id="co_link_I817ac49322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a> itself. Indeed the ′<a id="co_link_I817ac49422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a> claims priority from the JP ′199 application. Furthermore, the trial court did not rely on attorney argument or amendments during a foreign prosecution as in <a id="co_link_I817ac49522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2009645330&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Pfizer,</em></a> but consulted only the contents of the foreign priority application. The JP ′199 application strongly suggests that the ′<a id="co_link_I817ac49622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a> intentionally excluded Crystal B compounds. As discussed above, the JP ′199 application establishes unequivocally that Abbott knew and could describe both Crystal A and Crystal B. Abbott could have retained the disclosure of Crystal B to support the broader claims of the ′<a id="co_link_I817ac49722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a>, but instead disclosed and claimed A alone.</div></div><div class="co_paragraph"><div class="co_paragraphText">Furthermore, the prosecution history of the ′<a id="co_link_I817ac49822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a> shows a clear and intentional disavowal of claim scope beyond Crystal A. Co-inventor Takao Takaya, who prepared samples according to Examples 14 and 16 of the prior art ′<a id="co_link_I817ac49922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1985169484&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I3903a21071f311d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"> 334 patent</a> and a sample of “Crystal A of the present application,” offered a declaration that Crystal A was more stable than the prior art samples from the ′<a id="co_link_I817ac49a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1985169484&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I3903a21071f311d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">334 patent</a>. An analytical chemist, Yoshihiko Okamato, corroborated this evidence. J.A. 501–04. Beyond these declarations, the applicant specifically limited the invention to Crystal A: “the <em>method of preparation</em> of the crystalline form of the presently claimed compounds is not considered the heart of the present invention. The crystalline form of the compound represents the inventive concept hereof, and it is clear that [the ′<a id="co_link_I817ac49b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1985169484&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I3903a21071f311d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"> 334 patent</a>] does not anticipate or suggest said crystalline form.” J.A. 511 (Response to Office Action of May 11, 1989, received October 27, 1989, at 6).</div></div><div class="co_paragraph"><div class="co_paragraphText"> <span class="co_starPage" id="co_pp_sp_506_1291"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1291&quot; }" alt="metadata" type="hidden">*1291</span> Given the exclusive focus on Crystal A in the specification as well as the prosecution history of the ′<a id="co_link_I817ac49c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a>, the Eastern District of Virginia properly limited “crystalline” in claims 1–5 to “Crystal A.”</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I43bdb7fa22b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign2">2. proper interpretation of product-by process claims<sup id="co_footnoteReference_B00112018850794_ID0EGRBI"><a href="#co_footnote_B00112018850794" class="co_footnoteReference">1</a></sup></div><div class="co_paragraph"><div class="co_paragraphText">This court addresses Part III.A.2 of this opinion en banc, which addresses the proper interpretation of product-by-process claims in determining infringement.</div></div><div class="co_paragraph"><div class="co_paragraphText">Claims 2–5 of the ′<a id="co_link_I817ac49d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a> begin by reciting a product, crystalline cefdinir, and then recite a series of steps by which this product is “obtainable.” The Eastern District of Virginia correctly categorized claims 2–5 as product-by-process claims. On appeal, Abbott argues that the Eastern District erred in construing the process steps of claims 2–5 under the rule in <a id="co_link_I817ac49e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1992124244&amp;pubNum=350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_846&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_846"><em>Atlantic Thermoplastics,</em> 970 F.2d at 846–47,</a> that “process terms in product-by-process claims serve as limitations in determining infringement,”<input id="co_docMarker_9" type="hidden"> rather than in accordance with <a id="co_link_I817ac49f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1991051497&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_1583&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1583"><em>Scripps Clinic &amp; Research Foundation v. Genentech, Inc.,</em> 927 F.2d 1565, 1583 (Fed.Cir.1991)</a> (“[T]he correct reading of product-by-process claims is that they are not limited to product prepared by the process set forth in the claims.”). This court takes this opportunity to clarify en banc the scope of product-by-process claims by adopting the rule in <em>Atlantic Thermoplastics.</em></div></div><div class="co_paragraph"><div class="co_paragraphText">In <em>Atlantic Thermoplastics,</em> this court considered the scope of product-by-process claim 26 in the patent at issue: “[t]he molded innersole produced by the method of claim 1.” <a id="co_link_I817ac4a222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1992124244&amp;pubNum=350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_836&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_836">970 F.2d at 836.</a> The patentee urged that competing, indistinguishable innersoles made by a different method nonetheless infringed claim 26. <a id="co_link_I817ac4a322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1992124244&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 838.</a> This court rejected the patentee's position. This court in <em>Atlantic Thermoplastics</em> construed product-by-process claims as limited by the process. <a id="co_link_I817ac4a522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1992124244&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 846–47.</a></div></div><div class="co_paragraph"><div class="co_paragraphText">This rule finds extensive support in Supreme Court opinions that have addressed the proper reading of product-by-process claims. <em>See </em><a id="co_link_I817ac4a622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1876191350&amp;pubNum=0000780&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_780_493&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_780_493"><em>Smith v. Goodyear Dental Vulcanite Co.,</em> 93 U.S. 486, 493, 23 L.Ed. 952 (1877)</a> (“The process detailed is thereby made as much a part of the invention as are the materials of which the product is composed.”); <a id="co_link_I817ac4a722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1880197551&amp;pubNum=0000780&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_780_224&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_780_224"><em>Goodyear Dental Vulcanite Co. v. Davis,</em> 102 U.S. 222, 224, 26 L.Ed. 149 (1880)</a> (“[T]o constitute infringement of the patent, both the material of which the <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=mdev&amp;entityId=Iaea4eaad475411db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_Iaea4eaad475411db9765f9243f53508a">dental plate</a> is made ... and the process of constructing the plate ... must be employed.”); <a id="co_link_I817ac4a922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1876154712&amp;pubNum=0000780&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Merrill v. Yeomans,</em> 94 U.S. 568, 24 L.Ed. 235 (1877)</a>; <a id="co_link_I817ac4aa22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;pubNum=0000708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Cochrane v. Badische Anilin &amp; Soda Fabrik,</em> 111 U.S. 293, 4 S.Ct. 455, 28 L.Ed. 433 (1884)</a> ( <a id="co_link_I817ac4ab22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>BASF</em></a>); <a id="co_link_I817ac4ac22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1874193215&amp;pubNum=780&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>The Wood–Paper Patent,</em> 23 Wall. 566, 90 U.S. 566, 596, 23 L.Ed. 31 (1874)</a>; <a id="co_link_I817ae85022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1887180058&amp;pubNum=0000708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Plummer v. Sargent,</em> 120 U.S. 442, 7 S.Ct. 640, 30 L.Ed. 737 (1887)</a>; <a id="co_link_I817ae85122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1938122169&amp;pubNum=0000708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Gen. Elec. Co. v. Wabash Appliance Corp.,</em> 304 U.S. 364, 58 S.Ct. 899, 82 L.Ed. 1402 (1938)</a>; <em>see also </em><a id="co_link_I817ae85222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1992124244&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_839&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_839"><em>Atl. Thermoplastics,</em> 970 F.2d at 839–42</a> (discussing each of these cases). In these cases, the Supreme Court consistently noted that process terms that define the product in a product-by-process claim serve as enforceable limitations. In addition, the binding case law of this court's predecessor courts, the United States Court of Customs and Patent Appeals (<em>see </em><a id="co_link_I817ae85322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1974110542&amp;pubNum=350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_1219&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1219"><em>In re Hughes,</em> 496 F.2d 1216, 1219 (CCPA 1974)</a> (acknowledging that “true product claims” are “broader” in scope than product-by-process claims)),  <span class="co_starPage" id="co_pp_sp_506_1292"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1292&quot; }" alt="metadata" type="hidden">*1292</span> and the United States Court of Claims (<em>see </em><a id="co_link_I817ae85422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1969117740&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_751&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_751"><em>Tri–Wall Containers v. United States,</em> 187 Ct.Cl. 326, 408 F.2d 748, 751 (1969)</a>), followed the same rule.</div></div><div class="co_paragraph"><div class="co_paragraphText">This court's sister circuits also followed the general rule that the defining process terms limit product-by-process claims. <em>See, e.g., </em><a id="co_link_I817ae85522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1915100705&amp;pubNum=0000348&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_348_36&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_348_36"><em>Hide–Ite Leather v. Fiber Prods.,</em> 226 F. 34, 36 (1st Cir.1915)</a> (“It is also a well-recognized rule that, although a product has definite characteristics by which it may be identified apart from the process, still, if in a claim for the product it is not so described, but is set forth in the terms of the process, nothing can be held to infringe the claim which is not made by the process.”); <a id="co_link_I817ae85622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1977123842&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_876&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_876"><em>Paeco, Inc. v. Applied Moldings, Inc.,</em> 562 F.2d 870, 876 (3d Cir.1977)</a> (“A patent granted on a product claim describing one process grants no monopoly as to identical products manufactured by a different process.”). Indeed, this court itself had articulated that rule: “For this reason, even though <em>product-by-process claims are limited by and defined by the process,</em> determination of patentability is based on the product itself.” <a id="co_link_I817ae85722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1985157061&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_697&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_697"><em>In re Thorpe,<input id="co_docMarker_10" type="hidden"></em> 777 F.2d 695, 697 (Fed.Cir.1985)</a> (emphasis added).</div></div><div class="co_paragraph"><div class="co_paragraphText">The Supreme Court has long emphasized the limiting requirement of process steps in product-by-process claims. In <a id="co_link_I817ae85822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>BASF,</em></a> the Court considered a patent relating to artificial alizarine. Specifically, the patent claimed “[a]rtificial alizarine, produced from anthracine or its derivatives by either of the methods herein described, or by any other method which will produce a like result.” <a id="co_link_I817ae85922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;pubNum=0000708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">111 U.S. at 296, 4 S.Ct. 455</a> (quoting <a id="co_link_I817ae85a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1871172039&amp;pubNum=0004073&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9f20a0ed1b7911dbb0d3b726c66cf290&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">U.S. Patent Reissue No. RE 4,321</a>). In turn, the specification generally described a method for making artificial alizarine involving anthracine or its derivatives. Alizarine had been in use for thousands of years as a red textile dye, traditionally extracted from madder root. Pure alizarine has the chemical formula C<sub>14</sub>H<sub>8</sub> O<sub>4</sub>, but “artificial alizarines” available in the market at the time of the litigation varied from almost completely pure alizarine, to combinations of alizarine and anthrapurpurine, to pure purpurine containing no alizarine whatsoever. <a id="co_link_I817ae85b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;pubNum=708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 309–10, 4 S.Ct. 455.</a> The defendant's product contained approximately sixty percent anthrapurpurine. Thus both alizarine and artificial alizarines were known in the prior art. The Supreme Court clearly articulated some of the scope and validity problems that arise when process limitations of product-by-process claims are ignored:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">[The defendant's product] is claimed by the plaintiff to be the artificial alizarine described in No. 4,321, and to be physically, chemically, and in coloring properties similar to that. But what that is is not defined in No. 4,321, except that it is the product of the process described in No. 4,321. Therefore, unless it is shown that the process of No. 4,321 was followed to produce the defendant's article, or unless it is shown that that article could not be produced by any other process, the defendant's article cannot be identified as the product of the process of No. 4,321. Nothing of the kind is shown.</div></div></div><div class="co_paragraph"><div class="co_paragraphText"> * * *</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">If the words of the claim are to be construed to cover all artificial alizarine, whatever its ingredients, produced from anthracine or its derivatives by methods invented since Graebe and Liebermann invented the bromine process, we then have a patent for a product or composition of matter which gives no information as to how it is to be identified. <em>Every patent for a product or composition of matter must identify it so that it can be recognized aside from the description of the process for making it, or else nothing can be held to infringe the  <span class="co_starPage" id="co_pp_sp_506_1293"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1293&quot; }" alt="metadata" type="hidden">*1293</span> patent which is not made by that process.</em></div></div><div class="co_paragraphText co_flush"><a id="co_link_I817ae85c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;pubNum=708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 310, 4 S.Ct. 455</a> (emphasis added).</div></div><div class="co_paragraph"><div class="co_paragraphText">After <a id="co_link_I817ae85d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>BASF,</em></a> the Supreme Court continued to emphasize the importance of process steps in evaluating the infringement of product-by-process claims. <em>See, e.g., </em><a id="co_link_I817ae85e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1887180058&amp;pubNum=0000708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Plummer,</em> 120 U.S. at 448, 7 S.Ct. 640</a> (“[W]hatever likeness that may appear between the product of the process described in the patent and the article made by the defendants, their identity is not established unless it is shown that they are made by the same process.”); <a id="co_link_I817ae85f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1938122169&amp;pubNum=0000708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Gen. Elec. Co.,</em> 304 U.S. at 373, 58 S.Ct. 899</a> (“[A] patentee who does not distinguish his product from what is old except by reference, express or constructive, to the process by which he produced it, cannot secure a monopoly on the product by whatever means produced.” (footnote omitted)).</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F82018850794" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF8">8</a><a id="co_anchor_B82018850794"></a> Thus, based on Supreme Court precedent and the treatment of product-by-process claims throughout the years by the PTO and other binding court decisions, this court now restates that <input id="co_docMarker_11" type="hidden">“process terms in product-by-process claims serve as limitations in determining infringement.” <a id="co_link_I817ae86022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1992124244&amp;pubNum=350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_846&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_846"><em>Atl. Thermoplastics,</em> 970 F.2d at 846–47.</a> As noted earlier, this holding follows this court's clear statement in <em>In re Thorpe</em> that “product by process claims are limited by and defined by the process.” <a id="co_link_I817ae86222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1985157061&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_697&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_697">777 F.2d at 697</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">More recently, the Supreme Court has reiterated the broad principle that “[e]ach element contained in a patent claim is deemed material to defining the scope of the patented invention.” <a id="co_link_I817ae86322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997060689&amp;pubNum=708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Warner–Jenkinson,</em> 520 U.S. at 19, 117 S.Ct. 1040.</a> Although <em>Warner–Jenkinson</em> specifically addressed the doctrine of equivalents, this rule applies to claim construction overall. As applied to product-by-process claims, <em>Warner–Jenkinson</em> thus reinforces the basic rule that the process terms limit product-by-process claims. To the extent that <em>Scripps Clinic</em> is inconsistent with this rule, this court hereby expressly overrules <em>Scripps Clinic.</em></div></div><div class="co_paragraph"><div class="co_paragraphText">The dissenting opinions lament the loss of a “right” that has never existed in practice or precedent—the right to assert a product-by-process claim against a defendant who does not practice the express limitations of the claim. This court's en banc decision in no way abridges an inventor's right to stake claims in product-by-process terms. Instead this decision merely restates the rule that the defining limitations of a claim—in this case process terms—are also the terms that show infringement.</div></div><div class="co_paragraph"><div class="co_paragraphText">Thus this court does not question at all whether product-by-process claims are legitimate as a matter of form. The legitimacy of this claim form was indeed a relevant issue in the nineteenth century when <em>Ex parte Painter,</em> 1891 C.D. 200, 200–01 (Comm'r Pat. 1891), and some later cases were before the Commissioner of Patents. However, this court need not address that settled issue. The issue here is only whether such a claim is infringed by products made by processes other than the one claimed. This court holds that it is not.</div></div><div class="co_paragraph"><div class="co_paragraphText">The jurisprudence of the Court of Customs and Patent Appeals—a court with virtually no jurisdiction to address infringement litigation—can shed little light on the enforcement of the only claim limitations that an applicant chooses to define the invention. Indeed, this court's venerable predecessor expressed its ambivalence towards the relevant infringement analysis:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>The policy of the Patent Office in permitting product-by-process type claims to define a patentable product, where necessary, has developed with full cognizance of the fact that in infringement  <span class="co_starPage" id="co_pp_sp_506_1294"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1294&quot; }" alt="metadata" type="hidden">*1294</span> suits some courts have construed such claims as covering only a product made by the particular process set forth in the claim and not to the product per se.</div></blockquote></div></div><div class="co_paragraphText co_flush"><a id="co_link_I817ae86822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1965100591&amp;pubNum=350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_683&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_683"><em>In re Bridgeford,</em> 53 C.C.P.A. 1182, 357 F.2d 679, 683 n. 5 (1966)</a>. The reference to “some courts” in this prior citation, as this court notes en banc, includes the United States Supreme Court and every circuit court to consider the question, including this circuit. <em>See also</em> Jon S. Saxe &amp; Julian S. Levitt, <em>Product–by–Process Claims and Their Current Status in Chemical Patent Office Practice,</em> 42 J. Pat. Off. Soc'y 528, 530 (1960) (“[P]roduct-by-process claims have met with a most strict interpretation in the courts in infringement proceedings.... [T]he courts uniformly hold that only a product produced by the claim-designated process may be held to infringe the claim.”) (citing <a id="co_link_I817ae86a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1938122169&amp;pubNum=0000708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Gen. Elec. Co.,</em> 304 U.S. 364, 58 S.Ct. 899, 82 L.Ed. 1402</a> and <a id="co_link_I817ae86b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;pubNum=708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>BASF,</em> 111 U.S. at 310, 4 S.Ct. 455).</a></div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F92018850794" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF9">9</a><a id="co_anchor_B92018850794"></a> Product-by-process claims, especially for those rare situations when products were difficult or impossible to describe, historically presented a concern that the Patent Office might deny <input id="co_docMarker_12" type="hidden"><em>all</em> product protection to such claims. <em>See </em><a id="co_link_I817ae86c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1930128161&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>In re Butler,</em> 17 C.C.P.A. 810, 813, 37 F.2d 623 (1930)</a> ( “Process claims are valuable, and appellant thinks he is entitled to them; but it is submitted that he should not be limited to control of the process when the article which that process produces is new and useful.”). In the modern context, however, if an inventor invents a product whose structure is either not fully known or too complex to analyze (the subject of this case—a product defined by sophisticated PXRD technology—suggests that these concerns may no longer in reality exist), this court clarifies that the inventor is absolutely free to use process steps to define this product. The patent will issue subject to the ordinary requirements of patentability. The inventor will not be denied protection. Because the inventor chose to claim the product in terms of its process, however, that definition also governs the enforcement of the bounds of the patent right. This court cannot simply ignore as verbiage the only definition supplied by the inventor.</div></div><div class="co_paragraph"><div class="co_paragraphText">This court's rule regarding the proper treatment of product-by-process claims in infringement litigation carries its own simple logic. Assume a hypothetical chemical compound defined by process terms. The inventor declines to state any structures or characteristics of this compound. The inventor of this compound obtains a product-by-process claim: “Compound X, obtained by process Y.” Enforcing this claim without reference to its defining terms would mean that an alleged infringer who produces compound X by process Z is still liable for infringement. But how would the courts ascertain that the alleged infringer's compound is really the same as the patented compound? After all, the patent holder has just informed the public and claimed the new product solely in terms of a single process. Furthermore, what analytical tools can confirm that the alleged infringer's compound is in fact infringing, other than a comparison of the claimed and accused infringing processes? If the basis of infringement is not the similarity of process, it can only be similarity of structure or characteristics, which the inventor has not disclosed. Why also would the courts deny others the right to freely practice process Z that may produce a better product in a better way?</div></div><div class="co_paragraph"><div class="co_paragraphText">In sum, it is both unnecessary and logically unsound to create a rule that the process limitations of a product-by-process claim should not be enforced in some exceptional instance when the structure of the claimed product is unknown and the product can be defined only by reference to a process by which it can be made. Such a rule would expand the protection of  <span class="co_starPage" id="co_pp_sp_506_1295"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1295&quot; }" alt="metadata" type="hidden">*1295</span> the patent beyond the subject matter that the inventor has “particularly point[ed] out and distinctly claim[ed]” as his invention, <a id="co_link_I817ae86d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS112&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C. § 112</a> ¶ 6.</div></div><div class="co_paragraph"><div class="co_paragraphText">Thus, the Eastern District of Virginia correctly applied the rule that the recited process steps limit the product-by-process claims 2–5 for any infringement analysis.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I43bdb7fb22b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign2">3. “<em>obtainable</em> by”</div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F102018850794" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF10">10</a><a id="co_anchor_B102018850794"></a> In this case, Abbott's plain language argument, that “<em>obtainable</em> by” introduces an optional process, even if “<em>obtained</em> by” would introduce limiting process steps, is also unavailing. The <a id="co_link_I817ae86e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>BASF</em></a> case, an analogous situation to this case, controls. As noted above, the Supreme Court in BASF considered the following claim language: “Artificial alizarine, produced from anthracine or its derivatives by either of the methods herein described, <em>or by any other method which will produce a like result.<input id="co_docMarker_13" type="hidden"></em>” <a id="co_link_I817ae86f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;pubNum=0000708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">111 U.S. at 296, 4 S.Ct. 455</a> (emphasis added). The patentee argued that even though the defendant did not make artificial alizarine by “either of the methods herein described,” the claim should capture the product because of the “or by another method” language. <a id="co_link_I817ae87022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;pubNum=708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 309, 4 S.Ct. 455.</a> The Supreme Court refused to attach importance to those expansive words: “No. 4,321 furnishes no test by which to identify the product it covers, except that such product is to be the result of the process it describes.” <a id="co_link_I817ae87122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;pubNum=708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 305, 4 S.Ct. 455.</a> Abbott's claims 2–5, like those in <a id="co_link_I817ae87222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>BASF</em></a> and like product-by-process claims in general, do not furnish any test by which to identify the cefdinir crystals except that they are the result of their respectively claimed processes. As per <a id="co_link_I817ae87322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>BASF,</em></a> Abbott's claim cannot capture a product obtained by or obtainable by processes other than those explicitly recited in the claims.</div></div><div class="co_paragraph"><div class="co_paragraphText">If this court were to strip the process elements from the claims, as Abbott would urge, for infringement purposes, there would then be nothing to differentiate independent claim 2 from independent claim 5. After all, if those claims are not bound by the process terms but only “define” the basic cefdinir compound, then each of the claims recite the same thing, over and over again. Though Abbott argues that it merely intends to give meaning to the word “obtainable,” it instead seeks to have this court render meaningless the explicit process limitations that the applicant chose to define its invention.</div></div><div class="co_paragraph"><div class="co_paragraphText">The intrinsic evidence in this case further rebuts Abbott's contention that its claims are not limited to those products actually obtained by the processes recited. In column 2 of the ′<a id="co_link_I817ae87422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a>, under the title heading “The Process for Preparing Crystal A of the Compound (I),” the patentee used specific language to describe the very two processes that are mirrored in claims 2 and 5. ′<a id="co_link_I817ae87522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a> col.2 ll.13–51. This language is not open-ended, nor does it constitute a mere description of the product by reference to the manner in which it can be made, as Abbott argues. By drafting claims 2 and 5 to incorporate these specific processes, Abbott made a conscious choice to place process requirements on its claimed product. If Abbott had wanted to obtain broader coverage for crystalline cefdinir devoid of any process limitations, as it seeks to do here, it could have simply done so (if indeed, as it argues, it is really the product that is the heart of the invention, not the process). But it did not. The crystals of claims 2 and 5 are simply not identifiable other than by the processes disclosed in column 2. This court must enforce the ways and terms that a party chooses to define its invention.</div></div><div class="co_paragraph"><div class="co_paragraphText"> <span class="co_starPage" id="co_pp_sp_506_1296"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1296&quot; }" alt="metadata" type="hidden">*1296</span> The prosecution history also does not support Abbott's contention that “obtainable by” offers merely an optional set of definitional process conditions. During prosecution, Abbott faced obviousness rejections based on application claims 6–9, which were process claims that mirrored the <em>very</em> process limitations of issued claims 2–5. The PTO refused to issue the claims until one set of duplicates was cancelled. Abbott's action in cancelling claims 6–9 demonstrates its acquiescence to the PTO's view that the process elements of claims 2–5 are critical parts of those claims. In addition, in a response to the PTO's office action, Abbott chose to differentiate a cited § 103 reference, Takaya, on the basis that Abbott's claimed processes are different. For these reasons, the applicant's statement in the file wrapper that <input id="co_docMarker_14" type="hidden">“the method of preparation ... is not considered the heart of the present invention” should not be afforded undue gravitas. The process limitations cannot be haphazardly jettisoned for an infringement analysis when they were so important in the patentability analysis.</div></div><div class="co_paragraph"><div class="co_paragraphText">In sum, a patentee's use of the word “obtainable” rather than “obtained by” cannot give it a free pass to escape the ambit of the product-by-process claiming doctrine. Claims that include such ambiguous language should be viewed extremely narrowly. If this court does not require, as a precondition for infringement, that an accused infringer actually use a recited process, simply because of the patentee's choice of the probabilistic suffix “able,” the very recitation of that process becomes redundant. This would widen the scope of the patentee's claims beyond that which is actually invented—a windfall to the inventor at the expense of future innovation and proper notice to the public of the scope of the claimed invention. For all the above reasons, the Eastern District of Virginia correctly construed the process limitations beginning with “obtainable by” in claims 2–5 as limiting the asserted claims to products made by those process steps.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I43bdb7fc22b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign2">B. Summary Judgment</div><div class="co_paragraph"><div class="co_paragraphText">In the <em>Lupin</em> case, the Eastern District of Virginia granted summary judgment of noninfringement of claims 2–5, both literal and by equivalents, and of claim 1 by equivalents. <a id="co_link_I817ae87722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2012504755&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Lupin SJ Order.</em></a> Literal infringement of claim 1, i.e., whether Lupin's generic cefdinir product contains any Crystal A, is therefore not a live issue on appeal. As for claims 2–5, the Eastern District noted that “Abbott and Astellas have conceded that literal infringement of Claims 2–5 cannot be established if the product-by-process analysis is performed pursuant to <em>Atlantic Thermoplastics,</em>” given that “Abbott and Astellas have presented no evidence that Lupin is practicing the process steps set forth in Claims 2–5.” <a id="co_link_I817ae87922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2012504755&amp;pubNum=4637&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_4637_568&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_4637_568"><em>Lupin SJ Order,</em> 491 F.Supp.2d at 568.</a> Because the Eastern District correctly applied the rule from <em>Atlantic Thermoplastics</em> and likewise properly construed the limiting process terms in claims 2–5, only infringement by equivalents of claims 1–5 remains before this court.</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F112018850794" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF11">11</a><a id="co_anchor_B112018850794"></a><a href="#co_anchor_F122018850794" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF12">12</a><a id="co_anchor_B122018850794"></a> Infringement analysis under the doctrine of equivalents proceeds element-by-element; a generalized showing of equivalency between the claim as a whole and the allegedly infringing product or process is not sufficient to show infringement. <em>See </em><a id="co_link_I817ae87b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997060689&amp;pubNum=0000708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Warner–Jenkinson,</em> 520 U.S. at 29, 117 S.Ct. 1040</a> (“the doctrine of equivalents must be applied to individual elements of the claim, not to the invention as a whole”). The primary test for equivalency is the “function-way-result” or “triple identity” test, whereby the patentee may show an equivalent when the accused product or process performs substantially the same function, in substantially the same way, to achieve substantially the same result, as disclosed in the claim.  <span class="co_starPage" id="co_pp_sp_506_1297"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1297&quot; }" alt="metadata" type="hidden">*1297</span> <a id="co_link_I817ae87c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1950117294&amp;pubNum=0000708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Graver Tank &amp; Mfg. Co. v. Linde Air Prods. Co.,</em> 339 U.S. 605, 608, 70 S.Ct. 854, 94 L.Ed. 1097 (1950)</a>. But, because “[d]ifferent linguistic frameworks may be more suitable to different cases,” <a id="co_link_I817ae87d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997060689&amp;pubNum=708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Warner–Jenkinson,</em> 520 U.S. at 40, 117 S.Ct. 1040,</a> the function-way-result test is not the only test for equivalency. Equivalency may also be proven where the differences between the invention as claimed and the accused product or process are insubstantial. <a id="co_link_I817ae87e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1995163596&amp;pubNum=0000506&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1517&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1517"><em>Hilton Davis Chem. Co. v. Warner–Jenkinson Co.,</em> 62 F.3d 1512, 1517–18 (Fed.Cir.1995)</a> (en banc), <em>rev'd on other grounds,<input id="co_docMarker_15" type="hidden"></em> <a id="co_link_I817ae87f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997060689&amp;pubNum=0000708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">520 U.S. 17, 117 S.Ct. 1040, 137 L.Ed.2d 146 (1997)</a>. In no case, however, may the doctrine of equivalents ignore the individual claim elements. <em>See </em><a id="co_link_I817ae88022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997060689&amp;pubNum=0000708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Warner–Jenkinson,</em> 520 U.S. at 40, 117 S.Ct. 1040</a> (requiring “a special vigilance against allowing the concept of equivalence to eliminate completely any such [individual] elements”).</div></div><div class="co_paragraph"><div class="co_paragraphText">Because “crystalline” in claims 1–5 is limited to “Crystal A” as defined by the seven PXRD peaks enumerated in claim 1 and in the specification of the ′<a id="co_link_I817ae88122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"> 507 patent</a>, the doctrine of equivalents cannot capture crystals that are not themselves equivalent to Crystal A. In turn, the bounds of Crystal A equivalents cannot ignore the limits on Crystal A in the ′<a id="co_link_I817ae88222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a>, which as discussed above, includes a conscious decision to distinguish Crystal B from the claimed invention. To recall, the applicant removed Crystal B from the U.S. prosecution of the parent JP ′199 application. The ′<a id="co_link_I817ae88322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a> indisputably describes and claims Crystal A, and not Crystal B. The ′<a id="co_link_I817ae88422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a>, of course, could have claimed the known Crystal B formulation which was known to the inventors because it appeared in their priority JP ′199 application. The applicants chose not to claim Crystal B. Thus Crystal B compounds, most relevantly cefdinir monohydrate, fall outside the scope, literal or equivalent, of claims 1–5 of the ′<a id="co_link_I817ae88522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F132018850794" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF13">13</a><a id="co_anchor_B132018850794"></a> The parties agree that the “bulk” of Lupin's cefdinir product is Crystal B, not Crystal A. The degree to which Lupin's product may or may not also contain Crystal A is the central inquiry regarding the alleged literal infringement of claim 1, which is not part of the present appeal. Abbott cannot extend its exclusive right in the ′507 claims under the doctrine of equivalents to embrace known but unclaimed subject matter. In other words, Abbott effectively disclaimed Crystal B during prosecution of the ′<a id="co_link_I817ae88622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a>, by removing the Crystal B disclosure from the parent JP ′199 application and emphasizing the sole teaching of Crystal A in communications with the PTO as well as in the ′507 specification itself. Abbott cannot now recapture that unclaimed subject matter under the doctrine of equivalents because the Eastern District properly interpreted claims 2–5 to limit “crystalline” to Crystal A. To expand that claim term to embrace Crystal B would ignore the specific claim limitations of the ′<a id="co_link_I817ae88722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">Alternatively this court notes that this case seems to fit within the dedication doctrine that forecloses invocation of the doctrine of equivalents. The patent applicant clearly knew of the Crystal B forms of the claimed invention because it claimed and disclosed them in its Japanese priority application. Yet it declined to claim an embodiment expressly disclosed in its priority document, thus dedicating that embodiment to the public and foreclosing any recapture under the doctrine of equivalents. <em>See </em><a id="co_link_I817ae88822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002212441&amp;pubNum=0000506&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1054&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1054"><em>Johnson &amp; Johnston Assocs. v. R.E. Serv. Co.,</em> 285 F.3d 1046, 1054 (Fed.Cir.2002)</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">During prosecution, Abbott chose to eschew Crystal B and focus exclusively on Crystal A compounds. Without a complete record and no arguments about validity before this court on appeal, this court cannot speculate on the reasons for this  <span class="co_starPage" id="co_pp_sp_506_1298"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1298&quot; }" alt="metadata" type="hidden">*1298</span> choice. Nonetheless, the parties hotly contest whether Example 14, which reports obtaining “crystals” not specifically identified or described, and/or Example 16 of the ′<a id="co_link_I817ae88922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1985169484&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I3903a21071f311d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">334 patent</a> enable cefdinir monohydrate, i.e. Crystal B type crystals.</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F142018850794" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF14">14</a><a id="co_anchor_B142018850794"></a><a href="#co_anchor_F152018850794" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF15">15</a><a id="co_anchor_B152018850794"></a> Beyond the attempt to reinflate the claims to encompass Crystal B based on mathematical comparisons of the PXRD peak patterns of Crystal A and Crystal B, Abbott also asserts that Lupin effectively admitted infringement by equivalents when it claimed before the Food and Drug Administration that its cefdinir generic was a bioequivalent to Abbott's Omnicef product. While bioequivalency may be relevant to the function prong of the function-way-result test, bioequivalency and equivalent infringement are different inquiries. Bioequivalency is a regulatory and medical concern aimed at establishing that two compounds are effectively the same for pharmaceutical purposes. In contrast, equivalency for purposes of patent infringement requires an element-by-element comparison of the patent claim and the accused product, requiring not only equivalent function but also equivalent way and result. Different attributes of a given product may thus be relevant to bioequivalency but not equivalent infringement, and vice versa. As the Northern District of Illinois observed in the <input id="co_docMarker_16" type="hidden"><em>Sandoz</em> case, “[i]f bioequivalency meant per se infringement, no alternative to a patented medicine could ever be offered to the public during the life of a patent.” <a id="co_link_I817ae88b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2012184789&amp;pubNum=4637&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_4637_776&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_4637_776"><em>Sandoz PI Order,</em> 486 F.Supp.2d at 776.</a> Thus, while potentially relevant, the bioequivalency of an accused product with a product produced from the patent at issue is not sufficient to establish infringement by equivalents.</div></div><div class="co_paragraph"><div class="co_paragraphText">Because Crystal B is not an equivalent of Crystal A, the Eastern District of Virginia did not err in granting summary judgment of noninfringement of claims 2–5, both with respect to literal and equivalent infringement, and with respect to equivalent infringement of claim 1.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I43bdb7fd22b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign2"><span class="co_smallCaps">IV.</span></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F162018850794" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF16">16</a><a id="co_anchor_B162018850794"></a><a href="#co_anchor_F172018850794" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF17">17</a><a id="co_anchor_B172018850794"></a> This court reviews the grant or denial of a preliminary injunction for abuse of discretion. <a id="co_link_I817ae88c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2001144009&amp;pubNum=0000506&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1350&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1350"><em>Amazon.com, Inc. v. Barnesandnoble.com, Inc.,</em> 239 F.3d 1343, 1350 (Fed.Cir.2001)</a>. A district court may enter a preliminary injunction based on its consideration of four factors: “(1) the likelihood of the patentee's success on the merits; (2) irreparable harm if the injunction is not granted; (3) the balance of hardships between the parties; and (4) the public interest.” <a id="co_link_I817ae88d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2015279866&amp;pubNum=0000506&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1353&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1353"><em>Erico Int'l Corp. v. Vutec Corp.,</em> 516 F.3d 1350, 1353–54 (Fed.Cir.2008)</a> (quoting <a id="co_link_I817ae88e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2010684518&amp;pubNum=506&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1365&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1365"><em>PHG Techs., LLC v. St. John Cos., Inc.,</em> 469 F.3d 1361, 1365 (Fed.Cir.2006))</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">Sandoz and Teva's <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I36ca442d475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I36ca442d475111db9765f9243f53508a_1">Omnicef</a> generic products, like Lupin's, are also at least primarily <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3c66ba55475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3c66ba55475111db9765f9243f53508a_3">cefdinir</a> monohydrate, a Crystal B compound. <a id="co_link_I817ae89122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2012184789&amp;pubNum=4637&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_4637_769&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_4637_769"><em>Sandoz PI Order,</em> 486 F.Supp.2d at 769.</a> Before the Northern District of Illinois, the parties to the <em>Sandoz</em> litigation disputed whether Sandoz and Teva's products also contained small amounts of cefdinir anhydrate, i.e., Crystal A, which would fall within the literal scope of claim 1 of the ′<a id="co_link_I817ae89322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a>. Working primarily from the Eastern District of Virginia's claim construction, to which the parties to the <em>Sandoz</em> litigation agreed would bind their litigation as well for purposes of the preliminary injunction motion, the Northern District of Illinois denied Abbott's motion for a preliminary injunction, finding that Abbott was unlikely to prevail on the merits at trial.</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F182018850794" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF18">18</a><a id="co_anchor_B182018850794"></a> This court detects no abuse of discretion in the Northern District of Illinois' preliminary injunction denial. As described above, the ′<a id="co_link_I817ae89522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a> is properly construed to exclude Crystal B, both as to  <span class="co_starPage" id="co_pp_sp_506_1299"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1299&quot; }" alt="metadata" type="hidden">*1299</span> literal and equivalent infringement. Thus, this court need not delve into the Northern District of Illinois' clarifications of the Eastern District of Virginia's claim constructions. The Northern District of Illinois succinctly concluded: “[w]e know that Crystal B was known to the plaintiffs because it had been included in the Japanese ′199 patent. Thus we conclude that the plaintiffs deliberately excluded from the definition of Crystal A, cefdinir monohydrate, which is Crystal B.” <a id="co_link_I817ae89622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2012184789&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 775.</a></div></div><div class="co_paragraph"><div class="co_paragraphText">As to the alleged presence of small amounts of Crystal A in Sandoz and Teva's products, Abbott's evidence did not persuade the Northern District of Illinois. <a id="co_link_I817ae89822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2012184789&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> This court perceives that decision as well within the trial court's discretion. As additional support, the Northern District observed that there was no evidence that any trace amounts of cefdinir anhydrate, i.e. Crystal A, in Sandoz and Teva's products “could be a contributing factor in the efficacy” and that even “if there is a small amount of cefdinir anhydrate in defendants' products, we do not conclude that this could cause literal infringement.” <a id="co_link_I817ae89a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2012184789&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> While these may be misstatements of the law, because <em>de minimis</em> infringement can still be infringement, <input id="co_docMarker_17" type="hidden"><em>see</em> <a id="co_link_I817ae89b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS271&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RB&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_8b3b0000958a4">35 U.S.C. § 271(a)</a>; <em>see also </em><a id="co_link_I817ae89c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999197404&amp;pubNum=0000506&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1336&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1336"><em>SunTiger, Inc. v. Sci. Res. Funding Group,</em> 189 F.3d 1327, 1336 (Fed.Cir.1999)</a> (“If a claim reads merely on a part of an accused device, that is enough for infringement.”), this court need not reach that issue in a preliminary injunction context which affords the trial court broad leeway to discern a “likelihood of success.” Likewise the district court may have overstated the relevance of efficacy, because the ′<a id="co_link_I817ae89d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a> contains no claim limitations relating to efficacy. But these misstatements were harmless because they merely formed an alternative basis for the Northern District of Illinois' reasonable assessment of the evidence proffered by Abbott for its preliminary injunction motion. As noted, this court sustains the trial court's discretion based primarily on its administration of the proper claim construction and its finding that Abbott was not likely to show Sandoz and Teva's products contained any Crystal A at all.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I43bdb7fe22b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign2"><span class="co_smallCaps">CONCLUSION</span></div><div class="co_paragraph"><div class="co_paragraphText">The Eastern District of Virginia correctly construed the ′<a id="co_link_I817ae89e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a>'s recitation of “crystalline” in each of the asserted claims as limited to Crystal A, as outlined in the specification. Because Abbott scrubbed all references to Crystal B in the ′<a id="co_link_I817ae89f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a>'s specification, which were present in the ′<a id="co_link_I817ae8a022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a>'s parent foreign application, Abbott clearly demonstrated its intent to limit the ′<a id="co_link_I817ae8a122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990231633&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I274abbe072e711d7b100a463f186e11d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">507 patent</a> to Crystal A. This intent was further underscored by comments made during prosecution. As such, Abbott is unable to recapture Crystal B through broad claim language or under the doctrine of equivalents. The Eastern District of Virginia therefore properly concluded on summary judgment that Lupin's cefdinir product did not infringe claims 1–5 literally or claims 2–5 by equivalency. Similarly, the Northern District of Illinois did not abuse its discretion in declining to enter a preliminary injunction against Sandoz and Teva's cefdinir products.</div></div><div class="co_paragraph"><div class="co_paragraphText"><em>AFFIRMED</em></div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I43bdb7ff22b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign2"><span class="co_smallCaps">COSTS</span></div><div class="co_paragraph"><div class="co_paragraphText">Each party shall bear its own costs.</div></div></div></div></div></div></div><div class="co_contentBlock co_briefItState co_opinionBlock"><h2 id="co_dissent_opinion"></h2><div class="co_docDelivery_dottedLine"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/co_docDelivery_dottedLine.png" alt=""></div><div class="co_contentBlock x_opinionBlockBody"><div class="co_contentBlock x_opinionDissent"><div class="co_contentBlock x_dissentAuthorLineBlock"><div class="co_contentBlock x_dissentAuthorLine"><a id="co_link_I817ae8a222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0245882601&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">NEWMAN</a>, Circuit Judge, with whom Circuit Judges <a id="co_link_I817ae8a322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0146644601&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">MAYER</a> and <a id="co_link_I817ae8a422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0225327201&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">LOURIE</a> join, dissenting from en banc Section III.A.2.</div></div><div class="co_contentBlock x_opinionBody"><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I43bdb80422b911e89bf099c0ee06c731"><div class="co_paragraph"><div class="co_paragraphText">The court today acts <em>en banc</em> to overturn a century of precedent and practice, and holds that a new product that is difficult to describe without reference to how it was made, but that is nonetheless a new and unobvious product, cannot be protected as  <span class="co_starPage" id="co_pp_sp_506_1300"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1300&quot; }" alt="metadata" type="hidden">*1300</span> a product if its description is aided by reference to how it was made. Heretofore a new product whose structure was not fully known or not readily described could be patented as a product by including in the product description sufficient reference to how it can be made, to distinguish the new product from prior art products. Patentability was determined as a product, independent of any process reference in the claim, and validity and infringement were based on the product itself. This expedient for patenting products whose structure was not fully known at the time of filing the patent application has been called the “rule of necessity.” It was pragmatic, fair, and just, for it attuned patent law and practice to the realities of invention.</div></div><div class="co_paragraph"><div class="co_paragraphText">Today the court rejects this expedient and discards this practice, ruling that all claims containing a process term under the rule of necessity now must be construed, for purposes of infringement, as limited to use of any process term that was used to assist in defining the product. That is, such a product is not patented as a product, however it is produced, but is limited to the process by which it was obtained. This is a new restraint on patents for new products, particularly today's complex chemical and biological products whose structure may be difficult to analyze with precision. It is a change of law with unknown consequences for patent-based innovation.<input id="co_docMarker_18" type="hidden"></div></div><div class="co_paragraph"><div class="co_paragraphText">The court acts <em>sua sponte,</em> without explanation of what policy is intended to be served by this change, without consideration of the technologies that may be adversely affected by elimination of this expedient, without notice to those whose property rights may be diminished. In so doing, the court departs from statute, precedent, and practice. This change is as unnecessary as it is flawed, gratuitously affecting inventions past, present, and future. I respectfully dissent.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I43bdb80522b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign2"><span class="co_smallCaps">DISCUSSION</span></div><div class="co_paragraph"><div class="co_paragraphText">For most product inventions, the process by which the product was made, whether or not the process is itself a patentable invention, is not stated in the product claims. However, as the variety and complexity of invention and technology have increased, various forms of product claims with process terms have been used in specific circumstances, depending on the nature of the invention.<sup id="co_footnoteReference_B00212018850794_ID0EF3DI"><a href="#co_footnote_B00212018850794" class="co_footnoteReference">1</a></sup> The form here at issue relates to product claims for new and unobvious products whose structure is not fully known, and for which process parameters are used to aid in defining the product. This claiming expedient has been recognized since at least 1891.</div></div><div class="co_paragraph"><div class="co_paragraphText">The court today overturns this expedient for all circumstances, brooking no exception. Acting <em>en banc</em> for the purpose, the court rules that if any process term or descriptive aspect is included in a product claim to aid in distinguishing a new product, the claim cannot be infringed by the identical product unless the same process aspect is used in making the accused product. The court holds that it is irrelevant whether the product is new or was known, irrelevant whether the product could have been fully described by its structure at the time of the patent application, irrelevant whether the particular invention is a new product or is actually a process. The court adopts a simplistic universal rule,  <span class="co_starPage" id="co_pp_sp_506_1301"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1301&quot; }" alt="metadata" type="hidden">*1301</span> thereby targeting a small but significant class of inventions. The effect of this decision on innovation in complex fields of science and technology is unknown to the court, for we have had no advice on the consequences of this change of law. My dissent is directed as much to the court's procedure, as to the substance of the court's decision.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I43bdb80622b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign2"><span class="co_smallCaps">I</span></div><div class="co_headtext co_hAlign2"><span class="co_smallCaps">PROCEDURE</span></div><div class="co_paragraph"><div class="co_paragraphText">The court has given no notice of this impending <em>en banc</em> action, contrary to the Federal Rules of Appellate Procedure and contrary to the Federal Circuit's own operating procedures. The <em>en banc</em> court has received no briefing and held no argument, although the Federal Rules so require. The communities of inventors, innovators, and the public who may be affected by this change of law have had no opportunity to be heard. The court has received no information concerning the effect on patents that were granted based on this long-established practice, no advice on what kinds of inventions may now lie fallow because they are unprotected. Nor does the court explain its suspension of the standards of judicial process.</div></div><div class="co_paragraph"><div class="co_paragraphText">The Federal Rules have the force of law. <a id="co_link_I817ae8a622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=28USCAS2072&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">28 U.S.C. § 2072</a>. <a id="co_link_I817ae8a722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000599&amp;cite=USFRAPR34&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Federal Rules of Appellate Procedure 34</a> and <a id="co_link_I817ae8a822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000599&amp;cite=USFRAPR35&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35</a> are here implicated. <a id="co_link_I817ae8a922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000599&amp;cite=USFRAPR34&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Rule 34</a> provides that “oral argument must be allowed in every case” unless certain specific exceptions exist:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><strong><a id="co_link_I817ae8aa22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000599&amp;cite=USFRAPR34&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RB&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_d86d0000be040">Rule 34(a)(2)</a> Standards.</strong> Oral argument must be allowed in every case unless a panel of three judges who have examined the briefs and record unanimously agrees that oral argument is unnecessary for any of the following reasons:</div></div><div class="co_paragraph co_indentLeft2"><div class="co_paragraphText">(A) the appeal is frivolous;</div></div><div class="co_paragraph co_indentLeft2"><div class="co_paragraphText">(B) the dispositive issue or issues have been authoritatively decided; or</div></div><div class="co_paragraph co_indentLeft2"><div class="co_paragraphText">(C) the facts and legal arguments are adequately presented in the briefs and record, and the decisional process would not be significantly aided by oral argument.<input id="co_docMarker_19" type="hidden"></div></div><div class="co_paragraphText co_flush">Applying the <a id="co_link_I817ae8ab22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000599&amp;cite=USFRAPR34&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Rule 34</a> standards, it is clear that (A) this appeal is not frivolous and (B) the dispositive issue has not been authoritatively decided, for it is currently being addressed <em>en banc.</em> There has been (C) no briefing and no record to the court, and this is not a case in which the decisional process would not be aided by oral argument. The <em>en banc</em> court has heard no argument, and has received neither written nor oral exploration of the diverse aspects of this long-established claiming practice.</div></div><div class="co_paragraph"><div class="co_paragraphText"><a id="co_link_I817ae8ac22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000599&amp;cite=USFRAPR35&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Federal Rule of Appellate Procedure 35</a> has also failed of compliance. That rule recognizes the exceptional nature of <em>en banc</em> hearing or rehearing, and identifies the two circumstances warranting such procedure:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><strong>¢=BQP:0132</strong><a id="co_link_I817ae8ad22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000599&amp;cite=USFRAPR35&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RB&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_8b3b0000958a4"><strong>Rule 35(a)</strong></a>... An en banc hearing or rehearing is not favored and ordinarily will not be ordered unless:</div></div><div class="co_paragraph co_indentLeft2"><div class="co_paragraphText">(1) en banc consideration is necessary to secure or maintain uniformity of the court's decisions; or</div></div><div class="co_paragraph co_indentLeft2"><div class="co_paragraphText">(2) the proceeding involves a question of exceptional importance.</div></div><div class="co_paragraphText co_flush">When an <em>en banc</em> hearing or rehearing is ordered <em>sua sponte</em> by the court, whether for uniformity of decision or on a question of exceptional importance, the hearing or rehearing must receive the appellate process set by the Rules.</div></div><div class="co_paragraph"><div class="co_paragraphText">I agree that <em>en banc</em> review is appropriate, for this apparent conflict in our precedent has existed since 1992. Now that the court has undertaken to resolve the conflict, the withholding of public notice, or even notice to the parties to this case, is devoid of justification. The question is of importance, but there has been no assertion <span class="co_starPage" id="co_pp_sp_506_1302"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1302&quot; }" alt="metadata" type="hidden">*1302</span>  of urgency sufficient to require bypassing the standard appellate procedures. The breadth of the <em>en banc</em> court's ruling, the solidity of the precedent now overruled, the importance of the technologies affected, and the untold issued patents that are now placed in limbo, require this court's compliance with <a id="co_link_I817ae8ae22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000600&amp;cite=USFRCPR34&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Federal Rules 34</a> and <a id="co_link_I817ae8af22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000600&amp;cite=USFRCPR35&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">The Federal Circuit has recognized that it can benefit from the advice of those knowledgeable in the law and its purposes, in the areas of our nation-wide responsibility. Patent law has a direct impact on innovation, industry, and technological advance, and when an <em>en banc</em> ruling may change the law affecting some areas of technology and the industries based thereon, this court has routinely sought to be informed, by the parties and <em>amici curiae,</em> of relevant concerns. When the impact of a <em>sua sponte</em> change of law transcends the interests of the parties to the specific case, notice to the interested public, as well as to the parties, is fundamental to due and fair process. The Federal Circuit's Internal Operating Procedure (IOP) 14 was adopted to implement these principles:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>IOP 14.3(c) If the sua sponte petition for hearing en banc is granted, a committee of judges appointed by the chief judge, which shall normally include the judge who initiated the poll, shall within seven working days (fourteen working days between June 21 and September 11) transmit on a vote sheet to the judges who will sit en banc an order setting forth the questions proposed to be addressed by the court en banc. The clerk shall provide notice that a majority of the judges in regular service has acted under <a id="co_link_I817ae8b022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=28USCAS46&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">28 U.S.C. § 46</a> and <a id="co_link_I817ae8b122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000599&amp;cite=USFRAPR35&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RB&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_8b3b0000958a4">Fed. R.App. P. 35(a)</a> to order the appeal to be heard en banc, and indicate any questions the court may wish the parties and amici to address. Notice shall be given that the court en banc shall consist of all circuit judges in regular service who are not recused or disqualified. Additional briefing and oral argument will be ordered as appropriate.<input id="co_docMarker_20" type="hidden"></div></blockquote></div></div><div class="co_paragraphText co_flush"><em>United States Court of Appeals for the Federal Circuit, Internal Operating Procedures</em> at 40, <em>available at</em> http://www.cafc.uscourts.gov/pdf/IOPs 122006.pdf. This IOP has not been followed. No notice was given, even to the parties, that the court had ordered this question to be reheard <em>en banc;</em> nor did the court advise the parties or the public as to the aspects being addressed for <em>en banc</em> decision. The court is acting <em>sua sponte,</em> without notice and without argument and without an opportunity for participation. By bypassing this court's standard operating procedure, as well as violating the Federal Rules of Appellate Procedure, the court has deprived itself of input concerning the experience of precedent, of advice as to how this change of law may affect future innovation, and of guidance as to the effect on existing property rights.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I43bdb80722b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign2"><span class="co_smallCaps">II</span></div><div class="co_headtext co_hAlign2"><span class="co_smallCaps">PRECEDENT AND PRACTICE</span></div><div class="co_paragraph"><div class="co_paragraphText">The court's opinion does not mention the long-established precedent that it is overturning. This is not a simple conflict between isolated rulings of the Federal Circuit; it is a change of law and practice with roots in century-old decisions. I start with this precedent, for the expedient of what came to be called the “rule of necessity” originated in the recognition, by the courts and the Patent Office, that not all new products could be fully described by their structure, due to the state of scientific knowledge or available analytical techniques. It was also recognized, over a century ago, that sufficient distinction from prior art products could sometimes be achieved by reference to how the product was made. Thus the courts and patent administrators established the exception  <span class="co_starPage" id="co_pp_sp_506_1303"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1303&quot; }" alt="metadata" type="hidden">*1303</span> that permitted inclusion in a product claim of sufficient recitation of how the product was made, to aid in identifying the product and distinguishing it from the prior art. This claim form was loosely called a “product-by-process” form, although that term includes a variety of situations, <em>see</em> n. 1 <em>supra,</em> having diverse legal consequences. The only form here at issue is that in which the product is new and its structure is not fully or readily known, such that its definition as a product is aided by referring to how it was made. Since before 1891, this has been an accepted way to claim products as products, recognizing that this is an exception to the general rule that new products are claimed without reference to the process by which they are produced.</div></div><div class="co_paragraph"><div class="co_paragraphText">This exception was discussed in 1891 in <em>Ex parte Painter,</em> the Commissioner of Patents explaining that when there is entitlement to a patent on a new article of manufacture, it can be claimed by reference to the process of producing it, when the inventor lacks other language to “define and discriminate” the invention:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>It requires no argument to establish the proposition that <em>as a rule</em> a claim for an article of manufacture should not be defined by the process of producing that article. On the other hand, when a man has made an invention his right to a patent for it, or his right to a claim properly defining it, is not to be determined by the limitations of the English language. When the case arises that an article of manufacture is a new thing, a useful thing, and embodies invention, and that article cannot be properly defined and discriminated from prior art otherwise than by reference to the process of producing it, a case is presented which constitutes an exception to the rule.</div></blockquote></div></div><div class="co_paragraphText co_flush">1891 C.D. 200, 200–01 (Comm'r Pat. 1891). The Commissioner cited, as an earlier example of this exception, the claim in <input id="co_docMarker_21" type="hidden"><a id="co_link_I817ae8b222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884198573&amp;pubNum=0000348&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Globe Nail Co. v. U.S. Horse Nail Co.,</em> 19 F. 819 (C.C.D.Mass.1884)</a> (sustaining validity of claim directed to horse-shoe nail claimed by reference to its process of manufacture, and finding it infringed by the accused nail having only a “trivial and unsubstantial variation” from the claimed product). In contrast, where the patent application made clear that the product could be described by its structure, the Patent Office ruled that the exception did not apply. <em>See, e.g., Ex parte Scheckner,</em> 1903 C.D. 315, 315–16 (Comm'r Pat.1903) (sustaining rejection of claim directed to an etched printing-plate that “specifies certain steps by means of which the etching is accomplished” because other claims “define the plate in terms of its structure”).</div></div><div class="co_paragraph"><div class="co_paragraphText">This expedient has been discussed in various judicial decisions. In all cases the issue has not been whether this expedient was available, for its availability was not challenged; the issue was simply its application to the particular facts. For example, at a time when it heard direct appeals from Patent Office rulings, the D.C. Circuit remarked on this “only exception” to the general rule of product claiming, stating:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>It is a well-settled rule of patent law that claims for a product which is defined by the process of producing it will not be allowed; and the only exception to this rule seems to be in cases where the product involves invention and <em>cannot be defined except by the process used in its creation.</em> In extreme cases of this character, the product may be allowed; but that is not this case, especially in view of the broad claims allowed appellant in his copending application....</div></blockquote></div></div><div class="co_paragraphText co_flush"><a id="co_link_I817ae8b322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1929127554&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_874&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_874"><em>In re Brown,</em> 29 F.2d 873, 874 (D.C.Cir.1928)</a> (emphasis added).</div></div><div class="co_paragraph"><div class="co_paragraphText">The Court of Customs and Patent Appeals discussed precedent involving claims  <span class="co_starPage" id="co_pp_sp_506_1304"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1304&quot; }" alt="metadata" type="hidden">*1304</span> for processes and products in various factual situations, and summarized that:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>Where it is possible to define a product by its characteristics, the practice is clearly settled that this should be done. Where, however, the product is novel and involves invention and <em>cannot be defined except by the steps of the process involved in its creation,</em> there are cases holding that such a claim may be allowed, and it has been sustained by a Court.</div></blockquote></div></div><div class="co_paragraphText co_flush"><a id="co_link_I817ae8b422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1930128161&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_626&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_626"><em>In re Butler,</em> 17 C.C.P.A. 810, 37 F.2d 623, 626 (1930)</a> (emphasis added) (quoting <em>Ex Parte Feisenmeier,</em> 1922 C.D. 18 (Comm'r Pat.1922)). The CCPA then found this rule inapplicable to the facts of Butler's invention, explaining that “the record at bar does not meet this requirement [that the product was new].” <em>Id.</em></div></div><div class="co_paragraph"><div class="co_paragraphText">In <a id="co_link_I817ae8b622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1950117970&amp;pubNum=350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>In re Lifton,</em> 38 C.C.P.A. 1119, 189 F.2d 261 (1951)</a>, the CCPA again commented on this exception for product claims, stating that when “proper article claims” were possible they must be used, with the exception of when such claims are “impossible”:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>This court has uniformly held that a claim for an article must define the article by its structure and not by the process of making it. The one exception to this rule, where the invention is the article and <em>it is impossible to otherwise define it,</em> is clearly ruled out in the present case because appellant has demonstrated the possibility of proper article claims by including several devoid of process limitations.</div></blockquote></div></div><div class="co_paragraphText co_flush"><a id="co_link_I817ae8b722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1950117970&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_263&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_263"><em>Id.</em> at 263</a> (emphasis added, citations omitted). The court again recognized “the one exception,” holding once again that it does not apply when the product can be described independently of the process of making it.</div></div><div class="co_paragraph"><div class="co_paragraphText">These inquiries into the facts warranting application of the exception demonstrate that the rule of necessity was seldom applied, but was nonetheless recognized both by the courts and the Patent Office. Decisions of the Patent Office Board of Appeals illustrate the practice. <input id="co_docMarker_22" type="hidden"><em>See, e.g., </em><a id="co_link_I817ae8b822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1945008749&amp;pubNum=0000867&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Ex parte Pfenning,</em> 65 U.S.P.Q. 577 (Pat.Off.Bd.App.1945)</a> (allowing claim “directed to a product which results from the method of claim 9” in light of applicant's argument that “it is impossible in the instant case to define the product adequately in terms of the elements which compose it or in terms of its physical characteristics”); <a id="co_link_I817ae8b922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1943010020&amp;pubNum=0000867&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Ex parte Lessig,</em> 57 U.S.P.Q. 129 (Pat.Off.Bd.App.1943)</a> (allowing claim for a “product containing vulcanized rubber” strongly adhered to fibers which “has been prepared by the process of claim 4” because “it is not possible to otherwise distinguish over the art of record”).</div></div><div class="co_paragraph"><div class="co_paragraphText">Commentators have explained that this claiming practice became of increasing importance as the complex sciences blossomed. <em>See, e.g.,</em> Mark D. Passler, <a id="co_link_I817ae8ba22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=0105309093&amp;pubNum=0003194&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=LR&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Product–by–Process Patent Claims: Majority of the Court of Appeals for the Federal Circuit Forgets Purpose of the Patent Act,</em> 49 U. Miami L.Rev. 233, 233 n. 3 (1994)</a> (“Such claims are often used by companies to patent complex drug or chemical products whose structure is not completely understood and, therefore, can only be accurately described by the process through which it is made.”). It is well known that the full structure of some chemical and biological products is not always known at the time the patent application is filed. Indeed, it is a tenet of the scientific method that explanation and theory tend to follow, not precede, the observation of a development in the science.</div></div><div class="co_paragraph"><div class="co_paragraphText">The CCPA continued to recognize the use of process terms to aid in describing new products—the form of claim sometimes called a “pure” product-by-process claim, <em>see</em> n. 1 <em>supra</em>—and repeatedly ruled that such claims are properly viewed  <span class="co_starPage" id="co_pp_sp_506_1305"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1305&quot; }" alt="metadata" type="hidden">*1305</span> as product, not process, claims. The court also disallowed such claims where the product itself was not novel and unobvious. The court confirmed that such a claim, when justified for a novel and unobvious product, is properly construed as encompassing the full scope of a product claim. For example, in <a id="co_link_I817ae8bb22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1965100591&amp;pubNum=350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>In re Bridgeford,</em> 53 C.C.P.A. 1182, 357 F.2d 679 (1966)</a>, the court again explained that a new product may be defined by the process of making it if there is no other way to describe the product, stressing that “the invention so defined is a product and not a process,” <a id="co_link_I817ae8bc22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1965100591&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>id.</em> at 682.</a> The <em>Bridgeford</em> court relied on this view of the scope of the product-by-process claims in a related patent, and held unpatentable for double patenting claims that defined the “product per se.” <a id="co_link_I817ae8be22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1965100591&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 680.</a> The court explained that product-by-process claims are true product claims, and overruled the suggestion in <a id="co_link_I817ae8bf22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1947115170&amp;pubNum=350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_181&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_181"><em>In re Freeman,</em> 35 C.C.P.A. 920, 166 F.2d 178, 181 (1948)</a>, that product-by-process claims are “dependen[t] ... on process limitations” and therefore coextensive with process claims. <a id="co_link_I817ae8c022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1965100591&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_683&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_683"><em>Bridgeford,</em> 357 F.2d at 683 n. 6</a> (“While there is some language in <em>Freeman</em> to support the contention that a product-by-process type claim differs only ‘in scope’ from a process type claim and they therefore ‘are directed to a single invention,’ <a id="co_link_I817ae8c222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1947115170&amp;pubNum=350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_181&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_181">(166 F.2d at 181)</a> so far as this is inconsistent with our holding here it must be overruled.”).</div></div><div class="co_paragraph"><div class="co_paragraphText">My colleagues misstate the holding of <em>Bridgeford,</em> for <em>Bridgeford</em> directly contravenes today's holding. In <em>Bridgeford</em> the CCPA noted that “some courts” have construed claims with process steps as limited to the recited process, <a id="co_link_I817ae8c622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1965100591&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>id.</em> at 683 n. 5,</a> apparently without inquiring whether the rule of necessity justified full product scope for the invention at issue. The CCPA's observation that patents are construed inconsistently in other courts cannot be taken, as apparently do my colleagues, as error by the CCPA. To the contrary, the inconsistency among courts led eventually to consolidation.<input id="co_docMarker_23" type="hidden"><sup id="co_footnoteReference_B00322018850794_ID0E55AK"><a href="#co_footnote_B00322018850794" class="co_footnoteReference">2</a></sup></div></div><div class="co_paragraph"><div class="co_paragraphText">Again in <a id="co_link_I817ae8c822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1972109745&amp;pubNum=350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>In re Brown,</em> 59 C.C.P.A. 1036, 459 F.2d 531 (1972)</a>, the CCPA explained that product-by-process claims are product claims, not process claims, and that the patentability of the product must be established independently of the process by which it is identified. <em>See </em><a id="co_link_I817ae8c922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1972109745&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_535&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_535"><em>id.</em> at 535</a> (“[I]n spite of the fact that the claim may recite only process limitations, it is the patentability of the <em>product</em> claimed and <em>not</em> of the recited process steps which must be established.”).</div></div><div class="co_paragraph"><div class="co_paragraphText">Other decisions discussing application of this expedient to claims directed to complex new products include <a id="co_link_I817ae8ca22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1969105409&amp;pubNum=350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_1349&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1349"><em>In re Pilkington,</em> 56 C.C.P.A. 1237, 411 F.2d 1345, 1349 (1969)</a> (“While we are satisfied that the references of record do not anticipate appellant's glass or demonstrate that it would be obvious, the differences between that glass and the glass of the prior art do not appear to us to be particularly susceptible to definition by the conventional recitation of properties or structure.”), and <a id="co_link_I817ae8cb22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1974108841&amp;pubNum=350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_743&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_743"><em>In re Fessmann,</em> 489 F.2d 742, 743 (CCPA 1974)</a> (affirming obviousness rejection of product-by-process claim directed to a “liquid smoke” product, but observing that prior art compositions “are complex mixtures of the chemical compounds which can be derived from wood” which “defy simple characterization and this fact presumably accounts for the use of product-by-process  <span class="co_starPage" id="co_pp_sp_506_1306"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1306&quot; }" alt="metadata" type="hidden">*1306</span> claims”). The need for this expedient, and the proper scope afforded such claims, is summarized in the treatise <em>Walker on Patents:</em></div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">[P]atent rights over a chemical product are typically independent of the process by which the product is made, and are particularly valuable because of this fact. This independence is normally accomplished by defining the product in terms of its structural features alone, with no reference in the claims to process steps whatsoever. <em>The state of chemical technology, however, is sometimes too limited for a structural description of this type to be made.</em> The structure of some chemicals, especially those including elaborate polymer chains, cannot be accurately determined. The same chemicals, however, may be both economically valuable and technologically reproducible, in the sense that they can be reliably made by subjecting a particular set of raw materials to a particular set of process steps.</div></div></div><div class="co_paragraph"><div class="co_paragraphText"> * * *</div><div class="co_paragraph co_indentLeft1 co_indentFirstLine1"><div class="co_paragraphText">The law reacted to these difficulties by making it easier to obtain traditional product protection over this special class of chemicals. The inventor was allowed to describe such a chemical in terms of how one gained possession of it, that is, by way of the process steps by which it was made. Once he did so, the law preserved to the inventor the fullest measure of product-only protection that it could; <em>it treated the process recitations as proxies for the direct recitations of structure that could not be made.</em> Such a claim was therefore equivalent to one stated in terms of structure only. It would broadly dominate all methods by which the chemical could be made or used. At the same time, it carried the same dangers of running afoul of the art: it would be anticipated if the chemical had been produced previously, even if by a method other than what the inventor disclosed.</div></div><div class="co_paragraphText co_flush"><a id="co_link_I817ae8cc22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=0324532674&amp;pubNum=0166812&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=TS&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">1 <em>Moy's Walker on Patents</em> § 4:74 (4th ed.2008)</a> (emphases added).</div></div><div class="co_paragraph"><div class="co_paragraphText">The <em>en banc</em> court appears to misunderstand this precedent, for my colleagues now state that “binding case law” of the Court of Customs and Patent Appeals and the Court of Claims mandates a single rule for all claims that contain any process terms, whether the product is novel or known, citing <input id="co_docMarker_24" type="hidden"><a id="co_link_I817ae8cd22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1974110542&amp;pubNum=350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>In re Hughes,</em> 496 F.2d 1216 (CCPA 1974)</a>, for this proposition. However, <em>Hughes</em> does not state this proposition; <em>Hughes</em> stands for the contrary proposition. In <em>Hughes</em> the question was the patentability of claims directed to “shakes” as are used in roofing, as follows:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>12. Shakes manufactured from a shake bolt by the process of making a plurality of cuts into and across the shake bolt to an extent to establish predetermined tip lengths, and splitting the weather end portions of the shakes from the bolt by starting the splits at the inner ends of the cuts and continuing the splits to the end of the bolt.</div></blockquote></div></div><div class="co_paragraphText co_flush">This claim had been rejected as an improper product-by-process claim, on the ground that the product could be described without including process steps. The <em>Hughes</em> court acknowledged the general rule against product-by-process claiming, but also explained the “proper exception to the general rule” as first set forth in <em>Painter,</em> as follows:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>[T]he Commissioner of Patents enunciated the general rule that a product should not be defined in terms of the process of making it. In <em>Painter,</em> a proper exception to the general rule was found on the ground that the product could not be properly defined and discriminated from the prior art otherwise than by reference to the process of producing it. This basic rule and the exception <span class="co_starPage" id="co_pp_sp_506_1307"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1307&quot; }" alt="metadata" type="hidden">*1307</span>  have been recognized and followed continuously by the Patent Office and the Courts.</div></blockquote></div></div><div class="co_paragraphText co_flush"><a id="co_link_I817ae8d222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1974110542&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_1218&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1218"><em>Hughes,</em> 496 F.2d at 1218</a> (quoting approvingly the Solicitor's argument). The court reaffirmed that “in spite of the fact that a product-by-process claim may recite only process limitations, ‘it is the product which is covered by the claim and not the recited process steps.’ ” <em>Id.</em> Contrary to my colleagues' statement, <em>Hughes</em> did not eliminate this form of claim, or change its role as a product claim. Indeed, the <em>Hughes</em> court applied the exception and reversed the Board's rejection of a product-by-process claim, stating:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">We agree with appellant that the [general] rule should not be applied to the situation before us. We have been shown no true product claim which describes appellant's invention, in the words of the solicitor, “in terms of structure or physical characteristics.” When an applicant seeks to describe his invention by a product-by-process claim because he finds that his invention is incapable of description solely by structure or physical characteristics, it is incumbent upon the Patent Office to indicate where, or how, the applicant's invention is, or may be, so described.</div></div><div class="co_paragraphText co_flush"><a id="co_link_I817ae8d622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1974110542&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 1219.</a> My colleagues could hardly have selected less apt support for their construction of product-by-process claims, for <em>Hughes</em> explicitly states that such claims are for the product, not the process.</div></div><div class="co_paragraph"><div class="co_paragraphText">In addition to misstating precedent of the CCPA, the <em>en banc</em> court also mischaracterizes the decisions of our predecessor the Court of Claims, stating that the Court of Claims' decisions support today's ruling. The court cites <a id="co_link_I817ae8d822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1969117740&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Tri–Wall Containers v. United States,</em> 187 Ct.Cl. 326, 408 F.2d 748 (1969)</a>, for this purpose. That citation, too, is mysterious, for in <em>Tri–Wall Containers</em> the court found that the claimed product was not “new” because it had been on sale for more than the permitted period, although the product that was on sale had been made by a different process than the process stated in the claim. The Court of Claims stated that the evidence showed that “the prior art product and the claimed product are structurally identical,” <a id="co_link_I817ae8da22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1969117740&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>id.</em> at 751,</a> and explained that a known product cannot be patented by including process terms in the claim:<input id="co_docMarker_25" type="hidden"></div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">It is well established that a product claimed as made by a new process is not patentable unless the product itself is new. <a id="co_link_I817ae8db22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1874193215&amp;pubNum=780&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_780_596&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_780_596"><em>The Wood–Paper Patent,</em> 90 U.S. (23 Wall.) 566, 596, 23 L.Ed. 31 (1874)</a>, <a id="co_link_I817ae8dc22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;pubNum=0000708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Cochrane v. Badische Anilin &amp; Soda Fabrik [“BASF”],</em> 111 U.S. 293, 311, 4 S.Ct. 455, 28 L.Ed. 433 (1984)</a>....</div></div><div class="co_paragraph co_indentLeft1 co_indentFirstLine1"><div class="co_paragraphText">....</div></div><div class="co_paragraph co_indentLeft1 co_indentFirstLine1"><div class="co_paragraphText">More recent cases point out that the addition of a method step in a product claim, which product is not patentably distinguishable from the prior art, cannot impart patentability to the old product. <a id="co_link_I817ae8dd22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1947115644&amp;pubNum=0000345&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_345_928&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_345_928"><em>Jungersen v. Baden,</em> 69 F.Supp. 922, 928 (S.D.N.Y.1947)</a>, <em>aff'd,</em> <a id="co_link_I817ae8de22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1948117258&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">166 F.2d 807 (2d Cir.1948)</a>, <em>aff'd,</em> <a id="co_link_I817ae8df22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1949119907&amp;pubNum=0000708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">335 U.S. 560, 69 S.Ct. 269, 93 L.Ed. 235 (1949)</a>; <a id="co_link_I817ae8e022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1964105051&amp;pubNum=350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_1023&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1023"><em>In re Stephens,</em> 345 F.2d 1020, 1023, 52 C.C.P.A. 1409 (1965)</a>.</div></div><div class="co_paragraphText co_flush"><a id="co_link_I817ae8e122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1969117740&amp;pubNum=350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_750&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_750"><em>Tri–Wall Containers,</em> 408 F.2d at 750–51.</a> This case applied the standard rule that old products cannot be patented—it contains no statement limiting the scope of claims that include process aspects to aid in describing new products. The Supreme Court cases cited in <em>Tri–Wall</em> are all directed to new processes for making old products—these are the same cases that the <em>en banc</em> court today incorrectly applies to new products, as I discuss <em>post.</em></div></div><div class="co_paragraph"><div class="co_paragraphText">Contrary to my colleagues' statement, CCPA and Court of Claims precedent do not support today's <em>en banc</em> thesis. Our predecessor courts understood the complexity of patenting, and the CCPA consistently <span class="co_starPage" id="co_pp_sp_506_1308"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1308&quot; }" alt="metadata" type="hidden">*1308</span>  implemented the expedient whereby process terms contributed to the description of complex new products of incompletely known structure. These courts recognized the independence of product claims for new products, and did not limit such claims to the specific process steps that were used to aid in describing the product.<sup id="co_footnoteReference_B00432018850794_ID0EJWBK"><a href="#co_footnote_B00432018850794" class="co_footnoteReference">3</a></sup></div></div><div class="co_paragraph"><div class="co_paragraphText">With the advent of the Federal Circuit, this court continued to apply these principles. In <a id="co_link_I817ae8e722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1985157061&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>In re Thorpe,</em> 777 F.2d 695 (Fed.Cir.1985)</a>, the court explained that product-by-process claims are anticipated when the product existed in the prior art, even if the product was made by a different process. My colleagues are mistaken in stating that <em>Thorpe</em> held that all such claims are to be construed as process claims, even when the product is new and the rule of necessity justifies this mode of describing the invention. In <em>Thorpe</em> the product was not new; it was a known color developer for carbonless paper copy systems, and this court held that the PTO correctly rejected the claim to “the product of the process of claim 1,” explaining that since the product was old it could not be claimed as a product, whether or not process steps are recited in the claim.</div></div><div class="co_paragraph"><div class="co_paragraphText">The facts of <em>Thorpe</em> did not concern the exception and expedient where process terms are invoked to describe a new product of complex structure. This exception is rarely invoked. The general rule requiring claims to have a process-free definition of the structure of a new product accommodates most inventions. Some recent exceptions are seen in emerging aspects of biotechnology. For example, in <a id="co_link_I817ae8eb22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1989026056&amp;pubNum=0000345&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Amgen, Inc. v. Chugai Pharmaceutical Co.,</em> 706 F.Supp. 94 (D.Mass.1989)</a>, <em>aff'd in relevant part,</em> <a id="co_link_I817ae8ec22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1991048875&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">927 F.2d 1200 (Fed.Cir.1991)</a>, the district court considered the following claim:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>4. A procaryotic or eucaryotic host cell transformed or transfected with a DNA sequence according to claim 1, 2 or 3 in a manner allowing the host cell to express erythropoietin.</div></blockquote></div></div><div class="co_paragraphText co_flush"><a id="co_link_I817ae8ed22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1989026056&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 108.</a> The district court found claim 4 “ambiguous,” explaining that while it is directed to a new product—this host cell—the words “transformed or transfected” appear to invoke a process. The district court recognized that <input id="co_docMarker_26" type="hidden">“[i]n the traditional patent framework, a product is wholly separate and distinct from a process.” <a id="co_link_I817ae8ee22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1989026056&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 107.</a> The court observed that “[a] product patent gives the patentee the right to restrict the use and sale of the product regardless of how and by whom it was manufactured,” while “[a] process patentee's power extends only to those products made by the patented process.” <a id="co_link_I817ae8ef22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1989026056&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> (quoting <a id="co_link_I817ae8f022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1982106000&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_1127&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1127"><em>United States v. Studiengesellschaft Kohle,</em> 670 F.2d 1122, 1127–28 (D.C.Cir.1981)</a>). The district court, affirmed by the  <span class="co_starPage" id="co_pp_sp_506_1309"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1309&quot; }" alt="metadata" type="hidden">*1309</span> Federal Circuit, found this claim to be valid and infringed as a product claim, and although many issues and arguments were present in this litigation, the applicability of the venerable rule of necessity was not at issue.</div></div><div class="co_paragraph"><div class="co_paragraphText">In <a id="co_link_I817ae8f122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1991051497&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Scripps Clinic &amp; Research Foundation v. Genentech, Inc.,</em> 927 F.2d 1565 (Fed.Cir.1991)</a>, the Federal Circuit addressed the interpretation and scope of claims exemplified by claim 13:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>13. Highly purified and concentrated VIII:C prepared in accordance with the method of claim 1.</div></blockquote></div></div><div class="co_paragraphText co_flush">Claim 1 set forth the method referred to in claim 13, as follows:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">1. An improved method of preparing <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I39082612475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I39082612475111db9765f9243f53508a">Factor VIII</a> procoagulant activity protein [VIII:C] comprising the steps of</div></div><div class="co_paragraph co_indentLeft1 co_indentFirstLine1"><div class="co_paragraphText">(a) adsorbing a VIII:C/VIII:RP complex from a plasma or commercial concentrate source onto particles bound to a monoclonal antibody specific to VIII:RP,</div></div><div class="co_paragraph co_indentLeft1 co_indentFirstLine1"><div class="co_paragraphText">(b) eluting the VIII:C,</div></div><div class="co_paragraph co_indentLeft1 co_indentFirstLine1"><div class="co_paragraphText">(c) adsorbing the VIII:C obtained in step (b) in another adsorption to concentrate and further purify same,</div></div><div class="co_paragraph co_indentLeft1 co_indentFirstLine1"><div class="co_paragraphText">(d) eluting the adsorbed VIII:C, and</div></div><div class="co_paragraph co_indentLeft1 co_indentFirstLine1"><div class="co_paragraphText">(e) recovering highly purified and concentrated VIII:C.</div></div><div class="co_paragraphText co_flush">It was not disputed that the product was a new product, that the “highly purified and concentrated” blood clotting <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I39082612475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I39082612475111db9765f9243f53508a_0">Factor VIII</a>:C had not previously been obtained, and that a complete structural identification of Factor VIII:C was not available. The defendant Genentech had made its commercial <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I39082612475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I39082612475111db9765f9243f53508a_1">Factor VIII</a>:C not by the method set forth in claim 1, but by using a sample of the Scripps product to “clone” Factor VIII:C protein using recombinant DNA techniques. One question presented in the case was whether claims such as claim 13 were infringed by the same product produced by a different method, or whether such claims were infringed only if the accused infringer used the process of claim 1.</div></div><div class="co_paragraph"><div class="co_paragraphText">Scripps stressed that its product was novel and enabled and was patentable as a product, although the full structure of Factor VIII:C was not available at that stage of the science. The court addressed whether claims exemplified by claim 13, properly construed, were product claims, or whether they were limited to the specific processes in the process claims to which they referred. This court held that the claims were product claims. The court held that since claims are construed the same way for infringement as for validity, the question was whether the Genentech product was the same as the claimed product, not whether they were produced by the same process. The court remanded to the district court for this factual determination. <a id="co_link_I817ae8f522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1991051497&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_1584&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1584"><em>Scripps,</em> 927 F.2d at 1584</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">After <em>Scripps</em> was decided, a panel of this court decided an appeal concerning plastic innersoles for shoes. In <a id="co_link_I817ae8f722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1992124244&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Atlantic Thermoplastics Co. v. Faytex Corp.,</em> 970 F.2d 834 (Fed.Cir.1992)</a>, the claims at issue were represented by:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>Claim 24. The product produced by the method of claim 1.</div></blockquote></div></div><div class="co_paragraphText co_flush">In turn, claim 1 was as follows:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">1. In a method of manufacturing a shock-absorbing, molded innersole for insertion in footwear, which method comprises:</div></div><div class="co_paragraph co_indentLeft1 co_indentFirstLine1"><div class="co_paragraphText">(a) introducing an expandable, polyurethane into a mold; and<input id="co_docMarker_27" type="hidden"></div></div><div class="co_paragraph co_indentLeft1 co_indentFirstLine1"><div class="co_paragraphText">(b) recovering from the mold an innersole which comprises a contoured heel and arch section composed of a substantially open-celled polyurethane foam material, the improvement which comprises:</div></div><div class="co_paragraph co_indentLeft2 co_indentFirstLine1"><div class="co_paragraphText">(i) placing an elastomeric insert material into the mold, the insert material having greater shock-absorbing  <span class="co_starPage" id="co_pp_sp_506_1310"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1310&quot; }" alt="metadata" type="hidden">*1310</span> properties and being less resilient than the molded, open-celled polyurethane foam material, and the insert material having sufficient surface tack to remain in the placed position in the mold on the introduction of the expandable polyurethane material so as to permit the expandable polyurethane material to expand about the insert material without displacement of the insert material; and</div></div><div class="co_paragraph co_indentLeft2 co_indentFirstLine1"><div class="co_paragraphText">(ii) recovering a molded innersole with the insert material having a tacky surface forming a part of the exposed bottom surface of the recovered innersole.</div></div><div class="co_paragraphText co_flush">The panel held that a claim in the form of claim 24 always requires use of the referenced method, and that it is irrelevant whether the product was new or known. The court stated that the rule of necessity, as applied in <em>Scripps,</em> is contrary to Supreme Court rulings. The panel stated that the decision in <em>Scripps</em> is incorrect. A majority of the Federal Circuit declined to resolve the conflict <em>en banc,</em> resulting in several further opinions. <em>E.g., </em><a id="co_link_I817ae8fa22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1992146799&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Atlantic Thermoplastics Co. v. Faytex Corp.,</em> 974 F.2d 1279 (Fed.Cir.1992)</a> (dissents of Chief Judge Nies and Judges Rich, Newman, and Lourie from denial of rehearing <em>en banc</em> ). Judge Rich wrote:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">[T]his whole excursion was unnecessary because the patentee admitted that claim 24, the product-by-process claim, was limited to the process. The claim read: “The molded innersole produced by the method of claim 1.” There was, therefore, no occasion to review the law to determine how the claim should be construed.... We are not here to provide restatements of the law. Such restatements should not be made without an opportunity for all affected parties to be heard from. The affected parties here are not the vendors of inner soles but largely the entire chemical industry, particularly the pharmaceutical manufacturers.</div></div><div class="co_paragraphText co_flush"><a id="co_link_I817ae8fb22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1992146799&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_1280&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1280"><em>Id.</em> at 1280</a> (Rich, J., dissenting from denial of rehearing <em>en banc</em> ).</div></div><div class="co_paragraph"><div class="co_paragraphText">Most trial courts continued to recognize the rule of necessity. For example, in <a id="co_link_I817ae8fc22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2000655020&amp;pubNum=0004637&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Trustees of Columbia University v. Roche Diagnostics GmbH,</em> 126 F.Supp.2d 16 (D.Mass.2000)</a>, the district court considered claims such as the following.</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>72. A eukaryotic cell into which foreign DNA I has been inserted in accordance with the process of claim 54.</div></blockquote></div></div><div class="co_paragraphText co_flush">The court referred to the <em><a id="co_link_I817ae8fd22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1991051497&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Scripps</a>/<a id="co_link_I817ae8fe22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1992146799&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Atlantic</a></em> conflict, concluded that the earlier panel decision controlled under the Federal Circuit's rule, <em>see </em><a id="co_link_I817ae8ff22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1988166728&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_765&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_765"><em>Newell Companies, Inc. v. Kenney Manufacturing Co.,</em> 864 F.2d 757, 765 (Fed.Cir.1988)</a> (“This court has adopted the rule that prior decisions of a panel of the court are binding precedent on subsequent panels unless and until overturned <em>in banc.</em>”), and applied the <em>Scripps</em> ruling, holding that the new cell was not limited by the process by which it was made.</div></div><div class="co_paragraph"><div class="co_paragraphText">The PTO also continued to apply the rule of necessity. In instructing examiners that products should whenever possible be described without reference to how they were made, the PTO continued to point out the exception that patentability as a product is not foreclosed when independent description is not available. The Manual of Patent Examining Procedure (MPEP) instructs the examiner to consider the structure implied by any process steps in the claim:</div><div class="co_paragraph co_indentLeft1 co_indentFirstLine1"><div class="co_paragraphText"><blockquote><div>The structure implied by the process steps should be considered when assessing the patentability of product-by-process claims over the prior art, especially where the product can only be defined by the process steps by which the product is made, or where the manufacturing process steps would be expected to impart<input id="co_docMarker_28" type="hidden"> <span class="co_starPage" id="co_pp_sp_506_1311"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1311&quot; }" alt="metadata" type="hidden">*1311</span>  distinctive structural characteristics to the final product.</div></blockquote></div></div><div class="co_paragraphText co_flush"><a id="co_link_I817ae90122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;pubNum=1015320&amp;cite=MPEPs2113&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=TS&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">MPEP § 2113 (8th ed., July 2008 rev.)</a>. This has been the practice since at least <em>Ex parte Painter</em> in 1891. I am surprised at the <em>en banc</em> court's casual misstatement about “the treatment of product-by-process claims throughout the years by the PTO,” maj. op. at 1293, for the statement is directly contrary to the treatment of such claims throughout the years by the PTO.</div></div><div class="co_paragraph"><div class="co_paragraphText">The <em>en banc</em> court's insistence that one universal rule should now be applied is contrary to the entire body of decisional law, including the Supreme Court cases cited by my colleagues. As I next discuss, in most of the cited cases the product was not a new product and thus was not patentable as a product, whether or not any process term was included in the claim. The Court consistently held that when the product was old and only the process was a patentable invention, a claim for the “product of that process” could not cover the old product made by a different process. That is, and has always been, the law. I comment briefly on the Court's cases that my colleagues misinterpret and misapply:</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I43bdb80822b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign1"><strong><em>Cochrane v. BASF</em></strong></div><div class="co_paragraph"><div class="co_paragraphText">The <em>en banc</em> opinion relies primarily on <a id="co_link_I817ae90222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;pubNum=0000708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Cochrane v. Badische Anilin &amp; Soda Fabrik,</em> 111 U.S. 293, 4 S.Ct. 455, 28 L.Ed. 433 (1884)</a> (“<a id="co_link_I817ae90322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>BASF</em></a> ”), even though my colleagues acknowledge that the product in that case was the well-known dye alizarine. The patent before the Court was a reissue patent that claimed artificial alizarine in the following way:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>Artificial alizarine, produced by either of the methods herein described, or by any other method which will produce a like result.</div></blockquote></div></div><div class="co_paragraphText co_flush">The Court held that since alizarine was a known product, the claim was limited to the patentee's two processes, stating:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>It was an old article. While a new process for producing it was patentable, the product itself could not be patented, even though it was a product made artificially for the first time, in contradistinction from being eliminated from the madder root. Calling it artificial alizarine did not make it a new composition of matter, and patentable as such, by reason of its having been prepared, artificially, for the first time, from anthracite, if it was set forth as alizarine, a well-known substance. <a id="co_link_I817ae90422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1874193215&amp;pubNum=780&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_780_593&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_780_593"><em>Wood–Paper Patent,</em> 23 Wall. 566, 593 [23 L.Ed. 31 (1874) ].</a> There was therefore no foundation for <a id="co_link_I817ae90522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1871172039&amp;pubNum=0004073&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9f20a0ed1b7911dbb0d3b726c66cf290&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">reissue No. 4,321</a>, for the product, because, on the description given, no patent for the product could have been taken out originally.</div></blockquote></div></div><div class="co_paragraphText co_flush"><a id="co_link_I817ae90622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;pubNum=708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">111 U.S. at 311–12, 4 S.Ct. 455.</a> The Court accordingly limited the claim to the two processes described in the patent, and in the portion of <a id="co_link_I817ae90722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>BASF</em></a> quoted by my colleagues, the Court discussed the proofs needed to show infringement:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>[U]nless it is shown that the process of [the specification] was followed to produce the defendants' article, or unless it is shown that the article could not be produced by any other process, the defendants' article cannot be identified as the product of the process of [the specification]. Nothing of the kind is shown.</div></blockquote></div></div><div class="co_paragraphText co_flush"><a id="co_link_I817ae90822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;pubNum=708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 310, 4 S.Ct. 455.</a> The Court did not state, or imply, despite my colleagues' contrary theory, that a claim to a new and complex product that is of necessity defined and distinguished by the process by which it was made, can never be infringed unless that specific process is practiced. There was no issue in <a id="co_link_I817ae90922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>BASF</em></a> of a product that could not be defined without reference to how it was made. The <a id="co_link_I817ae90a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>BASF</em></a> Court, providing guidance, remarked on the importance of independent description of a <input id="co_docMarker_29" type="hidden"> <span class="co_starPage" id="co_pp_sp_506_1312"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1312&quot; }" alt="metadata" type="hidden">*1312</span> patented product, in the following sentence cited by my colleagues:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>Every patent for a product or composition of matter must identify it so that it can be recognized aside from the description of the process for making it, or else nothing can be held to infringe the patent which is not made by that process.</div></blockquote></div></div><div class="co_paragraphText co_flush"><a id="co_link_I817ae90b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;pubNum=708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 310, 4 S.Ct. 455.</a> This statement is indeed the general rule, as stated by the Patent Commissioner several years later in <em>Ex parte Painter.</em> However, <a id="co_link_I817ae90c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>BASF</em></a> did not present the situation for which the expedient of necessity was created, for as the Court stated, the invention was “a process for preparing alizarine, not as a new substance prepared for the first time, but as the substance already known as alizarine, to be prepared, however, by the new process, which process is to be the subject of the patent, and is the process of preparing the known product alizarine from anthracine.” <a id="co_link_I817ae90d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;pubNum=708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 308–09, 4 S.Ct. 455.</a></div></div><div class="co_paragraph"><div class="co_paragraphText">This was not an instance of a new product describable only in terms of its process of manufacture. The <a id="co_link_I817ae90e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>BASF</em></a> decision lends no support to today's <em>en banc</em> rule that every product claim that mentions a process step is always restricted to that process, with no exception, no expedient, no preservation of the distinctions among forms of claim based on the nature of the invention.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I43bdb80922b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign1"><strong><em>The Goodyear Dental cases</em></strong></div><div class="co_paragraph"><div class="co_paragraphText">The <em>en banc</em> court also states that its new ruling is supported by two cases relating to a patent on the use of vulcanized rubber to form a plate for holding dentures, <a id="co_link_I817ae90f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1876191350&amp;pubNum=780&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Smith v. Goodyear Dental Vulcanite Co.,</em> 93 U.S. (3 Otto) 486, 23 L.Ed. 952 (1876)</a>, and <a id="co_link_I817ae91022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1880197551&amp;pubNum=780&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Goodyear Dental Vulcanite Co. v. Davis,</em> 102 U.S. (12 Otto) 222, 26 L.Ed. 149 (1880)</a>. Review of these cases reveals no support for the <em>en banc</em> court's statement of their holdings. The claim at issue was:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>The plate of hard rubber or vulcanite, or its equivalent, for holding artificial teeth, or teeth and gums, substantially as described.</div></blockquote></div></div><div class="co_paragraphText co_flush"><a id="co_link_I817ae91122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1880197551&amp;pubNum=780&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_780_223&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_780_223"><em>Davis,</em> 102 U.S. (12 Otto) at 223.</a> The claim was written in the then-standard format of incorporating the description in the specification through the phrase “substantially as described.” This was not a product-by-process or product-of-the-process claim at all, for the claim contains no process distinction or limitation, but simply refers to the description in the specification. Nonetheless, the <em>en banc</em> majority appears to state that these cases mean that the Supreme Court requires that all claims for products whose method of production is set forth in the specification—as is required by the description and enablement requirement—cannot be infringed unless that method is used.</div></div><div class="co_paragraph"><div class="co_paragraphText">That is not what the <em>Goodyear Dental</em> cases said. The Court referred to the position of Goodyear Dental Vulcanite that its patent covered all <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=mdev&amp;entityId=Iaea4eaad475411db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_Iaea4eaad475411db9765f9243f53508a_0">dental plates</a> made of vulcanized rubber, and held, upon reviewing the specification and the prior art, that the process of manufacture was what distinguished this <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=mdev&amp;entityId=Iaea4eaad475411db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_Iaea4eaad475411db9765f9243f53508a_1">dental plate</a> from the prior art <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=mdev&amp;entityId=Iaea4eaad475411db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_Iaea4eaad475411db9765f9243f53508a_2">dental plates</a>, and concluded: “The invention, then, is a product or manufacture made in a defined manner. It is not a product alone, separated from the process by which it is created.” <a id="co_link_I817ae91622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1876191350&amp;pubNum=780&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_780_493&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_780_493"><em>Smith,</em> 93 U.S. (3 Otto) at 493.</a> Were the claim not limited to this process, the Court concluded that the claim would not have been patentable. <em>See </em><em>id.</em> at 492 (holding that if the patent were for a “mere substitution of vulcanite for other materials, which had previously been employed as a base for artificial sets of teeth” then it “constituted no invention”). Four years later, considering the same patent in <input id="co_docMarker_30" type="hidden"><em>Davis,</em> the Court emphasized <span class="co_starPage" id="co_pp_sp_506_1313"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1313&quot; }" alt="metadata" type="hidden">*1313</span>  that the claim was limited to use of vulcanized rubber or its equivalent, and held that since the accused infringer made its <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=mdev&amp;entityId=Iaea4eaad475411db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_Iaea4eaad475411db9765f9243f53508a_3">dental plate</a> with celluloid, there could not be infringement. <em>See</em> <a id="co_link_I817ae91a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1880197551&amp;pubNum=780&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_780_228&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_780_228">102 U.S. (12 Otto) at 228–30</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">The court today cites these cases as definitive of the interpretation of claims with process elements, although the only process referent is the phrase “substantially as described.” This flawed reasoning was disposed of in 1890 in the classic <em>Robinson on Patents,</em> and until now has not reappeared:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>In stating Claims certain phrases are frequently employed to which a special importance seems to be attached by applicants. Among these are the phrase “substantially as described” and others of the same meaning. These phrases import the same thing when used in a Claim as when elsewhere employed. They are neither necessary nor technical. The reference they make to the Description is always implied, and relates only to the essential features of the invention as therein delineated. They add nothing, therefore, to the certainty of the Claim, nor do they detract from it unless the claimant carelessly inserts them as a substitute for a more clear and definite statement of his invention.</div></blockquote></div></div><div class="co_paragraphText co_flush">II W.C. Robinson, <em>Robinson on </em><em>Patents</em> 517 (1890) (footnotes omitted).</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I43bdb80a22b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign1"><strong><em>Merrill v. Yeomans</em></strong></div><div class="co_paragraph"><div class="co_paragraphText">My colleagues also rely on <a id="co_link_I817ae91d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1876154712&amp;pubNum=780&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Merrill v. Yeomans,</em> 94 U.S. (4 Otto) 568, 24 L.Ed. 235 (1877)</a>. Again, the relevance is remote. The <em>Merrill</em> Court explained that the issue was the “correct construction of plaintiff's patent,” <a id="co_link_I817ae91f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1876154712&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>id.</em> at 569,</a> construing the following claim:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>[T]he above-described new manufacture of the deodorized heavy hydrocarbon oils, suitable for lubricating and other purposes, free from the characteristic odors of hydrocarbon oils, and having a slight smell like fatty oil, from hydrocarbon oils, by treating them substantially as hereinbefore described.</div></blockquote></div></div><div class="co_paragraphText co_flush"><a id="co_link_I817ae92022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1876154712&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 570.</a> The Court examined the specification to determine what was invented, and found that the invention was directed solely to a process, not to a product. The Court then concluded that the claim's usage “new manufacture” referred to the manufacturing process, and not to the product. The claim was thus a process claim, and no “product-by-process” issue was presented. The Court concluded that the defendant's oil, which was made by a different process, did not infringe.</div></div><div class="co_paragraph"><div class="co_paragraphText">The <em>Merrill</em> Court discussed its practice of looking to the patent application and interpreting the claim in light of what was “really invented”:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>[W]here it appears that a valuable invention has really been made, this court, giving full effect to all that is found in the application on which the Patent Office acted, will uphold that which was really invented, and which comes within any fair interpretation of the patentee's assertion of claim.</div></blockquote></div></div><div class="co_paragraphText co_flush"><a id="co_link_I817ae92222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1876154712&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 573.</a> This approach is inimical to the <em>en banc</em> court's theory that it is irrelevant what the patentee describes as his invention, and that if a process step is mentioned in the claim or “substantially described” in the specification, the claim always requires performance of that step. Although the Court in <em>Merrill</em> was not confronted with a situation of indescribable product or necessity bred of complexity—indeed no product at all was claimed—neither did the Court hold that every product invention must be limited by the process that produced the product.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I43bdb80b22b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign1"><strong><em>The Wood Paper Patent case</em></strong></div><div class="co_paragraph"><div class="co_paragraphText">The list of Supreme Court cases relied on by my colleagues continues with  <span class="co_starPage" id="co_pp_sp_506_1314"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1314&quot; }" alt="metadata" type="hidden">*1314</span> <a id="co_link_I817ae92422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1874193215&amp;pubNum=780&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_780_596&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_780_596"><em>The Wood–Paper Patent,<input id="co_docMarker_31" type="hidden"></em> 90 U.S. 566, 596, 23 Wall. 566, 23 L.Ed. 31 (1874)</a>, where claims with the standard “substantially as described” language were construed in two reissue patents relating to the pulping of wood to make paper. The Court explained that one reissue patent was for “a product or manufacture, and not for the process by which the product may be obtained,” and the other “for a process and not for its product.” <a id="co_link_I817ae92522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1874193215&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 593.</a> The Court examined the prior art and concluded that the claim for the product could not be sustained, because the product produced by the inventor's new pulping process was not new:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>Paper-pulp obtained from various vegetable substances was in common use before the original patent was granted to Watt &amp; Burgess, and whatever may be said of their process for obtaining it, the product was in no sense new. The <a id="co_link_I817ae92622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1863080657&amp;pubNum=0004073&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I24e84bb300ac11dbaaf9821ce89a3430&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">reissued patent, No. 1448</a>, is, therefore, void for want of novelty in the manufacture patented.</div></blockquote></div></div><div class="co_paragraphText co_flush"><a id="co_link_I817ae92722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1874193215&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 596.</a> The Court then discussed the reissue patent for the “process and not for its product,” and held this reissue void because it claimed a different invention than in the original patent. The Court also discussed several other patents directed to boilers used to produce paper-pulp, and to a process for bleaching straw. Nothing in this case concerns the product-by-process issue on which the court is today acting.</div></div><div class="co_paragraph"><div class="co_paragraphText">I cannot discern why the <em>en banc</em> court relies on <a id="co_link_I817ae92822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1874193215&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>The Wood–Paper Patent</em></a> case as invalidating <em>Scripps,</em> and the court has not attempted to explain.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I43bdb80c22b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign1"><strong><em>Plummer v. Sargent</em></strong></div><div class="co_paragraph"><div class="co_paragraphText">The <em>en banc</em> court also relies on <a id="co_link_I817ae92b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1887180058&amp;pubNum=0000708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Plummer v. Sargent,</em> 120 U.S. 442, 7 S.Ct. 640, 30 L.Ed. 737 (1887)</a>, which again provides no support for my colleagues' thesis. This case again illustrates the Court's practice of reviewing what the patentee stated he invented as set forth in the specification in light of the prior art. The claim in <em>Plummer</em> was for a “new manufacture,” “substantially as described”:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>What I claim and desire to procure by letters patent is the new manufacture hereinabove described, consisting of iron ornamented in imitation of bronze by the application of oil and heat, substantially as described.</div></blockquote></div></div><div class="co_paragraphText co_flush"><a id="co_link_I817ae92d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1887180058&amp;pubNum=708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 445, 7 S.Ct. 640.</a> The trial court had found non-infringement because the defendant had used a prior art process for bronzing iron. This prior process was work of F.W. Brocksieper, an employee of the defendant's predecessor company. The Supreme Court affirmed, stating that the claims were limited to the process described in the specification:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>It seems necessarily to follow from this view either that the Tucker patents are void by reason of anticipation practiced by Brocksieper, or that the patented process and product must be restricted to exactly what is described....</div></blockquote></div></div><div class="co_paragraphText co_flush"><a id="co_link_I817ae92e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1887180058&amp;pubNum=708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 449, 7 S.Ct. 640.</a> The Court thus limited the claims to the process described by the patentee, not because of any rule about limiting a product to how it was made in the specification, but to sustain validity of the patent in view of the Brocksieper prior art. The decision in <em>Plummer</em> is unrelated to any rule of claim construction based on whether process terms are included in the claim.</div></div><div class="co_paragraph"><div class="co_paragraphText">These nineteenth-century cases do not relate to the <em>en banc</em> court's new universal rule of claim construction, whereby all product claims having process terms are treated as process claims, whatever the nature of the product, whatever the need for process descriptors, or any other factor that precedent shows to be relevant to the exception that is here at issue as to the use of and construction of such claims. Nor do any more recent Court cases.<input id="co_docMarker_32" type="hidden"></div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I43bdb80d22b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign1"><strong><em>General Electric v. Wabash</em></strong></div><div class="co_paragraph"><div class="co_paragraphText">My colleagues also cite  <span class="co_starPage" id="co_pp_sp_506_1315"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1315&quot; }" alt="metadata" type="hidden">*1315</span> <a id="co_link_I817ae93122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1938122169&amp;pubNum=0000708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>General Electric Co. v. Wabash Appliance Corp.,</em> 304 U.S. 364, 58 S.Ct. 899, 82 L.Ed. 1402 (1938)</a>, although the relevance of this case is, again, not apparent, for it involved no product-by-process claims, but rather claims that recite the properties of the product. A typical claim is claim 25, which describes an electric lamp filament composed of tungsten grains of a size and shape that prevents sagging of the filament:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>25. A filament for electric incandescent lamps or other devices, composed substantially of tungsten and made up mainly of a number of comparatively large grains of such size and contour as to prevent substantial sagging and offsetting during a normal or commercially useful life for such a lamp or other device.</div></blockquote></div></div><div class="co_paragraphText co_flush"><a id="co_link_I817ae93222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1938122169&amp;pubNum=708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 368, 58 S.Ct. 899.</a> The Court held this claim “invalid on its face” for failing to provide a “distinct and definite statement of what he claims to be new, and to be his invention.” <a id="co_link_I817ae93322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1938122169&amp;pubNum=708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 369, 58 S.Ct. 899.</a> The Court stated that the description of the grains as “of such size and contour as to prevent substantial sagging and offsetting” was “inadequate as a description of the structural characteristics of the grains.” <a id="co_link_I817ae93422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1938122169&amp;pubNum=708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 370, 58 S.Ct. 899.</a> The Court also criticized the use of functional language in the claim, stating that such terms were too indefinite to provide clear guidance. <a id="co_link_I817ae93522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1938122169&amp;pubNum=708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 371, 58 S.Ct. 899.</a> There was no issue of whether process steps in the claims were regarded as limiting, for there were no process steps in the claims. Instead, the Court stated that even the implicit inclusion of process steps could not save the claim, because the description of the process in the specification was inadequate:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>Even assuming that definiteness may be imparted to the product claim by that part of the specification which purportedly details only a method of making the product, the description of the Pacz process is likewise silent as to the nature of the filament product.</div></blockquote></div></div><div class="co_paragraphText co_flush"><a id="co_link_I817ae93622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1938122169&amp;pubNum=708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 373, 58 S.Ct. 899.</a> The Court held the patent invalid for lack of a “distinct and definite” description of the invention, for the court “doubted whether one who discovers or invents a product he knows to be new will ever find it impossible to describe some aspect of its novelty.” <em>Id.</em> Whatever the inadequacies in the Pacz description of his invention, the Court's optimistic view of scientific capability cannot be deemed to have barred all recourse to the rule of necessity when it is warranted, or to have voided the ensuing seventy-one years of Patent Office and judicial recognition of this pragmatic expedient.</div></div><div class="co_paragraph"><div class="co_paragraphText">No Supreme Court case discussed the problems of complexity and structural analysis that warrant this expedient, or created a legal solution to these problems. It is inappropriate, unsupported by law or precedent, and contrary to the purposes of patent systems, for this court now to rule that such products cannot be patented as products.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I43bdb80e22b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign1"><strong><em>Regional circuit decisions</em></strong></div><div class="co_paragraph"><div class="co_paragraphText">My colleagues also rely on some decisions of the regional circuits preceding this court's formation, announcing that “our sister circuits also followed the general rule that the defining process terms limit product-by-process claims,” and citing two cases, one decided in 1915 and one in 1977. These cases do not support the <em>en banc</em> court's opinion,<sup id="co_footnoteReference_B00542018850794_ID0EV6DK"><a href="#co_footnote_B00542018850794" class="co_footnoteReference">4</a></sup> and raised no issue of an expedient based on necessity.</div></div><div class="co_paragraph"><div class="co_paragraphText"> <span class="co_starPage" id="co_pp_sp_506_1316"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1316&quot; }" alt="metadata" type="hidden">*1316</span> In <a id="co_link_I817ae93922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1915100705&amp;pubNum=0000348&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Hide–Ite Leather Co. v. Fiber Products Co.,</em> 226 F. 34 (1st Cir.1915)</a>, the appeal was of two process claims for making leatherboard, and a product claim for leatherboard “made from pulp” and reciting the second step in the process claims plus the reference “substantially as described.” The accused infringer did not use the same first step of the process. The court found that the invention was for a process, not a product, and therefore that the product claim was not infringed.<input id="co_docMarker_33" type="hidden"></div></div><div class="co_paragraph"><div class="co_paragraphText">My colleagues also cite <a id="co_link_I817ae93a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1977123842&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_876&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_876"><em>Paeco, Inc. v. Applied Moldings, Inc.,</em> 562 F.2d 870, 876 (3d Cir.1977)</a>, in which the court used the specification to resolve an ambiguity in the language of a product claim relating to “replica wooden beams” made of foamed urethane. The court reviewed whether ambiguous claim language required a closed or open mold, for this determined the question of anticipation based on a prior art reference that used an open mold. Thus the court stated that the manufacturing process described in the specification was “of paramount importance,” and construed the claim in light of that process as requiring a closed mold, thus preserving the claim's validity as against the prior art that used and open mold. The sentence quoted by my colleagues out of its context, does not relate to the <em>en banc</em> court's new rule concerning process terms in product claims, and the <em>Paeco</em> case raised no question of whether the product was capable of description apart from the process.</div></div><div class="co_paragraph"><div class="co_paragraphText">In addition to these two cases inaptly cited by the <em>en banc</em> court, other regional circuit decisions also contradict this court's new thesis. In <a id="co_link_I817ae93c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1919100091&amp;pubNum=0000348&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Dunn Wire–Cut Lug Brick Co. v. Toronto Fire Clay Co.,</em> 259 F. 258 (6th Cir.1919)</a>, the court stated: “Certain it is, in view of the weight of authority and the latest decisions, that the inventor of a new and useful product or article of manufacture may have a patent which covers it and gives a monopoly upon it regardless of great variations in the method of making.” <a id="co_link_I817ae93d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1919100091&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 261.</a></div></div><div class="co_paragraph"><div class="co_paragraphText">In <a id="co_link_I817ae93e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1935129782&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Buono v. Yankee Maid Dress Corp.,</em> 77 F.2d 274 (2d Cir.1935)</a> (L.Hand, J.), the court held invalid a product claim for a kind of “blind stitch” used in sewing, because the invention lay only in the process of producing the stitch, which itself “was not new.” <a id="co_link_I817ae93f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1935129782&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 279.</a> While the stitch had not been claimed as the product of a particular machine or process, the court remarked on the conceivability of patenting such a product “merely as the product of a machine or process, even though it were anticipated if made in other ways,” <a id="co_link_I817ae94022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1935129782&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>id.,</em></a> observing that such a claim might serve a useful purpose in protecting against products that were produced by the same machine or process abroad and then imported. Of such a claim, wherein the product itself was anticipated but the process was new, the court stated “it would in that case not be infringed by anything but the product of the ... process.” <a id="co_link_I817ae94122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1935129782&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> This routine statement of established <span class="co_starPage" id="co_pp_sp_506_1317"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1317&quot; }" alt="metadata" type="hidden">*1317</span>  law does not mean that when the product is itself new and useful and unobvious, it cannot be claimed as a product but must be tied to the machine that made it.</div></div><div class="co_paragraph"><div class="co_paragraphText">Judge Hand emphasized that this example related only to situations where the product itself was not new. The opinion explained that to be claimed as a product, the product “must be new as such, that is, regardless of the process or machine which makes it; and it must stand upon its own invention, again independently of the machine or process which makes it.” <a id="co_link_I817ae94222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1935129782&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> This was also the CCPA's view of product claims, providing the precedent carried forward to, and binding upon the Federal Circuit.<sup id="co_footnoteReference_B00652018850794_ID0E3IEK"><a href="#co_footnote_B00652018850794" class="co_footnoteReference">5</a></sup></div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I43bdb80f22b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign2"><span class="co_smallCaps">III</span></div><div class="co_headtext co_hAlign2"><span class="co_smallCaps">THE <em>EN BANC</em> RULING</span></div><div class="co_paragraph"><div class="co_paragraphText">Defying precedent, the <em>en banc</em> court adopts for all situations “the basic rule that the process terms limit product-by-process claims,” maj. op. at 1293, whether the product is novel or known, and whether or not the new product could not have been fully described by its structure alone. The court eliminates the long-accepted expedient for new products whose structure is not fully known. While the <input id="co_docMarker_34" type="hidden"><em>Scripps</em> decision is the only decision that is mentioned as “expressly overruled,” maj. op. at 1293, <em>Scripps</em> is only one of many cases now discarded.</div></div><div class="co_paragraph"><div class="co_paragraphText">The <em>en banc</em> majority's response to the dissenters is to state that “the inventor is absolutely free to use process steps to define this product” if its “structure is either not fully known or too complex to analyze,” maj. op. at 1294, but to eliminate the premise that the inventor thereby obtains a product claim, not a process claim. According to the majority, a patentee can continue to obtain product claims using process descriptors, but such product claims are treated as process claims for infringement. The applicant would still have to demonstrate patentability of the new product as a product (independent of the process), while enforcement of the patent against an identical product would be limited to the infringer's use of the process steps used as a descriptor. For the first time, claims are construed differently for validity and for infringement.</div></div><div class="co_paragraph"><div class="co_paragraphText">It has been an inviolate rule that patent claims are construed the same way for validity and for infringement. <em>See, e.g., </em><a id="co_link_I817ae94822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2003065297&amp;pubNum=0000506&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1330&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1330"><em>Amgen Inc. v. Hoechst Marion Roussel, Inc.,</em> 314 F.3d 1313, 1330 (Fed.Cir.2003)</a> (“It is axiomatic that claims are construed the same way for both invalidity and infringement.”); <a id="co_link_I817ae94922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2001144009&amp;pubNum=0000506&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1351&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1351"><em>Amazon.com, Inc. v. Barnesandnoble.com, Inc.,</em> 239 F.3d 1343, 1351 (Fed.Cir.2001)</a> (“Because the claims of a patent measure the invention at issue, the claims must be interpreted and given the same meaning for purposes of both validity and infringement analyses.”); <a id="co_link_I817ae94a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998210012&amp;pubNum=0000506&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1363&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1363"><em>C.R. Bard, Inc. v. M3 Systems, Inc.,</em> 157 F.3d 1340, 1363 (Fed.Cir.1998)</a> (“Claims must be interpreted the same way for determining infringement as was done to sustain their validity.”); <a id="co_link_I817ae94b22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1995106573&amp;pubNum=0000506&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1576&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1576"><em>Southwall Technologies, Inc. v.  <span class="co_starPage" id="co_pp_sp_506_1318"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1318&quot; }" alt="metadata" type="hidden">*1318</span> Cardinal IG Co.,</em> 54 F.3d 1570, 1576 (Fed.Cir.1995)</a> (“Claims may not be construed one way in order to obtain their allowance and in a different way against accused infringers.”); <a id="co_link_I817ae94c22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1994161680&amp;pubNum=0000506&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1163&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1163"><em>Beachcombers, International, Inc. v. WildeWood Creative Products, Inc.,</em> 31 F.3d 1154, 1163 (Fed.Cir.1994)</a> (“We have already interpreted the claims for purposes of assessing their validity. The same claim interpretation of course applies to the infringement analysis.”); <a id="co_link_I817ae94d22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1991051497&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_1583&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1583"><em>Scripps Clinic &amp; Research Foundation v. Genentech, Inc.,</em> 927 F.2d 1565, 1583 (Fed.Cir.1991)</a> (“claims must be construed the same way for validity and for infringement”); <a id="co_link_I817ae94e22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1988130005&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_882&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_882"><em>SmithKline Diagnostics, Inc. v. Helena Laboratories Corp.,</em> 859 F.2d 878, 882 (Fed.Cir.1988)</a> (“The claims of the ′970 patent measure the invention at issue; thus, the claims must be interpreted and given the same meaning for purposes of both validity and infringement analyses.”); <em>see also</em> 5A Chisum on Patents § 18.01 (2007) (“A fundamental tenet of patent law is that a claim must be interpreted consistently for purposes of infringement and validity.”); <em>id.</em> § 18.03[2][h] (collecting cases).</div></div><div class="co_paragraph"><div class="co_paragraphText">As interpreted for validity, the claims obtained under the expedient of necessity are product claims, and are subject to the requirements of novelty, unobviousness, and all other requirements for new products, independent of how the products can be made. My colleagues hold that these are product claims for validity, but process claims for infringement. Departure from the rule that forbids such deviation requires sound reason, and fuller exploration than the cursory brush-off dispensed by my colleagues.</div></div><div class="co_paragraph"><div class="co_paragraphText">I do agree with my colleagues that their logic is “simple.” Maj. op. at 1294. However, today's inventions are not simple. The needs of inventions of the past and present, and more so the future, are not simple. The public interest in invention and development of today's complex sciences, is not simple. The <input id="co_docMarker_35" type="hidden"><em>en banc</em> court's “simple” hypothetical about “compound X, obtained by process Y,” is simply irrelevant to the issues we must resolve. Scientists know that it is often easier to show that two products are the same, than to decipher their chemical or biological structure; for example, in the case at bar, comparing the X-ray diffraction patterns and absorption spectra could show that the products are the same, although their exact crystal structure is undefined. However, my colleagues announce that the only way to establish whether the accused compound is the same as the patented compound is by inquiring whether they were prepared by the same method. Maj. op. at 1293–94 (“[W]hat analytical tools can confirm that the alleged infringer's compound is in fact infringing, other than a comparison of the claimed and accused infringing processes?”). That question has many answers, now stated to be irrelevant.</div></div><div class="co_paragraph"><div class="co_paragraphText">While the section of this opinion decided by the <em>en banc</em> court is largely directed to its reversal of precedent, the implementation of its ruling remains with the original panel. The panel decision enlarges the <em>en banc</em> ruling, further binding this court. The claims at issue state processes by which the new crystal form is “obtainable,” although the specification states that other methods might be used. The panel rules that a claim “cannot capture a product obtained by or obtainable by processes other than those explicitly recited in the claims.” maj. op. at 1295, finding authority in <a id="co_link_I817ae94f22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>BASF,</em></a> which I have discussed <em>ante.</em> My colleagues thus continue to misapply the Court's ruling in <a id="co_link_I817ae95022b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>BASF,</em></a> where the Court stated repeatedly that the product in that case was a known product. <a id="co_link_I817ae95122b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;pubNum=0000708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>BASF,</em> 111 U.S. at 311, 4 S.Ct. 455 (“It was an old article.”)</a>. In <a id="co_link_I817ae95222b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>BASF</em></a> the Court responded to the patentee's argument that it was entitled to cover all artificial alizarine  <span class="co_starPage" id="co_pp_sp_506_1319"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1319&quot; }" alt="metadata" type="hidden">*1319</span> made by any process, by observing that the patentee had not shown how the infringing and patented products “can be recognized,” <a id="co_link_I817ae95322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;pubNum=708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>id.</em> at 310, 4 S.Ct. 455,</a> an aspect at the opposite pole from the case at bar, where the patentee provided elaborate details as to how the patented and accused crystal forms can be recognized.</div></div><div class="co_paragraph"><div class="co_paragraphText">The panel also states that “the applicant's statement in the file wrapper that ‘the method of preparation ... is not considered the heart of the present invention’ should not be afforded undue gravitas.” Maj. op. at 1296. This too is an aberration of precedent, and is contrary to the many rulings of the Supreme Court and this court that afford due gravitas to the applicant's statement of what has been invented. <a id="co_link_I817ae95422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;pubNum=0000708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>See, e.g., BASF,</em> 111 U.S. at 308, 4 S.Ct. 455</a> (“It is very plain that the specification of the original <a id="co_link_I817ae95522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1869152342&amp;pubNum=0004074&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I5300e76b00cf11db8b56def3c325596e&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">patent, No. 95,465</a>, states the invention to be a process for preparing alizarine, not as a new substance prepared for the first time, but as the substance already known as alizarine, to be prepared, however, by the new process, which process is to be the subject of the patent....”); <a id="co_link_I817ae95622b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1887180058&amp;pubNum=0000708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Plummer v. Sargent,</em> 120 U.S. at 443, 7 S.Ct. 640</a> (quoting specification of companion patent, where inventor stated “My invention consists in a process of covering iron with a very thin coating of oil, and then subjecting it to heat, the effect of which is to leave upon the iron a firm film, which is very durable, and gives the iron a highly ornamental appearance, like that of bronze”). The Federal Circuit's emphasis on the importance of the specification has been repeatedly stated. <em>E.g., </em><a id="co_link_I817ae95722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2006931523&amp;pubNum=0000506&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1315&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1315"><em>Phillips v. AWH Corp.,<input id="co_docMarker_36" type="hidden"></em> 415 F.3d 1303, 1315 (Fed.Cir.2005)</a> (<em>en banc</em> ) (“[T]he specification is always highly relevant to the claim construction analysis. Usually, it is dispositive; it is the single best guide to the meaning of a disputed term.” (internal quotation marks omitted)).</div></div><div class="co_paragraph"><div class="co_paragraphText">The <em>en banc</em> court appears to misjudge the implications of its ruling, for the court states that it is now making available to “others the right to freely practice process Z [a different process] that may produce a better product in a better way.” Maj. op. at 1294. If others can indeed make a better product, this expedient presents no impediment. That is not the issue of this case. The issue is the right to make the same product, by making a process change that does not change the product. By now assuring that right, the exclusionary value of the claim to a new product is lost.</div></div><div class="co_paragraph"><div class="co_paragraphText">The purpose of the rule of necessity is to allow inventors of complex new products to obtain the patent scope to which their invention is entitled—the scope of the novel product they invented, no more and no less. The majority's change of law simply imposes unfairness as well as legal error on patent-supported advances.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I43bdb81022b911e89bf099c0ee06c731"><div class="co_headtext co_hAlign2"><span class="co_smallCaps">SUMMARY</span></div><div class="co_paragraph"><div class="co_paragraphText">Precedent establishes that the correct construction of claims that recite process steps depends, like all claim construction, on what has been invented. No single rule fits all inventions. The construer must view the claims in light of the description of the invention in the specification, the prior art, and the prosecution history. In the complex law and practice of patents and inventions, the special expedient here of concern arises when the precise structure of a new product is not known from the information available when the patent application was filed. The law has enabled and endorsed this expedient of describing a product in order to claim it as a product, whereby validity and infringement are determined as a product, independent of any process term that was used to aid in defining the product. This expedient does not enlarge patent scope; it simply permits patenting what has been invented. A narrow <span class="co_starPage" id="co_pp_sp_506_1320"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1320&quot; }" alt="metadata" type="hidden">*1320</span>  but clear body of law has evolved to accommodate this need of complex technologies. This entire body of law is today overturned, <em>sua sponte</em> and without a hearing, without any participation of those affected, without identification of the intended benefits. I respectfully dissent from the <em>en banc</em> court's rulings, as well as the procedure by which they were reached.</div></div></div></div></div><div class="co_contentBlock x_opinionDissent"><div class="co_contentBlock x_dissentAuthorLineBlock"><div class="co_contentBlock x_dissentAuthorLine"><a id="co_link_I817ae95822b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0225327201&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">LOURIE</a>, Circuit Judge, dissenting from en banc Section III. A. 2.</div></div><div class="co_contentBlock x_opinionBody"><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I43bdb81322b911e89bf099c0ee06c731"><div class="co_paragraph"><div class="co_paragraphText">I respectfully dissent from the court's en banc holding in Section III. A. 2 that product-by-process claims always require use of the recited process in order to be infringed.</div></div><div class="co_paragraph"><div class="co_paragraphText">I agree that there is substantial Supreme Court precedent that holds that product-by-process claims require use of the recited process for there to be infringement. However, many of those cases applied overly broad language to fact situations involving old products or used vague language that makes it difficult to determine whether the products were old or new. Clearly, however, when a product is old, a product-by-process claim cannot be interpreted as a claim to the product made by any means. The product is old and unpatentable per se. <a id="co_link_I817ae95922b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>BASF</em></a> in fact involved an old product. <em>See </em><a id="co_link_I817ae95a22b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1884180151&amp;pubNum=0000708&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Cochrane v. Badische Anilin &amp; Soda Fabrik,</em> 111 U.S. 293, 311, 4 S.Ct. 455, 28 L.Ed. 433 (1884)</a> (“It was an old article.”).</div></div><div class="co_paragraph"><div class="co_paragraphText">There is arguably a different situation that should apply to chemical-biological products today than to mechanical products of more than a century ago. When a product is new and the inventor claims it by a process of preparation, I fail to see why the product-by-process claim should not be interpreted as a product claim that can be infringed even when the product is made by means other than that recited in the claim. Supreme Court precedent dealing with old products, while utilizing broad language, does not foreclose that possibility. The Court years ago did not have occasion to consider today's innovations or decide whether a distinction should be made between a new chemical-biological product and an old product made by a new process.<input id="co_docMarker_37" type="hidden"></div></div><div class="co_paragraph"><div class="co_paragraphText">And there may be differing results depending upon the exact wording of a claim at issue. For example, a claim reading “when made by” might only be infringed when the recited process is used by the accused, as it is situational. On the other hand, a claim reading “obtainable by” refers to capability, so it might not require use of the process to infringe. “Obtained by” is ambiguous. Bright lines have their uses, but judging should take account of differing circumstances. In addition, of course, in order to sustain any claim for infringement, a patent owner must prove that an accused product is the same as that covered by an asserted claim. If the reason a product was claimed by its process was that its structure was unknown, then, if, at the time infringement is asserted, there still is no means to ascertain structurally whether the accused product is the same as that claimed, the infringement claim fails. However, that should not mean that a new product claimed by a process of preparation cannot ever be infringed when made by another process.</div></div><div class="co_paragraph"><div class="co_paragraphText">It may be that with today's analytical techniques there is little need for product-by-process claims. After all, claim 1 of the Abbott patent is a claim to a compound, not only by name, but also by certain of its characteristics. A claim to a product defined by its characteristics or properties surely is a proper claim.</div></div><div class="co_paragraph"><div class="co_paragraphText">However, product-by-process issues still seem to come before us and I would make a distinction between old products and new products in interpreting product-by-process <span class="co_starPage" id="co_pp_sp_506_1321"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1321&quot; }" alt="metadata" type="hidden">*1321</span>  claims. Accordingly, I respectfully dissent from the court's en banc holding.</div></div></div></div></div></div></div><div class="co_parallelCites"><h2 id="co_allCitations" class="co_parallelCitesBlockLabel co_printHeading">All Citations</h2>566 F.3d 1282, 90 U.S.P.Q.2d 1769</div><div id="co_footnoteSection" class="co_footnoteSection co_briefItState"><h2 class="co_footnoteSectionTitle co_printHeading">Footnotes</h2><div><div class="co_footnoteNumber"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1291&quot; }" alt="metadata" type="hidden"><span id="co_footnote_B00112018850794"><a href="#co_footnoteReference_B00112018850794_ID0EGRBI">1</a></span></div><div class="co_footnoteBody"><div class="co_paragraph"><div class="co_paragraphText">This court, <em>sua sponte,</em> took en banc Section III.A.2 before issuing a panel opinion. The following judges join this section of the opinion: Chief Judge Michel and Judges Rader, Bryson, Gajarsa, Linn, Dyk, Prost, and Moore. Judges Newman and Lourie dissent in separate opinions. Judges Mayer and Lourie join in Judge Newman's dissent. Judge Schall did not participate as a member of the en banc court.</div></div></div></div><div><div class="co_footnoteNumber"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1300&quot; }" alt="metadata" type="hidden"><span id="co_footnote_B00212018850794"><a href="#co_footnoteReference_B00212018850794_ID0EF3DI">1</a></span></div><div class="co_footnoteBody"><div class="co_paragraph"><div class="co_paragraphText">As discussed by Eric P. Mirabel, <em>Product–By–Process Claims: A Practical Perspective,</em> 68 J. Pat. &amp; Trademark Off. Soc'y 3, 3–4 (1986), the various forms of product-by-process claims include “true” product-by-process claims, product claims with a process limitation, product claims with a process-derived structural element, and product claims with functional terms.</div></div></div></div><div><div class="co_footnoteNumber"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1305&quot; }" alt="metadata" type="hidden"><span id="co_footnote_B00322018850794"><a href="#co_footnoteReference_B00322018850794_ID0E55AK">2</a></span></div><div class="co_footnoteBody"><div class="co_paragraph"><div class="co_paragraphText">The Hruska Commission Report, which informed the debate that eventually led to the formation of our court, described the varying attitudes towards patents held by the regional courts of appeal and the variations in patent rulings among the circuits. <em>See </em><a id="co_link_I817ae8c722b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=0292103126&amp;pubNum=0000344&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=LR&amp;fi=co_pp_sp_344_370&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_344_370"><em>Commission on Revision of the Federal Court Appellate System Structure and Internal Procedures: Recommendations for Change,</em> 67 F.R.D. 195, 370 (1975)</a>.</div></div></div></div><div><div class="co_footnoteNumber"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1308&quot; }" alt="metadata" type="hidden"><span id="co_footnote_B00432018850794"><a href="#co_footnoteReference_B00432018850794_ID0EJWBK">3</a></span></div><div class="co_footnoteBody"><div class="co_paragraph"><div class="co_paragraphText">The <em>en banc</em> court impugns the CCPA's experience. Maj. op. at 1293 (stating that the CCPA had “virtually no jurisdiction to address infringement litigation”). The CCPA for many years addressed infringement litigation, in appeals from the International Trade Commission and its predecessor tribunals. <em>E.g., </em><a id="co_link_I817ae8e322b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1981111484&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Sealed Air Corp. v. Int'l Trade Comm'n,</em> 68 C.C.P.A. 93, 645 F.2d 976 (1981)</a> (issues of validity and infringement); <a id="co_link_I817ae8e422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1980102497&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Hale Fire Pump Co. v. Tokai, Ltd.,</em> 67 C.C.P.A. 121, 614 F.2d 1278 (1980)</a> (issues of validity, scope, and infringement); <a id="co_link_I817ae8e522b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1934129760&amp;pubNum=0000350&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>In re Orion,</em> 22 C.C.P.A. 149, 71 F.2d 458 (1934)</a> (issues of jurisdiction and infringement).</div><div class="co_paragraph"><div class="co_paragraphText co_indentFirstLine1">Our predecessor's legal and scholarly distinction in the field of patent law, and the high regard in which Congress and the innovation communities held the jurisprudence of the CCPA were a critical foundation for formation of the Federal Circuit and its charge to reinvigorate the role of the patent system in service to the nation's technological innovation. <input id="co_docMarker_38" type="hidden"><em>See</em> 125 Cong. Rec. 23,462 (1979) (statement of Sen. DeConcini) (“It is a reflection of high esteem which Congress has for the sitting judges of the Court of Claims and Court of Customs and Patent Appeals that these judges will become the first judges of the new Court of the Federal Circuit.”).</div></div></div></div></div><div><div class="co_footnoteNumber"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1315&quot; }" alt="metadata" type="hidden"><span id="co_footnote_B00542018850794"><a href="#co_footnoteReference_B00542018850794_ID0EV6DK">4</a></span></div><div class="co_footnoteBody"><div class="co_paragraph"><div class="co_paragraphText">It is curious to observe this <em>en banc</em> court extolling decisions of the regional circuits as authoritative, while it disregards the decisions of our predecessor courts and of this court. This court was created to remove patent law questions from the regional circuit courts. <em>See</em> H.R. Rep. 96–1300, at 20 (1980) (“Directing patent appeals to the new court will have the beneficial effect of removing these unusually complex, technically difficult, and time-consuming cases from the dockets of the regional courts of appeals.... [T]he central purpose is to reduce the widespread lack of uniformity and uncertainty of legal doctrine that exist in the administration of patent law.”); <em>see also Federal Courts Improvement Act of 1979: Hearings Before the Subcomm. on Improvements in Judicial Machinery of the Comm. on the Judiciary, U.S. Senate,</em> 96th Cong. 197 (1979) (statement of Hon. Henry J. Friendly) (“What is needed is a group of judges, some but not all patent lawyers, with scientific training and interest, aided both by law clerks of similar bent and by a staff of experts in a variety of technologies, such as the Court of Customs and Patent Appeals has had for years and the courts of appeals in the very nature of things, cannot ...”). To cite two regional circuit decisions, while jettisoning the precedents of the court uniquely qualified to address patent questions and selected to supplant the regional circuits, is puzzling.</div></div></div></div><div><div class="co_footnoteNumber"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;S367e169b5a7511deabded03f2b83b8a4&quot;, &quot;pageNumber&quot;: &quot;1317&quot; }" alt="metadata" type="hidden"><span id="co_footnote_B00652018850794"><a href="#co_footnoteReference_B00652018850794_ID0E3IEK">5</a></span></div><div class="co_footnoteBody"><div class="co_paragraph"><div class="co_paragraphText">There has been extensive commentary on this class of claim. <em>See, e.g.,</em> Jon S. Saxe &amp; Julian S. Levitt, <em>Product–by–Process Claims and Their Current Status in Chemical Patent Office Practice,</em> 42 J. Pat. Off. Soc'y 528, 559 (1960) (“Except in the chemical arts, a claim to a product must be in terms of the product's objective physical and chemical characteristics; but where these are unknown or impossible to express, a claim may define a product in terms of the process by which it is made. This product-by-process exception is to be distinguished from the use of process terminology as descriptive of a state of being.”); Brian S. Tomko, <a id="co_link_I817ae94422b911e89bf099c0ee06c731" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=0105312778&amp;pubNum=0003033&amp;originatingDoc=Ic0acd4ce445311dea82ab9f4ee295c21&amp;refType=LR&amp;fi=co_pp_sp_3033_1696&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_3033_1696"><em>Scripps or Atlantic: The Federal Circuit Squares Off Over the Scope of Product–by–Process Patents,</em> 60 Brook. L.Rev. 1693, 1696 (1995)</a> (the <em>Atlantic</em> decision “pared the scope of a product-by-process patent to that of a glorified process patent”).</div></div></div></div></div><table id="co_endOfDocument"><tbody><tr><td>End of Document</td><td class="co_endOfDocCopyright">© 2018 Thomson Reuters. No claim to original U.S. Government Works.</td></tr></tbody></table></div><input class="co_chunkNumber" value="0" type="hidden"><input id="co_finalChunkMarker" type="hidden"></div><input id="co_document_metaInfo_Ic0acd4ce445311dea82ab9f4ee295c21" value="{&quot;FirstLineCite&quot;:null,&quot;PU&quot;:null,&quot;accessControl&quot;:null,&quot;accessionNumber&quot;:&quot;&quot;,&quot;acquirerCompany&quot;:null,&quot;activeDate&quot;:null,&quot;additionalLinks&quot;:null,&quot;agreementDisplayDate&quot;:null,&quot;announcementDate&quot;:null,&quot;articleTitle&quot;:null,&quot;borrower&quot;:null,&quot;caseRequired&quot;:null,&quot;ciCompany&quot;:null,&quot;cicOfficer&quot;:null,&quot;cipOfficer&quot;:null,&quot;cite&quot;:&quot;566 F.3d 1282&quot;,&quot;citeAbbreviation&quot;:null,&quot;citePrimary&quot;:null,&quot;city&quot;:null,&quot;collection&quot;:&quot;w_cs_fed2&quot;,&quot;compoundTitle&quot;:null,&quot;containerId&quot;:null,&quot;containerType&quot;:null,&quot;contentType&quot;:&quot;Cases&quot;,&quot;contentTypeId&quot;:&quot;1&quot;,&quot;correlationIds&quot;:null,&quot;country&quot;:null,&quot;countryDocumentCountry&quot;:null,&quot;countryDocumentGuid&quot;:null,&quot;court&quot;:&quot;C.A.Fed. (Ill.)&quot;,&quot;courtDocumentType&quot;:null,&quot;courtNumber&quot;:&quot;4223&quot;,&quot;courtYear&quot;:&quot;C.A.Fed. (Ill.),2009.&quot;,&quot;date&quot;:&quot;May 18, 2009&quot;,&quot;dateFile&quot;:&quot;May 18, 2009&quot;,&quot;dealDate&quot;:null,&quot;dealTrackPublishDate&quot;:null,&quot;dealType&quot;:null,&quot;dealValue&quot;:null,&quot;description&quot;:null,&quot;docFamilyGuid&quot;:&quot;Ic0acd4cf445311dea82ab9f4ee295c21&quot;,&quot;docGuid&quot;:&quot;Ic0acd4ce445311dea82ab9f4ee295c21&quot;,&quot;docLink&quot;:&quot;https://1.next.westlaw.com/Document/Ic0acd4ce445311dea82ab9f4ee295c21/View/FullText.html?originationContext=document&amp;contextData=(sc.CustomDigest)&amp;needToInjectTerms=False&quot;,&quot;documentTitle&quot;:null,&quot;edgarFileNumber&quot;:null,&quot;entityId&quot;:null,&quot;expertType&quot;:null,&quot;fileName&quot;:null,&quot;fileNumber&quot;:&quot;&quot;,&quot;fileSize&quot;:0,&quot;fileType&quot;:null,&quot;filerCik&quot;:null,&quot;filerName&quot;:null,&quot;filingDate&quot;:null,&quot;filingYear&quot;:null,&quot;firmName&quot;:null,&quot;formNumber&quot;:null,&quot;formSubType&quot;:null,&quot;formType&quot;:null,&quot;formTypeDisplay&quot;:null,&quot;formVolume&quot;:null,&quot;functionalCite&quot;:&quot;566 F.3d 1282&quot;,&quot;fundFirmCompoundTitle&quot;:null,&quot;fundLocation&quot;:null,&quot;fundName&quot;:null,&quot;fundTargetSize&quot;:null,&quot;fundType&quot;:null,&quot;fundYear&quot;:null,&quot;fundraisingStatus&quot;:null,&quot;getTocData&quot;:false,&quot;hasDraftingNotes&quot;:null,&quot;hasVideoContent&quot;:null,&quot;impersonationKey&quot;:null,&quot;inlineKeyCiteFlagsIncluded&quot;:false,&quot;inlineKeyCiteFlagsResolutionStatus&quot;:null,&quot;insiderName&quot;:null,&quot;ip_assignmentsAction&quot;:null,&quot;ip_citeParallel&quot;:null,&quot;ip_derwentPublishedDate&quot;:null,&quot;ip_docket&quot;:null,&quot;ip_documentDate&quot;:&quot;May 18, 2009&quot;,&quot;ip_issuedDate&quot;:null,&quot;ip_litAlertAttorney&quot;:null,&quot;ip_patStatCode&quot;:null,&quot;ip_patentOwner&quot;:null,&quot;ip_publishedDate&quot;:null,&quot;ip_shortTitle&quot;:null,&quot;isDisplayMiniReport&quot;:false,&quot;isGatewayDocument&quot;:false,&quot;isLargeDocument&quot;:false,&quot;isPersistedContent&quot;:false,&quot;isPublicRecordsBlockedByPermissibleUse&quot;:false,&quot;isPublicRecordsBlockedBySocialSecurityAdmin&quot;:false,&quot;isPublicRecordsDocument&quot;:false,&quot;isRefsAndAnnos&quot;:false,&quot;isRegChangeDocument&quot;:false,&quot;isSearchable&quot;:null,&quot;isSecureContent&quot;:false,&quot;issueDate&quot;:null,&quot;issuerName&quot;:null,&quot;jobDescription&quot;:null,&quot;judge&quot;:&quot;RADER, Circuit Judge.&quot;,&quot;jurisAbbrev&quot;:null,&quot;jurisdiction&quot;:&quot;IL&quot;,&quot;jurisdictionFacet&quot;:&quot;Federal|**|Cts. of Appeals|**|Federal Cir.&quot;,&quot;jurisdictionText&quot;:&quot;Illinois&quot;,&quot;knos&quot;:null,&quot;lastRoundExitComb&quot;:null,&quot;legacyId&quot;:&quot;2018850794&quot;,&quot;letterType&quot;:null,&quot;locationOfIncorporation&quot;:null,&quot;maxOfferingPrice&quot;:null,&quot;natureOfTransaction&quot;:null,&quot;newsImageHrefLarge&quot;:null,&quot;newsImageHrefSmall&quot;:null,&quot;normalizedDocType&quot;:null,&quot;normalizedFormType&quot;:null,&quot;offeringType&quot;:null,&quot;organizationName&quot;:null,&quot;originatingDoc&quot;:null,&quot;pageCount&quot;:null,&quot;persistedDocGuid&quot;:null,&quot;plcFirmStyleAvailable&quot;:false,&quot;plcResourceName&quot;:&quot;&quot;,&quot;portfolioCompanyLocation&quot;:null,&quot;portfolioCompanyName&quot;:null,&quot;prMetaInfo1&quot;:null,&quot;prMetaInfo2&quot;:null,&quot;prMetaInfo3&quot;:null,&quot;prMetaInfo4&quot;:null,&quot;prMetaInfo5&quot;:null,&quot;primaryEditorialService&quot;:null,&quot;profileType&quot;:null,&quot;pubSeries&quot;:null,&quot;publishDate&quot;:null,&quot;questionText&quot;:null,&quot;redlined&quot;:false,&quot;registrationDate&quot;:null,&quot;renditionId&quot;:&quot;I298F20BA1DD211B29A81A900920CB1E6&quot;,&quot;royaltyId&quot;:&quot;0&quot;,&quot;rulebookNViews&quot;:null,&quot;serialNumber&quot;:&quot;2018850794&quot;,&quot;status&quot;:null,&quot;subContentType&quot;:&quot;Caselaw - NRS&quot;,&quot;subContentTypeId&quot;:&quot;27&quot;,&quot;subTitle&quot;:null,&quot;targetCompany&quot;:null,&quot;testimonyType&quot;:null,&quot;titleHtml&quot;:&quot;Abbott Laboratories v. Sandoz, Inc.&quot;,&quot;titleText&quot;:&quot;Abbott Laboratories v. Sandoz, Inc.&quot;,&quot;totalAmountIssuedWithCurrency&quot;:null,&quot;totalPages&quot;:&quot;&quot;,&quot;trademarkStatus&quot;:null,&quot;transactionAmountWithCurrency&quot;:null,&quot;transactionValue&quot;:null,&quot;valuationComb&quot;:null,&quot;viewExpressions&quot;:&quot;ED1|EZ5|E3I|P3D|000&quot;,&quot;westlawDatabaseIdentifier&quot;:&quot;AWFED2&quot;,&quot;westlawDocumentNumber&quot;:&quot;1485199&quot;}" type="hidden"><input id="co_document_documentNavigation_Search_Search-v1-results-navigation-i0ad604ab000001630667802a2028f1f7-Nav-CUSTOMDIGEST-fragmentIdentifier-Ic0acd4ce445311dea82ab9f4ee295c21-startIndex-1-contextData--28sc.CustomDigest-29-transitionType-CustomDigestItem_CUSTOMDIGEST_326" value="{&quot;AnswerSnippetId&quot;:null,&quot;CurrentDocumentGuid&quot;:&quot;Ic0acd4ce445311dea82ab9f4ee295c21&quot;,&quot;CurrentPosition&quot;:326,&quot;CurrentWatsonAnswerText&quot;:null,&quot;EnableConceptCounts&quot;:false,&quot;HighlightPoints&quot;:null,&quot;HighlightTerms&quot;:null,&quot;InPlanUrl&quot;:null,&quot;IsSnapSnippet&quot;:false,&quot;ListCount&quot;:1157,&quot;Message&quot;:null,&quot;NextDocument&quot;:{&quot;SkipLinkOutDoc&quot;:false,&quot;Title&quot;:&quot;SmithKline Beecham Corp. v. Apotex Corp.&quot;,&quot;Url&quot;:&quot;/Document/I0436d836a55411da9cfda9de91273d56/View/FullText.html?navigationPath=Search%2Fv1%2Fresults%2Fnavigation%2Fi0ad604ab000001630667802a2028f1f7%3FNav%3DCUSTOMDIGEST%26fragmentIdentifier%3DI0436d836a55411da9cfda9de91273d56%26startIndex%3D1%26contextData%3D%2528sc.CustomDigest%2529%26transitionType%3DCustomDigestItem&amp;listSource=Search&amp;list=CUSTOMDIGEST&amp;rank=327&amp;grading=na&amp;sessionScopeId=7f37bc759ec9f9864b92cef6ac1b964c4cf54544f9347b0fcb95acf38263c8f1&amp;originationContext=Custom%20Digest&amp;transitionType=CustomDigestItem&amp;contextData=%28sc.CustomDigest%29&amp;listPageSource=edc4a850c828227f4c8d5f819b26133f#co_anchor_F22008535409&quot;},&quot;NovusQueryType&quot;:null,&quot;NovusSearchResult&quot;:null,&quot;NumberOfSnips&quot;:0,&quot;ParagraphId&quot;:null,&quot;PreviousDocument&quot;:{&quot;SkipLinkOutDoc&quot;:false,&quot;Title&quot;:&quot;Amgen Inc. v. F. Hoffman-La Roche Ltd&quot;,&quot;Url&quot;:&quot;/Document/Ie59924e3a21711dea82ab9f4ee295c21/View/FullText.html?navigationPath=Search%2Fv1%2Fresults%2Fnavigation%2Fi0ad604ab000001630667802a2028f1f7%3FNav%3DCUSTOMDIGEST%26fragmentIdentifier%3DIe59924e3a21711dea82ab9f4ee295c21%26startIndex%3D1%26contextData%3D%2528sc.CustomDigest%2529%26transitionType%3DCustomDigestItem&amp;listSource=Search&amp;list=CUSTOMDIGEST&amp;rank=325&amp;grading=na&amp;sessionScopeId=7f37bc759ec9f9864b92cef6ac1b964c4cf54544f9347b0fcb95acf38263c8f1&amp;originationContext=Custom%20Digest&amp;transitionType=CustomDigestItem&amp;contextData=%28sc.CustomDigest%29&amp;listPageSource=edc4a850c828227f4c8d5f819b26133f#co_anchor_F312019808227&quot;},&quot;ReturnTo&quot;:{&quot;SkipLinkOutDoc&quot;:false,&quot;Title&quot;:&quot;list&quot;,&quot;Url&quot;:&quot;/Search/Results.html?jurisdiction=CTAF&amp;saveJuris=False&amp;contentType=CUSTOMDIGEST&amp;querySubmissionGuid=i0ad604ab000001630667802a2028f1f7&amp;startIndex=1&amp;tocGuid=I4aee2539c6f64c1812a4c2f3395c2607&amp;categoryPageUrl=Home%2FWestKeyNumberSystem&amp;searchId=i0ad604ab000001630667802a2028f1f7&amp;kmSearchIdRequested=False&amp;simpleSearch=False&amp;isAdvancedSearchTemplatePage=False&amp;skipSpellCheck=False&amp;isTrDiscoverSearch=False&amp;ancillaryChargesAccepted=False&amp;proviewEligible=False&amp;transitionType=ReturnToList&amp;contextData=%28sc.CustomDigest%29#Ic0acd4ce445311dea82ab9f4ee295c21&quot;},&quot;SearchQuery&quot;:null,&quot;SearchQueryType&quot;:null,&quot;SearchWithinQuery&quot;:null,&quot;SecondaryHighlightTerms&quot;:null,&quot;ShowSkipOutOfPlanOption&quot;:false}" type="hidden"><div id="co_nrsOutline" class="co_hideState"></div><input id="co_documentContentCacheKey" value="WestlawNext|none|Ic0acd4ce445311dea82ab9f4ee295c21|||||||Search|Search/v1/results/navigation/i0ad604ab000001630667802a2028f1f7?Nav=CUSTOMDIGEST&amp;fragmentIdentifier=Ic0acd4ce445311dea82ab9f4ee295c21&amp;startIndex=1&amp;contextData=%28sc.CustomDigest%29&amp;transitionType=CustomDigestItem|CUSTOMDIGEST|326|False|True|{&quot;HighlightPoints&quot;:null,&quot;HighlightTerms&quot;:null,&quot;SearchWithinQuery&quot;:null,&quot;SecondaryHighlightTerms&quot;:null}|False|||False|False|||True|S|False|Core|||001|False|False|False|False|False|" type="hidden"><input id="co_documentFlagInfo" value="{&quot;docGuid&quot;:&quot;Ic0acd4ce445311dea82ab9f4ee295c21&quot;,&quot;flags&quot;:[{&quot;categoryId&quot;:&quot;kcJudicialHistory&quot;,&quot;id&quot;:&quot;negative.indirect.history.mild&quot;,&quot;link&quot;:&quot;https://1.next.westlaw.com/Link/RelatedInformation/Flag?docGuid=Ic0acd4ce445311dea82ab9f4ee295c21&amp;originationContext=docHeaderFlag&amp;transitionType=Document&amp;contextData=%28sc.CustomDigest%29&quot;,&quot;metadata&quot;:{&quot;court&quot;:&quot;S.D.N.Y.&quot;,&quot;docFamilyGuid&quot;:&quot;I9eded3e97ddb11e3a659df62eba144e8&quot;,&quot;docGuid&quot;:&quot;I9eded3e87ddb11e3a659df62eba144e8&quot;,&quot;liveDate&quot;:&quot;January 14, 2014&quot;,&quot;title&quot;:&quot;In re OxyContin Antitrust Litigation&quot;,&quot;titleLink&quot;:&quot;https://1.next.westlaw.com/Document/I9eded3e87ddb11e3a659df62eba144e8/View/FullText.html?navigationPath=RelatedInfo%2Fv4%2Fkeycite%2Fnav%2F%3Fguid%3DI9eded3e87ddb11e3a659df62eba144e8%26ss%3D2018850794%26ds%3D2032543591&amp;listSource=RelatedInfo&amp;list=NegativeCitingReferences&amp;rank=0&amp;originationContext=docHeader&amp;transitionType=NegativeTreatment&amp;contextData=%28sc.CustomDigest%29&quot;,&quot;treatmentPhrase&quot;:&quot;Declined to Extend by&quot;},&quot;type&quot;:&quot;negative.indirect.history&quot;,&quot;value&quot;:&quot;mild&quot;}],&quot;metas&quot;:[{&quot;contentType&quot;:&quot;CASELAW&quot;,&quot;docCollection&quot;:&quot;w_cs_fed2&quot;,&quot;docFamilyGuid&quot;:&quot;Ic0acd4cf445311dea82ab9f4ee295c21&quot;,&quot;legacyId&quot;:&quot;2018850794&quot;,&quot;sourcePubId&quot;:&quot;506&quot;}]}" type="hidden">




							</div>

				</div>
			</div>
		</div>
	</div>
	<!-- LEFT COLUMN -->  
	<div id="co_leftColumn">
		<div class="co_innertube">
			<div id="coid_website_folderingWidgetDiv"></div>
		</div>
	</div>
			<!-- RIGHT COLUMN -->
			<div id="co_rightColumn" class="co_addFocusCorrection">
				<div class="co_innertube">		
					<div id="coid_website_relatedInfoIPWidgetDiv" style="display: none;" aria-expanded="false">
					</div>




<div id="coid_website_documentToolWidgetDiv"></div>
		<div id="coid_website_relatedInfoWidgetDiv"> </div>
		<div id="coid_website_recommendedDocuments" class="co_recommendedDocumentContainer">
		</div>

<div id="downloadUserDocument"></div>
					<div id="downloadUserDocument"></div>
				</div>
			</div>

 <input class="hideTopTopics" id="hideTopTopics" name="hideTopTopics" type="hidden">
		<div class="co_clear"></div>
	</div>


	<!-- BEGIN FOOTER -->
	<div id="co_footerContainer"><div id="co_cookiePolicyContainer">
	<div class="co_cookiePolicyContent">
			<h3><b>Our policy towards the use of cookies</b></h3>
			<p>All Thomson Reuters websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.</p>
			<ul class="co_inlineList">
				<li>
					<a id="coid_website_cookiePolicyLinkOut" href="javascript:void(0)">Read cookie policy</a>
				</li>
				<li>
					<a id="coid_website_closeCookiePolicy" href="javascript:void(0)">Close</a>
				</li>
			<p></p>
			<button type="button" id="coid_website_cookiePolicyAcknowledged" title="Close message to acknowledge cookie policy" class="co_absolute">
				<span class="icon25 icon_close_x"></span>
			</button>
	</ul></div>
</div>


		
		<div class="co_innertube co_clearfix" id="co_footer" style="display: none;">







<div class="co_floatLeft">
	<div id="co_footerLinks">
		<ul class="co_inlineList">
					<li><a id="coid_websiteFooter_userSettings" href="javascript:void(0);"><span class="icon25 icon_gear_document"></span>Preferences</a></li>
				<li><a id="coid_websiteFooter_helplink" href="javascript:void(0);"><span class="icon25 icon_question_mark"></span>Training &amp; Support</a></li>
				
					<li><a id="coid_websiteFooter_signofflink" href="javascript:void(0);"><span class="icon25 icon_exit_door"></span>Sign Off</a></li>

		</ul>
	</div>
	<div id="co_footerCopyright">
		<ul class="co_inlineList">

			<li>Westlaw. <a href="/Copyright?transitionType=Default&amp;contextData=(sc.Default)"> © 2018</a> Thomson Reuters</li>
			<li><a id="coid_websiteFooter_privacyPolicyLink" href="javascript:void(0)">Privacy Statement</a></li>
			<li><a href="/Accessibility?transitionType=Default&amp;contextData=(sc.Default)">Accessibility</a></li>
				<li id="co_footer_supplier"><a id="coid_website_supplierTerms" href="javascript:void(0);">Supplier Terms</a></li>
				<li id="co_footerContactUs"><a href="/ContactUs?transitionType=Default&amp;contextData=(sc.Default)">Contact Us</a></li>
				<li id="co_footerCs">1-800-REF-ATTY (1-800-733-2889)</li>
				<li id="co_footer_improve"><strong><a id="coid_websiteFooter_pageSurvey" href="javascript:void(0);">Improve Westlaw</a></strong></li>
		</ul>


	</div>
</div>





<div id="co_trLogo" class="co_floatRight">

	<a id="co_trLogo_link" href="#">
		<img alt="Thomson Reuters" src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/v2/co_logo_thomsonReuters.png" width="134" height="30">
	</a>
</div>



		</div>
	</div>
			<div id="coid_Trmr" style="display:none; visibility:hidden"></div>
		</div>
	</div>
	
	<!--static content version number-->
<script type="text/javascript">





	
		window['Server/Routing'] = {
			Search: 'search.int.next.westlaw.com',
			TypeAhead: 'typeahead.int.next.westlaw.com',
			Nlu: 'nlu.int.next.westlaw.com',
			Document: 'document.int.next.westlaw.com',
			Foldering: 'foldering.int.next.westlaw.com',
			CSS: 'ca.next.westlaw.com/StaticContent_40.1.1015',
			Images: 'ia.next.westlaw.com/StaticContent_40.1.1015',
			JavaScript: 'ja.next.westlaw.com/StaticContent_40.1.1015',
			RelatedInfo: 'relatedinfo.int.next.westlaw.com',
			Events: 'events.int.next.westlaw.com',
			KM: 'NONE',
			RequestDirector: 'www.westlaw.com',
			SocialPlatform: 'https://community-sso.thomsonreuters.com',
			Sync: 'sync.westlaw.com',
			Video: 'v1.next.westlaw.com',
			FormsAssembly: 'formsassembly.int.forms.westlaw.com',
			Publishing: 'publishing.int.next.westlaw.com',
			WebContent: 'webcontent.int.next.westlaw.com',
			Alert: 'alert.int.next.westlaw.com',
			Report: 'report.int.next.westlaw.com',
			ProductMetadata: 'pmd.int.next.westlaw.com/pmd',
			Website: '1.next.westlaw.com',
			WebsiteDefault: '1.next.westlaw.com',
			HistoryListener: 'historylistener.int.next.westlaw.com',
			FormsAssemblyTest: ''
		};
	
		
			if (window.location.host !== '1.next.westlaw.com') {
				window['Server/Routing'].ProxiedWebsite = '1.next.westlaw.com';
				window['Server/Routing'].Website = window.location.host;
				window['Server/Routing'].WebsiteDefault = window.location.host;
			}
		
</script>

<script type="text/javascript"></script>

	<script type="text/javascript" src="https://1.next.westlaw.com/v2/js/UrlRouting.40.1.1013.0.js"></script>
	
	<script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="https://ja.next.westlaw.com/StaticContent_40.1.1015/External/vendor/datejs@1.0/cultures/en-US.js"></script>
<script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="https://ja.next.westlaw.com/StaticContent_40.1.1015/v2/Products/WestlawNext/js/LocalizationResources/Localized/Messages.js"></script>

	
<script type="text/javascript">

	







</script>





















	
	














<script type="text/javascript">
window['Server/User'] = {
  "FirmName": "SEOUL NATIONAL UNIV (LV A)",
  "_AlertsIsAdmin": false,
  "_FeatureExposure": "Released",
  "ClientId": "SEOUL NU - WL NEXT",
  "_AlertsAccessFunctionalityTurnedOn": true,
  "_AlertsAccessCategoryApplied": false,
  "_ShowErrorDetails": false,
  "OnePassUserName": "5405685",
  "OnePassUserNameEncoded": "5405685",
  "ClientMatter": {
    "ClientId": "SEOUL NU - WL NEXT",
    "CompositeClientMatter": "SEOUL NU - WL NEXT",
    "DefaultClientId": "Seoul NU - WL Next",
    "ClientIdPromptText": "",
    "IsClientNonChargeable": "False",
    "NoClientId": "False",
    "TrackableCode": "D",
    "UserTurnedTrackingOn": false
  },
  "ClientReportingAttributes": {
    "PracticeArea": "",
    "ResearchReasonCode": "",
    "ResearchDescription": ""
  },
  "BillingMethodForDisplayOnly": "TRANSACTIONAL",
  "HasFlashPlayer": false,
  "IsUltra": true,
  "CustomerStorageKey": "E41F133AB8A01ED395E1D85D67D9406C",
  "SessionCreatedDateTime": "04/27/2018 09:20:24",
  "HasLoggedAggregateNotificationCount": false
};


window['Server/ViewModelData'] = {
  "DocumentGuid": "Ic0acd4ce445311dea82ab9f4ee295c21",
  "DocumentCitation": "566 F.3d 1282",
  "DocumentTitle": "Abbott Laboratories v. Sandoz, Inc.",
  "DocumentMetaDescription": "View on Westlaw or start a FREE TRIAL today, Abbott Laboratories v. Sandoz, Inc., Cases",
  "ViewType": "FullText",
  "Rank": 326,
  "Grading": "na",
  "KMEnableTermNavigation": false,
  "KMEnableDocumentNavigation": false,
  "LegacyId": "2018850794",
  "DocumentSource": {
    "Key": "f1d366ef84a64f21a20e2feca7ddaa1a",
    "NavigationPath": "Search/v1/results/navigation/i0ad604ab000001630667802a2028f1f7?Nav=CUSTOMDIGEST&fragmentIdentifier=Ic0acd4ce445311dea82ab9f4ee295c21&startIndex=1&contextData=%28sc.CustomDigest%29&transitionType=CustomDigestItem",
    "ListSource": "Search",
    "List": "CUSTOMDIGEST",
    "ListPageSourceKey": "edc4a850c828227f4c8d5f819b26133f"
  },
  "HasDraftingNotes": false,
  "HasDocumentSections": false,
  "EnableBestPortion": true,
  "SubContentTypeId": "27",
  "DisableDocMetaInfoRetrievalOnWarningPage": false,
  "TermNavigationPreference": "AllTerms",
  "ShowMainToolbar": true,
  "ShowRelatedAnalysis": false,
  "ListSource": "Search",
  "IsRelatedFullTextView": false,
  "KeyCiteAlertWarning": "None",
  "DocketTrackWarning": "None",
  "DocumentSections": [],
  "RulebookMode": false,
  "RulebookModeContent": false,
  "NotesOfDecisionsCount": 0,
  "TocReportDocGuids": [],
  "TocReportViewMode": false,
  "IsMedLitStubDocument": false,
  "TrackableCode": "D",
  "NonTrackableCode": "H",
  "FullTocOnDoc": false,
  "ViewExpressions": []
};


window['Server/WidgetDomIds'] = {
  "DocToolbar": "co_docToolbar",
  "DocDisplay": "coid_website_documentWidgetDiv",
  "DocTools": "coid_website_documentToolWidgetDiv",
  "DocTopToolbar": "co_docTopToolbar",
  "DocRightToolbar": "co_newDocToolbar",
  "TopTopics": "coid_website_relatedInfoWidgetDiv",
  "DocBottomToolbar": "co_docFooterToolbar"
};


window['Server/PageData'] = {
  "DocumentTabView": {
    "IsSkipOutOfPlanChecked": false,
    "IsUserDocument": false,
    "UserDocumentData": {
      "documentGuid": "Ic0acd4ce445311dea82ab9f4ee295c21"
    },
    "HasProfileSubTab": false,
    "DisplayOptions": {
      "showMainToolbar": true,
      "isNewDocumentView": false,
      "disableDocToolbar": false,
      "isAbstractView": false,
      "chunkSize": "L",
      "chunkableHeadnotes": false,
      "doCompleteSizeChecking": true,
      "ViewType": "FullText",
      "stickyHeader": true,
      "displayRelatedContentLink": true,
      "snippetRelocationInfo": {
        "contentType": "Cases",
        "subContentTypeId": "27"
      }
    },
    "ShowMainToolbar": true,
    "DocumentPersisted": false,
    "DocumentGuidNotFound": false,
    "ContentType": "Cases",
    "ExpandDocumentLevelTOC": true
  },
  "CobaltPageHeader": {
    "ShowPauseLink": false,
    "ShowCommunityContainer": false,
    "EnablePageHeaderV2": true,
    "ShowBetaFeedbackLink": false,
    "Notifications": {
      "HideNotificationToastAfterDuration": false,
      "NotificationClickGoDirectlyToAlerts": false
    }
  },
  "CompartmentStartPageId": "",
  "CobaltMasterFooterInSession": {
    "TRLogoImageLinkUrl": "http://www.thomsonreuters.com",
    "ShowWhatIsNewLink": false,
    "Unreleased": false,
    "IsAnonymousSession": false,
    "ShowMyContacts": false,
    "ShowPromotions": false,
    "ShowResetPromotions": false,
    "ShowCampusPolicy": false,
    "IsTransferContentAvailable": false,
    "ShowProductStartGuide": false,
    "HelpGuideDisplayName": "",
    "HelpGuideFileName": "",
    "HelpGuidePath": "",
    "CampusPolicyDisplayName": "",
    "CampusPolicyPath": "",
    "ShowAnalyticsLink": false,
    "AnalyticsPath": "Session/SignOn.html?transitionType=Default&contextData=(sc.Default)",
    "ShowMyAccountLink": false,
    "MyAccountPath": "WESTLAW/Common/Landing/MyAccountLanding",
    "LegalSolutionsLink": "http://legalsolutions.thomsonreuters.com/law-products/westlaw-legal-research/training-support",
    "SupplierTermsUrl": "http://legalsolutions.com/westlaw-additional-terms",
    "PrivacyPolicyPath": "https://www.thomsonreuters.com/en/privacy-statement.html"
  },
  "ActOnTracking": {
    "EnableActOnTracking": false,
    "ActOnTrackingInstanceId": ""
  },
  "CobaltPage": {
    "SetInCache": [
      {
        "Vertical": "Global",
        "Name": "ResultsPerPage",
        "Value": 20
      },
      {
        "Vertical": "Global",
        "Name": "ResultsPerPageAllowableValues",
        "Value": [
          "100",
          "20",
          "50"
        ]
      },
      {
        "Vertical": "Global",
        "Name": "Locale",
        "Value": ""
      },
      {
        "Vertical": "Global",
        "Name": "TimeZone",
        "Value": "Central Standard Time"
      },
      {
        "Vertical": "Global",
        "Name": "MultiFacetsEnabled",
        "Value": false
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_CASE",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_ANALYTICAL",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_PENDINGREG",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_PENDINGLEG",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_KNOWHOW",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "JurisdictionsContentType",
        "Value": "default"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_DOCKET",
        "Value": "CASE_TITLE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_BRIEF",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_TRIAL-TRANSCRIPTS",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_ADMINDECISION",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_FORM",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_NEWS",
        "Value": "DATE_DESCENDING"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_ORAL-ARGUMENTS",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "InstantSuggestions",
        "Value": true
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_TCO",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultNews_DuplicateIdentifier",
        "Value": false
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_REGULATION",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_EXPERTWITNESS",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "SliderDetail",
        "Value": "default"
      },
      {
        "Vertical": "Search",
        "Name": "ViewExpression",
        "Value": ""
      },
      {
        "Vertical": "Search",
        "Name": "DefaultPage",
        "Value": "ALL"
      },
      {
        "Vertical": "Search",
        "Name": "JurisdictionsGlobal",
        "Value": "CTAF"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_PMM",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_STATUTE",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_JURYVERDICT",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "SuppressRecentFiltersTooltip",
        "Value": false
      },
      {
        "Vertical": "Document",
        "Name": "HeadnotesDualColumnView",
        "Value": false
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorRulesSet",
        "Value": "standard"
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorItalicizeTitle",
        "Value": false
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorParallelCites",
        "Value": "CAFormat"
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorUseForCopyWithReference",
        "Value": true
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorCitationStyle",
        "Value": "LegalBriefs"
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorIncludeHistory",
        "Value": true
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorUnderlineTitle",
        "Value": true
      },
      {
        "Vertical": "Document",
        "Name": "HideHeadnotesBox",
        "Value": false
      },
      {
        "Vertical": "Foldering",
        "Name": "ShowAnnotationsPreferenceKey",
        "Value": "checked"
      },
      {
        "Vertical": "Website",
        "Name": "ShowKeyboardInstructions",
        "Value": true
      },
      {
        "Vertical": "Website",
        "Name": "DocumentFullscreenShowTerms",
        "Value": true
      },
      {
        "Vertical": "Website",
        "Name": "NewFeatureLightboxDisplayBlackList",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DocumentFullscreenTextSize",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DocumentFullscreenMargin",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DeliveryOptionSelected",
        "Value": "None"
      },
      {
        "Vertical": "Website",
        "Name": "DocumentFullscreenShowLinks",
        "Value": true
      },
      {
        "Vertical": "Website",
        "Name": "LastViewNotificationDate",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DocumentDisplayTextSize",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DisplaySearchTerms",
        "Value": true
      },
      {
        "Vertical": "Website",
        "Name": "KnowHowSpeedReadExpandAll",
        "Value": true
      },
      {
        "Vertical": "Website",
        "Name": "DocumentDisplayFont",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DocumentDisplayMargin",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DocumentFullscreenFont",
        "Value": ""
      },
      {
        "Vertical": "SAP",
        "Name": "PLAN ICONS",
        "Value": "NO"
      },
      {
        "Vertical": "SAP",
        "Name": "SKIP OUT OF PLAN",
        "Value": "NO"
      },
      {
        "Vertical": "SAP",
        "Name": "WARNING FLAG",
        "Value": "N"
      }
    ],
    "PingSync": "false",
    "ViewData": {
      "IsSponsorSession": true,
      "SearchWidgetParameters": {
        "search": {
          "renderCustomPageSearchWidget": false,
          "categoryPageTitle": "291 PATENTS",
          "isCategoryPageTopical": false,
          "topicKeyText": "291 PATENTS",
          "filters": {
            "jurisdiction": "CTAF",
            "sequence": 0,
            "content": "CUSTOMDIGEST",
            "index": false,
            "customDigest": true,
            "collectionSets": [
              "w_cs_cd_toc"
            ],
            "tocNode": "I4aee2539c6f64c1812a4c2f3395c2607",
            "keyNumber": "291",
            "displayJurisdictionSelector": true,
            "displayAdvancedSearchLink": false,
            "categoryPageUrl": "Home/WestKeyNumberSystem",
            "categoryPageContentType": "CUSTOMDIGEST",
            "categoryPageCheckboxLimit": 0,
            "resultsLimit": 0,
            "categoryPageAlertClippable": false,
            "isAdvancedSearchTemplatePage": false
          },
          "CustomPageSetForZone": false,
          "supportedFeatures": [],
          "skipSpellCheck": false,
          "browseHierarchyPathFromRoot": []
        },
        "SearchCompartmentName": "WestlawNext",
        "SearchDropDownItems": [],
        "grading": "na",
        "searchWidgetPosition": "Default",
        "hideSearchWidget": false,
        "makeSearchWidget": true,
        "prefersForceTnc": false,
        "prefersForceTncSingleQuote": true,
        "forceTncCounter": 0,
        "forceTncCounterThreshold": 5,
        "enableFavoriteSearch": false,
        "dynamicPage": false,
        "isAdvancedSearchTemplatePage": false
      },
      "ShowClientIdWidget": true,
      "OpenFindDropDown": false,
      "TimeoutInMinutes": 90,
      "FeatureConfigurations": {
        "FOLDERS": false,
        "HISTORY": true,
        "FOLDER_SHARING": false,
        "HIGHLIGHTS": false,
        "NOTES": false,
        "ANNOTATIONS": false,
        "BLOCK NOTES SHARING": false,
        "CONTACTS": false,
        "FAVORITES": false,
        "USER PROFILE": false,
        "KM": false,
        "FolderCachingDisabled": true,
        "KM IPAD": false,
        "SAO_INVITING": true,
        "SAO_SAMEEMAILDOMAIN": false,
        "CASENOTEBOOKEXPORT": false,
        "DOWNLOADDELIVERY": true,
        "DROPBOXDELIVERY": false,
        "EMAILDELIVERY": true,
        "EMAILWITHREFERENCEDELIVERY": false,
        "KINDLEDELIVERY": false,
        "PRINTDELIVERY": true,
        "KEYCITEALERTS": false,
        "LEGACYALERTACCESS": false,
        "BLOCKPERSISTENTINFO": true,
        "BLOCK100KANCILLARY": false,
        "DISPLAYMASHUPCHARGEWARNING": false,
        "SHOWCHARGEONWARNINGSCREEN": false,
        "SHOWCHARGELINKONWARNINGSCREEN": false,
        "USERISTRANSACTIONAL": true,
        "USER FORM UPLOAD": false,
        "MATTERUPLOADUSERDOC": false,
        "FOLDERUPLOADUSERDOC": false,
        "DISPLAY SESSION PAUSE LINK": false,
        "PASSTHRUPDFS": false,
        "processRIHistoryAsynchronously": true,
        "processDocumentHistoryAsynchronously": true,
        "PRINTBLANKFORMS": false,
        "WFBTRIALBLOCKSHARE": false,
        "ATTORNEY PORTAL": false,
        "SMALLLAWWORKBENCHMATTERTREE": false,
        "JUDICIALCHAMBERS": false,
        "CITATIONUS": false,
        "CITATIONCAN": false,
        "MYPLANSTATICDOC": true,
        "ALLOWFOLDERSHAREACROSSORGS": true,
        "BLOCKFOLDERSHAREFROMORGS": true,
        "ALLOWOFFLINEACCESS": false,
        "WEBHOSTEDCLIENTID": false,
        "WEBHOSTEDCLIENTIDIPAD": false,
        "WEBHOSTEDCLIENTIDSELECTION": false,
        "PRERELCONTENTFEAT": false,
        "ALERTS": false,
        "ALERTS ENHANCED": false,
        "ISEMULATEUSER": false,
        "WCLP": false,
        "NEWSLETTER": false,
        "KCALERT": false,
        "COINV ALERTS": false,
        "CITRANSITION": false,
        "BLCALERT": false,
        "DKTALERT": false,
        "DKTTRACK": true,
        "PUBALERT": false,
        "CWALERT": false,
        "POB ALERT": false,
        "POB WATCH": false,
        "CWALERTPremium": false,
        "CAPITOLWATCH": false,
        "ALERT SUMMARY REPORT": false,
        "WCLP CONTINUOUS": false,
        "KCALERT CONTINUOUS": false,
        "CWALERT CONTINUOUS": false,
        "POBA CONTINUOUS": false,
        "POBW CONTINUOUS": false,
        "NEWSLETTER DLY": false,
        "NEWSLETTER WKDY": false,
        "KCALERT DLY SINGLE": false,
        "KCALERT WKDY SINGLE": false,
        "BIALERT DLY SINGLE": false,
        "BLCALERT DAILY": false,
        "BLCALERT MULTI DAILY": false,
        "CWALERT DAILY": false,
        "BIALERT WKDY SINGLE": false,
        "BLCALERT BIWEEKLY": false,
        "BLCALERT CONTINUOUS": false,
        "WCLP WEEKLY": false,
        "NEWSLETTER WEEKLY": false,
        "KCALERT WEEKLY": false,
        "BIALERT WEEKLY": false,
        "BLCALERT WEEKLY": false,
        "DKTALERT WEEKLY": false,
        "DKTTRACK WEEKLY": true,
        "POBA WEEKLY": false,
        "POBW WEEKLY": false,
        "WCLP BIWEEKLY": false,
        "KCALERT BIWEEKLY": false,
        "BIALERT BIWEEKLY": false,
        "DKTALERT BIWEEKLY": false,
        "DKTTRACK BIWEEKLY": true,
        "NEWSLETTER BIWEEKLY": false,
        "POBA BIWEEKLY": false,
        "POBW BIWEEKLY": false,
        "WCLP MONTHLY": false,
        "NEWSLETTER MONTHLY": false,
        "KCALERT MONTHLY": false,
        "BIALERT MONTHLY": false,
        "BLCALERT MONTHLY": false,
        "DKTALERT MONTHLY": false,
        "DKTTRACK MONTHLY": true,
        "POBA MONTHLY": false,
        "POBW MONTHLY": false,
        "WCLP DLY SINGLE": false,
        "WCLP DLY MULT": false,
        "WCLP WKDY SINGLE": false,
        "WCLP WKDY MULT": false,
        "PUBALERT DLY SINGLE": false,
        "PUBALERT WKDY SINGLE": false,
        "DKTALERT WKDY SINGLE": false,
        "DKTALERT DLY SINGLE": false,
        "DKTTRACK WKDY SINGLE": true,
        "DKTTRACK DLY SINGLE": true,
        "CAPITOLWATCHTRACK DLY SINGLE": false,
        "CAPITOLWATCHTRACK DLY MULT": false,
        "CAPITOLWATCHTRACK WKDY SINGLE": false,
        "CAPITOLWATCHTRACK WKDY MULT": false,
        "CAPITOLWATCHTRACK WEEKLY": false,
        "CAPITOLWATCHTRACK BIWEEKLY": false,
        "CAPITOLWATCHTRACK MONTHLY": false,
        "POBA DLY SINGLE": false,
        "POBA DLY MULT": false,
        "POBA WKDY SINGLE": false,
        "POBA WKDY MULT": false,
        "POBW DLY SINGLE": false,
        "POBW DLY MULT": false,
        "POBW WKDY SINGLE": false,
        "POBW WKDY MULT": false,
        "showMatterTree": false,
        "WELCOME TO WLN BOX": false,
        "dataRoomReadSource": "Original",
        "dataRoomWriteDestination": "Single",
        "dataRoomFoldersWriteDestination": "SingleDataRoom",
        "showNapaContent": true,
        "PublicRecordsAccess": false,
        "PublicRecordsEnhancedSecurity": false,
        "PublicRecordsBlockRoaming": false,
        "PublicRecordsBlockHomeTrust": false,
        "PublicRecordsAllowRoamTrust": false,
        "PublicRecordsBypassCountry": false,
        "PublicRecordsBlockIPUndefined": false,
        "PublicRecordsBlockUndefinedTrust": false,
        "PublicRecordsDowngradeEmailIPRoaming": false,
        "PublicRecordsDowngradeEmailIPUndefined": false,
        "PublicRecordsUnmaskRoam": false,
        "DISABLE PR ANC MASK": false,
        "PublicRecordsSsnOnlyOK": false,
        "ReversePhoneGateway": false,
        "QSentReport": false,
        "CreditHeaderContentDatabaseGroup": false,
        "PolkGateway": false,
        "PolkReport": false,
        "DriversLicenseRecordsContentDatabaseGroup": false,
        "UCC COLUMN RESULTS": false,
        "matterTreeType": "None",
        "ISCAMPUSUSER": false,
        "ISCAMPUSNEWSUSER": false,
        "ISCAMPUSBUSINESSUSER": false,
        "isUnreleasedFeatureExposure": false,
        "WLANALYTICS ACCESS": false,
        "NEWSALERTAUTHOR": false,
        "NEWSALERTEDITOR": false,
        "UNRELEASED CAT PAGES": false,
        "INTERNAL ADMIN LIMITS": false,
        "DATAROOMALERTS": false,
        "DLVRY SESSION LIMIT": false,
        "DLVRY DAILY LIMIT": false,
        "DLVRY SESSION LIMIT PRAC LAW": false,
        "DLVRY DAILY LIMIT PRAC LAW": false,
        "DLVRY SESSN LIMIT PRAC LAW TRL": false,
        "DLVRY DAILY LIMIT PRAC LAW TRL": false,
        "CONTENT DLVRY RSTRCT": true,
        "BLOCKAUWLN": false,
        "BLOCKCANWLN": false,
        "BLOCKHKWLN": false,
        "BLOCKUKWLN": false,
        "ALERTS ADDRESS BOOK": true,
        "ALERTS BATCH PROCESSING": false,
        "ALERTS CALENDARING": true,
        "ALERTS FUNCTIONALITY": true,
        "ECHACCESS": false,
        "PMD VERSION": "5207",
        "USER ACADEMIC": true,
        "USER CORPORATE": false,
        "USER DEVELOPER": false,
        "USER GOVERNMENT": false,
        "USER INTERNAL": false,
        "USER LARGE LAW": false,
        "USER MEDIUM LAW": false,
        "USER SMALL LAW": false,
        "SIGNOFF SURVEY": false,
        "INLINE KC CASES BRIEF": false,
        "BYPASS WARN INLINE KC": false,
        "BLOCK PL ITEMS": false,
        "PRACTICAL LAW": false,
        "PRDCT PLCUK": false,
        "PRDCT PLCAU": false,
        "DISABLE PL REL CONTENT CACHE": false,
        "HISTORY UI": true,
        "EDSECTIONALLOW": false,
        "TAPSELECTED": false,
        "REDLINING": false,
        "WLNBYPASSBLOCK": false,
        "BLOCK NATIVE SIGNIN": false,
        "BLC ZONE": false,
        "CUSTOM PAGES": false,
        "CUSTOM PAGES READ": false,
        "CUSTOM PAGE ADMIN": false,
        "ELIBRARIES CP ZONE": false,
        "TYPE AHEAD": false,
        "PATRONHELP": false,
        "HISTORY RETENTION 1": false,
        "HISTORY RETENTION 180": false,
        "BLC POWERSEARCH": false,
        "PRDCT CORRECTIONAL": false,
        "EASY EDIT": false,
        "ENHANCED RB": false,
        "ENHANCED RB STICKY": false,
        "WMGRAPHICAL": false,
        "PRPTSUBSCRIBER": false,
        "BLOCK PRPT BLC": false,
        "PLCT DISPLAY LEGAL ANALYTICS": false,
        "PRPT SMALL": false,
        "PRPT CORPCOUNSEL": false,
        "PRPT LARGE": false,
        "BLOCK PRPT LARGE PAGES": false,
        "PRPT GOVT": false,
        "PRPT NONTRACKABLE": false,
        "PRPT KM LITIGATION": false,
        "PRPT KM TRANSACTIONAL": false,
        "WAYWO": false,
        "AnonymousSession": false,
        "AnonymousSessionBlock": false,
        "SOCIAL PLATFORM": false,
        "BLOCK TNP PLUS": false,
        "TNP TEPC CALC": false,
        "TNP CORTC CALC": false,
        "APFF ACCESS": false,
        "TDRC": false,
        "FPC": false,
        "FPP": false,
        "TAXHYPERION NLTR": false,
        "WCO ACCESS": false,
        "BLOCKMYSTARTPAGELINK": false,
        "TNP CEC CALC": false,
        "TNPNATLANG": false,
        "TAXNEWSCATEGORIES": false,
        "TNPDIGMCMECHAN": false,
        "TNPDIGBROWN": false,
        "TNPDIGNIKOLAKAKIS": false,
        "TNPDIGHAYHOETAXATION": false,
        "TNPDIGKERZNER": false,
        "TNPDIGSCHWARTZ": false,
        "TNPDIGINNES": false,
        "TNPDIGARON": false,
        "TNPDIGCARR": false,
        "TNPDIGGAMBLE": false,
        "TNPDIGTAXATIONOFREALESTATE": false,
        "TNPDIGBROOKS": false,
        "TNPDIGMUNRO": false,
        "TNPDIGTHAW": false,
        "TNPDIGVINER": false,
        "TNPDIGFRIEDLANDER": false,
        "TNPDIGBUTCHER": false,
        "TNPDIGALEXANDER": false,
        "TNPDIGHAYHOECASELAW": false,
        "TNPDIGHAYHOEFEDPROVLEGIS": false,
        "TNPDIGHAYHOEGOVPUBLICATIONS": false,
        "TNPDIGJOLIN": false,
        "TNPDIGSTILLABOWER": false,
        "TNPDIGCASESINDEXCITATOR": false,
        "TNPDIGSEGUIN": false,
        "TNPDIGWISE": false,
        "TNPDIGBOWEN": false,
        "TNPDIGBISCOTT": false,
        "TNPDIGEDMUNDS": false,
        "TNPDIGMANNGUIDETOREVIEW": false,
        "TNPDIGCOMPILATIONENGAGEMENTS": false,
        "TNPDIGGUIDETOESTATEANDTRUSTS": false,
        "TNPDIGITIZATION": false,
        "TNPLITIGATOR": false,
        "TNPCROSSREFFILTER": false,
        "RESULTLISTEASYEDIT": false,
        "RESULTLISTQDRAFT": false,
        "DISPLAY TEST PREF TAB": false,
        "BlindLog": false,
        "EncryptLog": false,
        "MASS EMAILER": false,
        "ADCVERREDLININGTOGGLE": false,
        "ENVHEALTHSAFETYPRACPG": false,
        "INSURCOMPLIANCEPRACPG": false,
        "BLOCK WLN PATRON": false,
        "DSP INT HEADNOTE INFO": false,
        "PRDCT WLNLINKS": false,
        "GAO LH PDFS OPEN IN LINKS": false,
        "WLNLINKS UK": false,
        "BLOCK WLNLINKS EMBEDDED LINKS": false,
        "BLOCK LICENSE AGREEMENT": false,
        "FIRMSTYLE": false,
        "SMART BREADCRUMB DISPLAY": false,
        "IRS WLN PAGE": false,
        "FORMSAUTOSHAREOFF": false,
        "WLNPLTRACK": false,
        "WLNPL GOVTHOMEPAGE": false,
        "WLNPL CORPHOMEPAGE": false,
        "WLNPL DEFAULTHOMEPAGE": true,
        "ENABLE-LEGI-GOV-LINKS": false,
        "ENABLE BAILII LINKS": false,
        "BLOCK SHARE NOTE LINK": false,
        "BLCCAN ZONE": false,
        "BLCCAN SUBSCRIBER": false,
        "BLOCKBLCCAN": true,
        "BLOCKBLC": false,
        "WM SEARCH RESULTS": false,
        "WMHK SEARCH RESULTS": false,
        "WMAU SEARCH RESULTS": false,
        "TAX PWC USER": false,
        "TAX KPMG USER": false,
        "COPY USER DATA": false,
        "ASSIGNCLIENTFILE": false,
        "RESEARCH REPORT": false,
        "FOLDER ANALYSIS": false,
        "FOLDER ANALYSIS ADDL CONTENT": false,
        "TIME ZONE AUSTRALIA": false,
        "TIME ZONE NEW ZEALAND": false,
        "EY WLN PAGE": false,
        "FOLDER DESCRIPTION": false,
        "ENABLE CONTRACT EXPRESS": false,
        "CONTRACT EXPRESS PL AU": false,
        "CONTRACT EXPRESS PL US": false,
        "ASK-EDITOR": false,
        "BLOCK OPEN WEB": false,
        "PLUK SUBSCRIBER": false,
        "WLUK SUBSCRIBER": false,
        "LIBRARY SUBSCRIBER": false,
        "CHECKPOINTDIRECTLINK": false,
        "BLOCKCHECKPOINTLINKS": false,
        "LINK BUILDER": false,
        "BCICALCULATOR": false,
        "PLUK-ENAB-ALLCONTACTS": false,
        "ALLOW ICLR": true,
        "BLOCK PROVIEW FEDERATED SEARCH": false,
        "DOC ANALYSIS": false,
        "DT DocAnalysis": false,
        "GENERATE WLUK TRANSTOKEN": false,
        "WFB USEMOCKFORMS": false,
        "BLOCKSESSIONPAUSEDISPLAY": false,
        "PWC WLN PAGE": false,
        "KPMG WLN PAGE": false,
        "CROSSBORDER DASHBOARD": false,
        "TR DISCOVER SEARCH": false,
        "VIRTUAL ASSISTANT": false,
        "BLCDEALTRACKALERT": false,
        "BLCDEALTRACKALERT BIWEEKLY": false,
        "BLCDEALTRACKALERT CONTINUOUS": false,
        "BLCDEALTRACKALERT DAILY": false,
        "BLCDEALTRACKALERT MONTHLY": false,
        "BLCDEALTRACKALERT MULTIDAY": false,
        "BLCDEALTRACKALERT WEEKLY": false,
        "EY MIGRATION POP UP": false,
        "KPMG MIGRATION POP UP": false,
        "PWC MIGRATION POP UP": false,
        "IRS MIGRATION POP UP": false,
        "TAX MIGRATE": false,
        "SEARCH TABS": false,
        "JOURNAL PURCHASE FORM": false,
        "WLUK EDITORS PICKS TAB": false,
        "LEGAL LIT ANALYTICS": false,
        "UKMATTERMAPS": false,
        "USMATTERMAPS": false,
        "DISPLAY PL MESSAGE 1": false,
        "DISPLAY PL MESSAGE 2": false,
        "GRADING TOOL": false,
        "MODERN DOC DISPLAY": false,
        "INDIGO SEARCH": false,
        "INDIGO DISPLAY": false,
        "PSEUDO BLOCK INDIGO DISPLAY": true,
        "INDIGO DISPLAY PREF": false,
        "INDIGO HOT DOCS": false,
        "INDIGO RESEARCH REPORT": false,
        "COMPARE BLACKLINING": false,
        "NOTIFICATION CENTER": false,
        "PRIOR USER INTERACTIONS": false,
        "COLD START": false,
        "TOC FOR CASES": false,
        "MATERIAL KEY FACT FILTER": false,
        "PROCEDURAL POSTURE FILTER": false,
        "FAVORITE SEARCHES": false,
        "FOLDER KEYCITE CHANGE": false,
        "FOLDER RECOMMEND CHANGE": false,
        "FOLDER RECOMMEND ALERT": false,
        "RECENT FILTERS": false,
        "SEARCH RESULT CITING REFS": false,
        "SEARCH RESULT NEG HISTORY": false,
        "QUESTIONANSWERING": false,
        "ITDEPENDS": false,
        "ITDEPENDSQUESTIONANSWER": false,
        "WLUK DOC ALERTS": false,
        "WLUK JCL ALERTS": false,
        "PA REGULATIONS STATUS FILTER": false,
        "ALWAYS CLIENT ID PROMPT": false,
        "PL US BANNER": false,
        "ANSWERS FEEDBACK": false,
        "KC IMPLIED OVERRULINGS": false,
        "ENHANCED THEME": false,
        "DOC ANALYZER TOUR": false,
        "LIT ANALYTICS TOUR": false,
        "HOME PAGE TOUR": false,
        "BUSINESS DEVELOPMENT PL US": false,
        "WLNPL SLF HOMEPAGE": false
      },
      "IsUserMigrated": false,
      "SupportedFeatures": [
        "PRACTICALLAW",
        "ALERTS",
        "BROWSE",
        "BROWSEPREVIEW",
        "CASEEVALUATORWLN",
        "CDN",
        "CLIENTID",
        "CONTACTS",
        "CONTENTTYPEDELIVERYLIMIT",
        "COREUI",
        "CUSTOMPAGES",
        "DELIVERY",
        "DOCKETS",
        "DOCUMENTORDERING",
        "DOCUMENTS",
        "DROPBOX",
        "ERRORS",
        "FAVORITESORGANIZER",
        "FINDANDPRINT",
        "FOLDERS",
        "FOLDERSEXTERNALSHARING",
        "GLOSSARY",
        "WAYWO",
        "IOS",
        "IPAD",
        "FACTORANALYSIS",
        "KEYNUMBERSEARCH",
        "KM",
        "LINKIN",
        "LINKOUT",
        "LIVECHAT",
        "MOBILE",
        "MYPLAN",
        "NYOFFICALDIGEST",
        "PRICINGGUIDE",
        "PROMOTIONS",
        "PUBLICATIONFAVORITES",
        "RELATEDINFORMATION",
        "RELATEDTOPICS",
        "REPORTSHARED",
        "REVERSEPROXY",
        "SEARCH",
        "SHAREPOINTSEARCH",
        "SHAREPOINTWIDGETS",
        "SOCIALPLATFORM",
        "SURVEY",
        "USERAGREEMENT",
        "USERDOCUMENTS",
        "USEREMULATION",
        "USERSETTINGS",
        "BANKRUPTCYEXPLORER",
        "BUSINESSINVESTIGATOR",
        "BUSINESSLAWCENTER",
        "CASENOTEBOOK",
        "DUNANDBRADSTREETBUSINESS",
        "EXPERIANBUSINESSCREDIT",
        "EXPERTDUEDILIGENCE",
        "EXPERTEVALUATOR",
        "MATTERBENCHMARKING",
        "RECENTHISTORY",
        "WEB2MASHUP",
        "AUTHORITYCOMPILER",
        "SEARCHTEMPLATEPREVIEW",
        "PEOPLEMAP",
        "PUBLICRECORDS",
        "DOCKETGATEWAY",
        "WEBCONTENT",
        "PROFESSIONAL",
        "SUGGESTEDDOCUMENTS",
        "EMBEDDEDTEXT",
        "PRODUCTVIEW",
        "PRIVATEFILES",
        "STATEQACOMPARE",
        "SOURCELINK",
        "PMDPROTECTEDCONTENT",
        "ROADRUNNER",
        "REDLINE",
        "SUPERBROWSE",
        "TOCREPORTVIEW",
        "DATACOMPARISONREPORT",
        "GRAPHICALFACETS",
        "COPYUSERDATA",
        "SHAREDNOTES",
        "RESEARCHACCELERATOR",
        "WEBINARS",
        "READINGMODE",
        "ANALYTICS",
        "HIDESEARCHTERMHIGHLIGHTINGPREFERENCE",
        "MONETIZATION",
        "SHOWDOCUMENTANALYZEROVERVIEWPREFERENCE",
        "SHOWLITANALYTICSOVERVIEWPREFERENCE",
        "SHOWHOMEPAGEOVERVIEWPREFERENCE",
        "FOUNDATION"
      ],
      "ActiveBrowserPingInitialWaitInMinutes": 3,
      "ActiveBrowserPingFrequencyInMinutes": 3,
      "ShowClientIdToast": false,
      "DataRoomFeatures": [],
      "SocialPlatformProductId": "140",
      "MaxFileUploadSize": 157286400,
      "SnapEngageScriptUrl": "",
      "DeliveryQueueQueried": false,
      "DeliveryQueueTotal": 0,
      "DeliveryQueueInProgress": 0,
      "DeliveryQueueDocketsInProgress": 0,
      "DeliveryQueueInError": 0,
      "DeliveryQueueNotification": 0
    },
    "WidgetDomIds": {
      "FooterDivId": "co_footer",
      "ErrorSummaryWidget": "coid_website_errorsSummaryPlaceHolder",
      "DockWidget": "co_dockContainer",
      "RecentFoldersWidget": "co_recentFoldersContainer",
      "RecentHistoryWidget": "co_recentHistoryContainer",
      "FrequentFavoritesWidget": "co_frequentFavoritesContainer",
      "AlertsCenter": "co_alertsCenterContainer",
      "ClientIdWidget": "co_clientIdContainer",
      "SignOff": "co_signOffContainer",
      "WhatIsNext": "co_whatIsNextContainer",
      "SearchWidget": "coid_website_searchWidget"
    },
    "RedirectError": {
      "Show": false
    },
    "DomStorageHasBeenCleared": false,
    "LiveChat": {
      "Show": false,
      "Options": {
        "QueueNumber": 0
      }
    },
    "WelcomeLightbox": {
      "Show": false
    },
    "SyncInitiated": false,
    "SyncCapable": false,
    "SubscriptionRenewalBanner": {
      "Show": false
    },
    "IsBusinessLawCenter": false
  },
  "TabScripts": {
    "DocSource": "f1d366ef84a64f21a20e2feca7ddaa1a",
    "DocGuid": "Ic0acd4ce445311dea82ab9f4ee295c21",
    "NavigationPath": "Search/v1/results/navigation/i0ad604ab000001630667802a2028f1f7?Nav=CUSTOMDIGEST&fragmentIdentifier=Ic0acd4ce445311dea82ab9f4ee295c21&startIndex=1&contextData=%28sc.CustomDigest%29&transitionType=CustomDigestItem",
    "ListSource": "Search",
    "List": "CUSTOMDIGEST",
    "Rank": 326,
    "DocumentVersionNumber": 0
  }
};


window['Server/KM'] = {
  "SessionId": "",
  "FirmName": "",
  "FirmLogoUri": "",
  "FirmWelcomeUri": "",
  "Protocol": "http"
};


window['Server/Configuration'] = {
  "CompartmentName": "WestlawNext",
  "CookieDomain": "next.westlaw.com",
  "EnableIpad": false,
  "EnableIphone": false,
  "IsIPadAppRenderingMode": false,
  "IsIPhoneAppRenderingMode": false,
  "IOSNativeVersion": "0.0.0",
  "EnableSync": false,
  "EnableDeliveryQueue": true,
  "EnableDeliveryWidget": true,
  "ProductName": "WestlawNext",
  "ProductDisplayName": "Westlaw",
  "ProductDisplayDelimiter": "|",
  "ProductViewName": "none",
  "DailyDeliveryLimit": -1,
  "DailyDeliveryCount": -1,
  "SessionDeliveryLimit": 20,
  "SupportedAlertTypes": [
    "WestClip",
    "KeyCite",
    "DocketAlert",
    "DocketTrack",
    "DealTrack",
    "PublicationAlert",
    "Newsletter",
    "BusinessInvestigator",
    "CourtWire",
    "BusinessLawCenterAlert",
    "PeopleMap",
    "CapitolWatchTrack"
  ],
  "EnableDataRoomAlerts": true,
  "GlobalizationKeyMode": "Default",
  "IsAnonymousSession": false,
  "EnableAccessibleLightbox": true,
  "EnableContactsPaging": true,
  "IsCrawlerSession": false,
  "IsGlobalizationI18NLocaleEnabled": false,
  "IsGlobalizationI18NLibraryLookupEnabled": true,
  "IsProcessCategoryPagesWithDifferentLocalesOn": false,
  "OverrideResultsPerPage": 0,
  "UseExpandableToc": true,
  "Locale": "en-US",
  "IsSmartFoldersEnabled": true,
  "IsFeatureOverlayEnabled": true,
  "IsTRDiscoverEnabled": true,
  "IsVideoTourEnabled": true,
  "IsBestPortionNavigationEnabled": true,
  "UsePageHeaderV2": true,
  "UseTypeAhead": true,
  "UseSnapshots": true,
  "IsBriefAnalyzerEnabled": true,
  "IsChargeableByDefaultForSession": true,
  "IsIssueFinderEnabled": true,
  "IsWestlawAnswersEnabled": true,
  "IsSharedHighlightsEnabled": true,
  "IsRealTimeNotificationEnabled": true,
  "EnableA11YLightboxKeyboardScroll": true,
  "IsA11YRedesignedHeaderEnabled": true,
  "IsA11YPreferencesLightboxEnabled": true,
  "SpeechToTextCustomizationIdOverride": "default",
  "InfrastructureAccessControls": [
    "iac-a11y-asbuilder-tmpl",
    "iac-a11y-header-redesign",
    "iac-accessible-clientid-widget",
    "iac-add-timezone",
    "iac-alert-admin-settings",
    "iac-alert-ny-sct-hourly",
    "iac-alerts-cal",
    "iac-alerts-customerinfo-olc",
    "iac-alerts-cw",
    "iac-alerts-docket-guid",
    "iac-alerts-productaware-history",
    "iac-alerts-standart-email-format",
    "iac-all-citations",
    "iac-allow-robots-indexing-sitemap-wln",
    "iac-analyticsclientidfeaturesenabled",
    "iac-analytics-related-filings",
    "iac-annotation-filtering",
    "iac-anonymous-cdn",
    "iac-appcommand",
    "iac-asm-policy",
    "iac-au-compartments",
    "iac-au-seo",
    "iac-autosuggest-au",
    "iac-batch-getsynopsis",
    "iac-bestlaw-tracking",
    "iac-blc-filersearch",
    "iac-blc-fs-next",
    "iac-blc-redlining",
    "iac-blc-ri-agreementsenh",
    "iac-blc-ri-newpathway",
    "iac-blc-ri-privateequity",
    "iac-blind-encrypted",
    "iac-blind-encrypted-header-enabled",
    "iac-block-uk-westlaw",
    "iac-blt-alertfulltext",
    "iac-blt-alert-type-mna-trans",
    "iac-blt-alert-type-sec-insider",
    "iac-blt-alert-type-sec-noninsider",
    "iac-blt-feature18",
    "iac-blt-feature3",
    "iac-blt-hoovers",
    "iac-blt-incorporationdata",
    "iac-blt-news",
    "iac-blt-oct2014-release",
    "iac-blt-officerlinks",
    "iac-blt-report-advisors",
    "iac-blt-securities",
    "iac-blt-securities-alerts",
    "iac-blt-subsidiaries",
    "iac-blt-table-sections",
    "iac-blt-tagged-sections",
    "iac-blt-tickercik",
    "iac-blt-webkitpdf",
    "iac-blt-xmlmindrtf",
    "iac-businesslawcenter-tdr",
    "iac-canadian-content",
    "iac-casetracking",
    "iac-change-uk-ntz-clientid",
    "iac-cig-addfoldereditem",
    "iac-cig-facet-orphan",
    "iac-cig-group-orphan",
    "iac-cig-orphan",
    "iac-cig-orphan-ind",
    "iac-cig-report-orphan",
    "iac-ci-resultlist",
    "iac-citation-reordering",
    "iac-client-chargeable-by-default",
    "iac-clientid-new-validation",
    "iac-concourselibrary-wln",
    "iac-content-finder",
    "iac-correct-dock-user-property-value",
    "iac-courtexpress",
    "iac-cpet-browseparts-novus",
    "iac-cr-effective-date-display",
    "iac-crossborder-dashboard",
    "iac-crossborder-itg",
    "iac-display-applied-filter-names-on-ssp",
    "iac-display-recent-items",
    "iac-docanalyzer-caselc-atlaslc",
    "iac-docanalyzer-cited-statutes",
    "iac-docanalyzer-filter",
    "iac-docanalyzer-footnotes",
    "iac-docanalyzer-rdintegration",
    "iac-docanalyzer-relevantportion",
    "iac-docanalyzer-secondarysources",
    "iac-docanalyzer-statutes",
    "iac-docanalyzer-ui-march-release",
    "iac-doc-medical-entities-link-out",
    "iac-docversioning-wln",
    "iac-dpa-browse-juris-landing-pg",
    "iac-dpa-curated",
    "iac-dpa-delivery-watson-answer",
    "iac-dpa-enforcementmap",
    "iac-dpa-featured-content",
    "iac-dpa-keyword-newjurs",
    "iac-dpa-keyword-novus",
    "iac-dpa-knowledgegraph",
    "iac-dpa-related-concepts",
    "iac-dpa-usabilla",
    "iac-dpa-watson-v11",
    "iac-dpa-watson-v12",
    "iac-dr-client-missed",
    "iac-dtp-bankruptcy-claims",
    "iac-dtp-dktptynmtbl",
    "iac-dtp-experts",
    "iac-dtp-openweb",
    "iac-dyn-stem-exceptions",
    "iac-enable-news-summary-alerts-delivery",
    "iac-enacted-legislation-link",
    "iac-enhanced-search-term-tooltip",
    "iac-factoranalysis-history",
    "iac-fa-searchbilling",
    "iac-fastdom-standarddocument",
    "iac-feature-overlay",
    "iac-findandprint",
    "iac-firmlibrary-wln",
    "iac-foldering-get-descendants-new",
    "iac-folderingshareacrossorgs",
    "iac-forcesignon-orphansession",
    "iac-gateway-do",
    "iac-get-renewalandtrialdata",
    "iac-grantonlyfacsinsessionbindings",
    "iac-guid-chasing-disable",
    "iac-hide-docket-monthly-frequency",
    "iac-hide-territorial-options",
    "iac-historical-datacorrections",
    "iac-image-module",
    "iac-improved-navigation",
    "iac-indigo-coldstart",
    "iac-indigo-cpet-browseparts",
    "iac-indigo-display-pref",
    "iac-indigo-fav-searches",
    "iac-indigo-folder-kc-change",
    "iac-indigo-folder-recommend-change",
    "iac-indigo-hot-docs",
    "iac-indigo-notification-center",
    "iac-indigo-paymenttype",
    "iac-indigo-pui",
    "iac-indigo-recent-filters",
    "iac-indigo-research-report",
    "iac-indigo-statutes-compare",
    "iac-indigo-typeahead",
    "iac-inlinehtmldelivery-dockettrackalert",
    "iac-internationalfind",
    "iac-ios-newadvancedsearch",
    "iac-ip2-markman",
    "iac-ip-trademark-viennacode-facet",
    "iac-itdepends",
    "iac-itg-tab",
    "iac-kc-alerts-patents",
    "iac-kc-citing-references",
    "iac-kc-citing-refs-enhanced-sw",
    "iac-kc-flags",
    "iac-kc-flags-green-c-by-boolean",
    "iac-kc-judicial-history",
    "iac-kc-negative-treatment",
    "iac-kc-rules-affected-by",
    "iac-kc-statutes-affected-by",
    "iac-kc-table-of-authorities",
    "iac-kc-validity",
    "iac-kc-wave-the-white-flag",
    "iac-keycite-nod-redesign-old-rels",
    "iac-keycite-sort-by-court-level",
    "iac-keynumber-facets",
    "iac-km-aliveserverconnection",
    "iac-km-fiacctprefs",
    "iac-la-case-outcomes",
    "iac-la-case-types",
    "iac-la-courts",
    "iac-la-delivery",
    "iac-la-law-firms",
    "iac-linkbuilder-docandcatpages",
    "iac-linkbuilder-searchresultspages",
    "iac-linkbuilder-topic-search",
    "iac-linkouturl-pubandserial",
    "iac-log-prdct-wlus-deny",
    "iac-lt-dpa-watson-integration",
    "iac-master-page",
    "iac-mattermaps-deliver-image",
    "iac-mattermaps-editmap",
    "iac-matters-by-number-wln",
    "iac-medlit",
    "iac-modal-footnotes",
    "iac-modernization-wln-ios-doc",
    "iac-most-cited-sort",
    "iac-move-menus-down",
    "iac-multipart-pdf",
    "iac-new-newsletter-template",
    "iac-newsroom-images",
    "iac-non-unique-cites",
    "iac-novustimezone",
    "iac-nyofficial-digestlink",
    "iac-oversized-and-error-email-delivery",
    "iac-pa-regulations-status-facets",
    "iac-partytype-checkbox",
    "iac-patron-category-page",
    "iac-pdf-multipart-check",
    "iac-planz-application-enabled",
    "iac-plconnect-tasks-and-synonyms",
    "iac-plconnect-tasks-ux-redesign",
    "iac-plc-rss-feeds",
    "iac-plct-crossclientid",
    "iac-plct-crossproductclientid",
    "iac-plct-globalsearch",
    "iac-plct-linkbuilder",
    "iac-plct-smalllawfirmmgmt",
    "iac-plct-ssrulebooks",
    "iac-plct-startupssmallbus",
    "iac-plct-viewalltasks",
    "iac-plc-viewonlydraftingnotes",
    "iac-plc-waywo",
    "iac-plplus-application-enabled",
    "iac-plplus-calendar",
    "iac-pl-scrollissues",
    "iac-pluk-asset-page-enable-wln-links",
    "iac-pluk-cdn-available-for-ip",
    "iac-plus-clientidinsession",
    "iac-plus-clientidpromptpltowl",
    "iac-plus-documentononepage",
    "iac-plus-feedback",
    "iac-plus-homebanner",
    "iac-plus-knowhowbooleanquery",
    "iac-plus-linkbuilder",
    "iac-plus-notesformating",
    "iac-plus-searchcontext",
    "iac-plus-truncatejurinsearch",
    "iac-plus-unhideannotations",
    "iac-plus-viewmorelessdetails",
    "iac-portalmanager-combined",
    "iac-portalmanager-contentlinks",
    "iac-portalmanager-findbypartyname",
    "iac-portalmanager-search",
    "iac-practical-law-display-changes",
    "iac-practicallaw-itg-dropdown",
    "iac-practical-law-subheadings",
    "iac-practiceareas-asterisknote",
    "iac-practicepoint-smartsearch-onesynonym",
    "iac-practicepoint-smartsearch-synonyms",
    "iac-practicepoint-smartsearch-treatises",
    "iac-practitioner-insights-alerts-no-logo",
    "iac-pr-add-bing",
    "iac-pr-addfoldereditem",
    "iac-pr-entity-extraction",
    "iac-pr-fein-plus3",
    "iac-price-guide-link",
    "iac-pricing-guide-redirect",
    "iac-privacy-policy",
    "iac-pr-polkrpt",
    "iac-pr-qsentrpt",
    "iac-pr-section-delivery",
    "iac-pr-ssn-only-search",
    "iac-pr-use-pipl-v5",
    "iac-public-record-prod-gateway",
    "iac-public-records",
    "iac-public-records-alerts",
    "iac-public-records-firstamerican",
    "iac-public-records-report-excel-delivery",
    "iac-public-records-report-filtering",
    "iac-pubrec-real-time-monitor",
    "iac-qanda",
    "iac-qanda-pinpoint",
    "iac-qanda-typeahead",
    "iac-raise-document-limit",
    "iac-ra-no-rank1docs-cache",
    "iac-remove-nyor-hard-coded-collections",
    "iac-remove-securedatatoken",
    "iac-research-accel",
    "iac-research-accel-synopsis",
    "iac-ri-bill-activity",
    "iac-ri-bill-tracking",
    "iac-ri-capitol-watch",
    "iac-ri-category-delivery",
    "iac-ri-citestyles-endpoint-v2-enable",
    "iac-ri-context-analysis",
    "iac-ri-editorial-materials",
    "iac-ri-filings",
    "iac-ri-fnd-newpathway",
    "iac-ri-form-families",
    "iac-ri-legislative-timeline",
    "iac-ri-no-single-rn-uds-post",
    "iac-ri-notes-of-decisions",
    "iac-ri-opinions",
    "iac-ri-professional-references",
    "iac-ri-reduce-uds-rn-data",
    "iac-ri-topics",
    "iac-ri-versions",
    "iac-sb-list-items-delivery",
    "iac-search-como-group1",
    "iac-search-como-group2",
    "iac-search-como-group3",
    "iac-search-como-group4",
    "iac-search-como-group6",
    "iac-search-como-group7",
    "iac-search-como-group8",
    "iac-search-como-public-records",
    "iac-search-como-recodocs",
    "iac-search-como-reghist",
    "iac-search-custom-nyor-reranking",
    "iac-search-delivery-group1",
    "iac-search-delivery-group2",
    "iac-search-delivery-group3",
    "iac-search-delivery-group4",
    "iac-search-delivery-group5",
    "iac-search-firmcentral",
    "iac-search-knowhowrankoption",
    "iac-search-matterroom",
    "iac-search-nl-thresholding-option",
    "iac-search-pmd-result-types",
    "iac-search-result-duplicate-identifier",
    "iac-search-suggestions",
    "iac-search-within-favourites-plcuk",
    "iac-searchwithin-ios",
    "iac-shared-highlights",
    "iac-share-folders-with-cobalt-contacts",
    "iac-sharing-with-the-same-domain",
    "iac-show50statesurvey-inlineflags",
    "iac-small-law-survey-redirect",
    "iac-smartbreadcrumb-add-navid",
    "iac-smartbreadcrumbs-au",
    "iac-smartfolders-ss",
    "iac-snapshots-state",
    "iac-snowdonia-beta",
    "iac-sortoption-courtlevel-pref",
    "iac-starpages-plcuk",
    "iac-staticqa",
    "iac-staticqa-history",
    "iac-staticqa-searchbilling",
    "iac-statutes-new-ast-pdfs",
    "iac-superbrowse-mult-gradeheads",
    "iac-superbrowse-paging",
    "iac-taxpage-eylogo",
    "iac-term-frequency-sorting",
    "iac-transfer-content",
    "iac-trd-alternate-search",
    "iac-trd-juris-facet",
    "iac-trd-legalanalytics",
    "iac-trd-lpafacet-subsearch",
    "iac-trillium-crsw-doc-enhance",
    "iac-trillium-link",
    "iac-uk-a11y-clientid-lightbox",
    "iac-uk-clientid",
    "iac-uk-compartments",
    "iac-uk-fd-and-fs",
    "iac-uk-keywordfinder",
    "iac-uk-linkbuilder",
    "iac-uk-linkbuilder-copy",
    "iac-uk-nonpltracking",
    "iac-uk-performance-new-static-content-or",
    "iac-unlink-unmigrated",
    "iac-use-new-training-user",
    "iac-userdoclink-wln",
    "iac-us-knowhow-algorithm",
    "iac-v3inapplibrary",
    "iac-validity-highlighting",
    "iac-verify-eaddress-against-existance",
    "iac-webinars",
    "iac-website-throttle",
    "iac-westsearch-cases-keynumberfacet",
    "iac-westsearch-cases-partyfacet",
    "iac-westsearch-cases-synopsis",
    "iac-westsearch-cases-topicfacet",
    "iac-westsearch-enhancements",
    "iac-without-flash-dependencies",
    "iac-wln-cig-linkedreport",
    "iac-wlndoc-sharednotes",
    "iac-wln-global-search-judicial-chambers",
    "iac-wln-historicalheader",
    "iac-wln-ios-display-toa",
    "iac-wln-newfiletype",
    "iac-wlnopenweb-serverbrowsepage",
    "iac-wln-ri-tabs",
    "iac-wln-save-snippet",
    "iac-wln-strong-downgrade-email",
    "iac-wlntax-blue-flag",
    "iac-wln-toc-keyciteflag",
    "iac-wl-startpage",
    "iac-wl-striphash",
    "iac-wordsphrases-snippet-support"
  ],
  "IsTypeAheadNewUiEnabled": true,
  "ContactsPageSize": 300,
  "ShowPrivacyPolicy": true,
  "ShowCookiePolicy": true,
  "ResearchReportDocumentLimit": 1000,
  "IsSaveSnippetEnabled": true,
  "IsHideAnnotationsSharedByInactiveUsersEnabled": true,
  "AllowPauseOnLinkOut": true,
  "IsMaintainDocumentPositionRIEnabled": true,
  "IsFormsEngine2Enabled": false,
  "IsFormsEngine2DownloadEnabled": false,
  "IsIndigoDisplayEnabled": false
};


window['Server/Mobile'] = {
  "IsNativeIPad": false,
  "IsNativeIPhone": false
};


window['Server/Messages'] = {
  "ProductName": "Westlaw",
  "ProductSupportNumber": "1-800-WESTLAW (1-800-937-8529)"
};


window['Server/Net'] = {
  "PageContextData": "(sc.CustomDigest)",
  "CacheScopeList": [
    "^/RelatedInfo/v[3456]/keycite/content/",
    "^/RelatedInfo/v3/content/json/",
    "^/RelatedInfo/v1/wlncCaselawHistory\\\\?",
    "^/RelatedInfo/v1/wlncCitingReferences\\\\?",
    "^/RelatedInfo/v1/wlncCourtDocs\\\\?",
    "^/RelatedInfo/v1/wlncLegalMemos\\\\?",
    "^/RelatedInfo/v1/kcJudicialHistory\\\\?",
    "^/RelatedInfo/v1/kcCitingReferences\\\\?",
    "^/RelatedInfo/v1/riFilings\\\\?",
    "^/RelatedInfo/v1/kcNegativeTreatment\\\\?",
    "^/RelatedInfo/v1/kcTableOfAuthorities\\\\?",
    "^/RelatedInfo/v1/kcBillDrafts\\\\?",
    "^/RelatedInfo/v1/kcLegislativeMaterials\\\\?",
    "^/RelatedInfo/v1/kcRegulatoryHistory\\\\?",
    "^/RelatedInfo/v1/kcValidity\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnAgreements\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnAgreementsTwoStep\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnSecCommentLetters\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnSecCommentLettersTwoStep\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFilingsAndDisclosures\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFilingsAndDisclosuresTwoStepViaMA\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFilingsAndDisclosuresExhibits\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFilingsAndDisclosuresExhibitsTwoStep\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFilingsAndDisclosuresExhibitsTwoStepViaMAAndFD\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnMergersAndAcquisitions\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnMergersAndAcquisitionsEnhanced\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnMergersAndAcquisitionsEnhancedTwoStep\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnMergersAndAcquisitionsRelated\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnRandPTransactionFullTextCategory\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnRandPTransactionFullTextCategoryTwoStep\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFilingFullTextCategory\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFundsInvestments\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFundsInvestmentsV2\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFundsInvestmentsTwoStepViaMA\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFundsInvestmentsTwoStepViaFDAndMA\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnPefundsFundsFirms\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnAgreementsEnh\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnAgreementsEnhTwoStep\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnAgreementsEnhTwoStepViaMA\\\\?",
    "^/RelatedInfo/v1/tnpCases\\\\?",
    "^/RelatedInfo/v1/tnpCommentary\\\\?",
    "^/RelatedInfo/v1/tnpCompliance\\\\?",
    "^/RelatedInfo/v1/tnpGovernmentDocuments\\\\?",
    "^/RelatedInfo/v1/tnpHistory\\\\?",
    "^/RelatedInfo/v1/tnpHistoryAndTreatments\\\\?",
    "^/RelatedInfo/v1/tnpLegislation\\\\?",
    "^/Search/v1/search/external/results",
    "^/Search/v3/search/results",
    "^/Search/v1/results",
    "^/Document/v1/fulltext/",
    "^/Document/v1/list/fulltext/",
    "^/Document/v1/Mobile/FullText/",
    "^/Document/v1/fixedheader/",
    "^/Document/v1/list/fixedheader/",
    "^/Document/v1/list/Mobile/Fulltext/",
    "^/Document/v[12]/MetaInfo/"
  ],
  "SessionScope": "7f37bc759ec9f9864b92cef6ac1b964c4cf54544f9347b0fcb95acf38263c8f1",
  "UserScope": "5405685",
  "CacheScope": "c5c0d2db6e55df6121cad08f66637027"
};


window['Server/Events'] = {
  "PageEventIdentifier": "510d732479de4fceb07b33749223ee34",
  "PageName": "Cobalt.Website.ServerPage.Document",
  "ResourceToken": "v1|9af691d51c0b05c065025f6b406b80663e5430b7bc449a44786ed75ed3ea5721"
};

</script>


	
	

<!-- View Path: ~/Document/Views/DocumentTabView.cshtml -->
<script type="text/javascript">
window.__viewName = '~/Document/Views/DocumentTabView.cshtml';
</script>
<script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="https://ja.next.westlaw.com/StaticContent_40.1.1015/webpack/Products/WestlawNext/webpack-loader.js"></script>

	

<div id="co_searchDisableDiv" class="co_screenOverlay co_hideState"></div></body></html>